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ABSTRACT 
 
 
The G protein coupled receptor (GPCR)-kinase (GRK) interacting protein 1 
(GIT1) is a multidomain protein that plays an important role in cell adhesion, motility, 
cytoskeletal remodeling, and membrane trafficking.  GIT1 mediates the localization of 
p21-activated kinase (PAK) and PAK-interactive exchange factor (PIX) to focal 
adhesions, and its activation is regulated by the interaction between its C terminal 
paxillin-binding domain (PBD) and the LD motifs of paxillin.   
 
In this dissertation, we determined the solution structure of rat GIT1 PBD by 
nuclear magnetic resonance (NMR) spectroscopy.  The PBD folds into a four-helix 
bundle, which is structurally similar to the focal adhesion targeting (FAT) domain and the 
vinculin tail (Vt) domain.  The PBD is more stable than the FAT domain and there is no 
evidence of helix 1 swapping.   
 
Previous studies showed that GIT1 interacts with paxillin through the LD4 motif.  
However, studies in this dissertation demonstrated that in addition to the LD4 motif, the 
GIT1 PBD can also bind to the paxillin LD2 motif; and both LD2 and LD4 motifs 
competitively target the same site on the PBD surface.  This dissertation also probed the 
function of paxillin splice variants by comparing their interaction with GIT1 PBD.  It 
seems the paxillin isoforms did not play an important role in determining the affinity to 
GIT1.  We also revealed that paxillin S272 phosphorylation does not influence GIT1 
PBD binding in vitro.  These results are in agreement with the notion that 
phosphorylation of paxillin S272 plays an essential role in regulating focal adhesion 
turnover. 
 
This dissertation also computationally derived the complex structures of GIT1 
PBD bound with either LD2 peptide or LD4 peptide, based on the experimental binding 
site information.  The LD2 and LD4 peptides bound to GIT1 PBD in a manner similar to 
the crystal structure of FAT-LD2 complex.  The complex structures visualized the reason 
why both LD2 and LD4 can bind to the same GIT1 binding site.  It also addressed the 
specificity problem in determining paxillin binding to GIT1 versus FAK.  
 
Our finding reconciles the controversial observations of earlier studies and 
provides a clearer picture of focal adhesion regulation.  The structural studies of GIT1 
PBD presented in this dissertation shed more light on the understanding of GIT functions.  
The novel findings also allow us to propose a working model regarding FA disassembly.   
 v
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CHAPTER 1.  INTRODUCTION 
 
 
1.1 Overview of the dissertation 
 
Focal adhesion plays a central role in cell attachment and migration; it controls 
embryogenesis, tissue repair, inflammatory response and tumor invasion.  GIT1 is one of 
the important components in focal adhesions.  This dissertation focuses on the structural 
and functional study of GIT1 and discusses the focal adhesion regulations through some 
novel discoveries.  To briefly outline the dissertation, Chapter 1 introduces the biological 
background of Focal Adhesion and its major components. Chapter 2 describes the 
techniques used in the study, including NMR based structure determination and 
interaction study as well as computational complex structure modeling. Chapter 3 
illustrates the GIT1 PBD structure determined by solution NMR and presents some 
insights into the GIT1 interactions.  Chapter 4 examines GIT1 binding specificity, 
supported by the NMR driven complex structure models.  Chapter 5 concludes the 
findings and discusses their implications into the understanding of focal adhesion 
regulations.   
 
 
1.2 An introduction to the focal adhesion (FA) 
 
The cell’s ability to adhere to an external surface and to respond to outside 
environmental cues is essential for the survival of all the life forms, ranging from 
unicellular organisms to complex multi-cellular organisms.  The simple unicellular 
organisms evolved the ability of attaching to the extracellular substrate and reacting 
correspondingly.  They can move toward the food source and away from the repellents, 
as well as change cell morphology in response to either prey or mating cells.  Similarly, 
individual cells from multi-cellular metazoans are capable of attaching to more diverse 
extracellular matrix (ECM) and reacting with more complicated behaviors.   
 
For metazoans, cell adhesion and migration is critical for embryogenesis, tissue 
repair, inflammatory response, tumor invasion and metastasis.1  In embryogenesis, 
progenitor cells migrate as sheet or loosely attached cell populations to form complicated 
tissues and organs.  In adult organisms, tissue repair depends on the migration of 
epithelial cells, fibroblasts or other connective tissue cells from the nearby healthy tissues.  
During inflammatory response, leukocytes migrate through connections between vascular 
endothelial cells into the insult area, where it executes phagocytosis, cytotoxic killing or 
organizes more effective immune responses through cytokines.  Cell adhesion signaling 
and migration also plays an important role in tumor invasion and metastasis.  Tumor cells 
can migrate out of their original site and survive the apoptosis signaling due to the loss of 
attachment.   
 
The cell-ECM attachment site is called focal adhesion (FA).  Complicated protein 
complexes at the FA carry out the function of cell adhesion and signaling.  To date, there 
are more than 50 protein components identified in FA.2,3  They are divided into three 
1 
 
 
groups by their locations: extracellular, transmembrane and cytoplasmic.3  The 
extracellular proteins are found in ECMs as FA targets, e.g. collagen, fibronectin, heparin 
sulfate and laminin.  The transmembrane proteins are mainly the integrin family members 
that mediate both physical and signaling connections between the extracellular and 
intracellular world.  Besides integrin, there are some other transmembrane proteins in the 
FA, including LAR-PTP receptor, syndecan4 and layilin.  The majority of FA 
components are located inside the cell membrane and they can be further divided into 
three groups: structural proteins, signaling proteins and adapter proteins.  Structural 
proteins include components forming cytoskeleton and those that execute movement, for 
example, actin, α-actinin, ezrin, talin, tensin and vinculin.  The signaling proteins range 
from kinases, phosphatases to small GTPase modulators, for example, FAK, Pyk2, Src, 
PAK, ILK, PTP1-B, SHP-2, GIT, PIX and PKL.  The adaptor proteins are multi-domain 
proteins mediating recruitment of other components into the FA, for example, paxillin, 
Hic-5, p130Cas, DOCK180 and FRNK.   
 
Cell attachment, migration and signaling are highly coordinated cellular functions.  
They are dynamically regulated in both temporal and spatial scales.  For simplicity, the 
cell attachment, cell migration and FA signaling will be introduced in separate sections, 
although those functions are closely interlaced.  
 
 
1.2.1 Cell attachment 
 
Cells adhere to ECM with the transmembrane ECM receptor integrin.  Cells 
migrate by securing attachments in the leading edge and extending forward by 
cytoskeleton remodeling.  At the trailing edge, the FA degrades and releases attachments 
so that the cell can move forward.  While this appears simple, in reality there is an array 
of elegantly regulated events taking place in order for the cells to attach and migrate.  
 
The first step in cell adhesion involves the interaction of peri-cellular components 
with their complementary substrate.4  The peri-cellular components are normally 
glycolproteins or glycosaminoglycan receptors, such as CD44 and galectins.5,6  The 
interactions are characterized as weak, transient, non-specific interactions.  It often 
involves multiple copies of polysaccharides binding cooperatively to achieve the 
necessary affinity.  The step occurs on at subsecond time scale and the distance between 
the cell membrane and the substrate surface is several micrometers.4  The interaction is 
transient; the cell can detach from the surface if further intergrin based tighter 
interactions can not be created.  The transient attachment is important because it creates 
the necessary time allowing integrin to approach to its specific substrate, otherwise 
simply random encounters can only result in a small fraction of stable interactions.   
 
The next step involves the development of stable, specific interactions between 
cell surface integrin and its substrates.  Integrin is a family of transmembrane receptors 
that does not contain enzymatic activity and actin binding function.  All the signaling and 
structural connection functions are mediated by other FA proteins that are recruited by 
integrin.  Under regulation of kinases and phosphatases, FA can further mature into a 
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“focal contact” through recruitment of more integrins and cytoskeleton components.  
Without maturation, FA is easily disassociated and the attachment is released.   
 
 
1.2.2 Cell migration 
 
Cell migration is the result of dynamic FA assembly and disassembly that occurs 
in cooperation with actin cytoskeleton remodeling.  It can be dissected into four steps. 
 
1. At the beginning of migration, membrane extensions such as lamellipodia and 
filopodia are developed at the leading edge of the cell.7,8  In the protrusions, small 
FA attachments form, anchoring the cell’s front edge with the ECM components.  
Since integrin links the ECM components to the actin filaments (through adapter 
proteins), the linkage physically attaches the cell cytoskeleton with the ECM. 
 
2. The polymerization of actin adds new actin protomers at the front tip of the 
cytoskeleton, pushing the plasma membrane protrusion at the lamellipodia and 
filopodia.  The membrane protrusion will be anchored by newly formed FA 
attachments (focal complexes) in front of the older ones.  
 
3. The focal complexes are weak transient cell-ECM adhesions, which can 
disassociate easily if not further stabilized.  Under intracellular and extracellular 
tensions, more integrin can be recruited into the focal complexes and more actins 
polymerize.  Thus, the FA attachments mature into a “focal contact”.  The focal 
contact is more stable and more robust, often found in stationary cells.  
Conversely, stable focal contacts are not observed in rapidly moving cells, e.g. 
leukocytes.9   
 
4. At the trailing edge, stable focal contacts disassociate to allow the movement of 
the cell body.  The dissociation is caused by focal adhesion disassembly, or focal 
adhesion turnover.  Compared to FA assembly, little is known about FA 
disassembly, although it is as important as FA assembly.  Part of this dissertation 
tries to understand the mechanism of FA disassembly.    
 
 
1.2.3 Cell signaling through FA 
 
Focal adhesions have traditionally been thought of as simple receptors that anchor 
the cell to the ECM or other cells.    However, more and more evidence has shown that in 
addition to physical linkage, FA plays critical signaling roles in regulating cell 
proliferation, survival and motility.  In particular, FA relays cellular signaling in both 
an“inside-out” and “outside-in” fashion.  In addition, FA acts as a “mechanosensor” that 
integrates mechanical cues with biochemical responses.  Also, FA signaling collaborates 
with various growth factor receptor pathways in promoting survival and proliferation.  
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1.2.3.1  Inside-out signaling  
 
Many integrins often exist in an inactive state.  The integrin cannot bind to its 
ECM ligand unless activated by signals from inside of the cell.  The regulated integrin 
activation modulates the affinity between cells and ECM, allowing cells to be motile or 
stationary according to functional needs.  For instance, the circulating platelet has high 
density surface integrins, mainly αIIbβ3 heterodimer.  However, all the integrins are in 
an inactive state without activation of the thrombotic cascade.  When the platelet is 
activated, e.g. for hemostasis, the activation signal can be sent from inside of the plasma 
membrane.  The activation of αIIbβ3 integrin leads to rapid and strong adherence to 
fibrinogen, fibronectin and von Willebrand factors, which in turn crosslink more platelets 
and form thrombosis.   
 
As transmembrane proteins, integrins have a large extracellular domain and a 
small intracellular tail for both the α and β subunits.  More structure details are reviewed 
in section 1.3.1.  Without activation, the integrin extracellular domain is in a bend 
conformation that corresponds to the inactivated state (Figure 1-1a).  During inside-out 
activation, the binding of the intracellular FA protein talin to the cytoplasmic tail of 
integrin leads to the separation of α and β subunits.  The separation of the intracellular 
domains results in a long-range transmembrane conformational change, which opens the 
integrin extracellular domain in a “switchblade” fashion.10,11  The long-range allosteric 
change exposes a new binding interface, and the integrin is fully activated.  The exposed 
epitope is termed ligand induced binding site (LIBS).   
 
 
1.2.3.2 Outside-in signaling 
 
The outside-in signaling is the classic function of FA, by which the cell detects 
the chemical environment.  The engagement of integrin extracellular domain to the ECM 
component can deliver the information, such as the chemical nature of the ECM 
components and their density, into the plasma membrane and allow the cell to respond 
correspondingly.  Thus, FA can function as chemical sensors by outside-in signaling. 
 
The same allosteric conformational change occurs when the extracellular 
substrate binding domain is occupied by the ECM component.  The interaction stabilizes 
the integrin extracellular domain, locking the intracellular tails in a separated active state 
(Figure 1-1b).  Thus, this conformational change promotes the interactions between the 
integrin cytoplasmic tail and the complex FA signaling and structural proteins, e.g. talin.  
Actually, this allosteric change is bidirectional and reciprocal.  The inside-out and 
outside-in signaling should be viewed as the two aspects of a single allosteric change.  
The binding of either ECM components or the intracellular FA components can stabilize 
integrin in an active form, facilitating the interaction at the other side. 
 
During FA maturation, more integrins participate in the crosslinking and 
clustering, forming stable focal contacts.   Upon “outside-in” activation, the integrin 
cytoplasmic tails recruit many signaling molecules into the FA, including focal adhesion 
4 
 
 
  
Figure 1-1 Schematic view of integrin heterodimer and activation. 
Integrins are obligate heterodimers formed by a large extracellular domain and small 
transmembrane and intracellular domains.  The α and β subunits are colored in green 
and blue respectively.  (a) the inactive bend conformation.  (b) the active extended 
conformation.   
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kinase (FAK), Src family kinases (SFK) and integrin linked kinase (ILK).  To begin with, 
the integrin β3 tail binds talin, which recruits FAK into FA.  Upon trans-
autophosphorylation, FAK is activated and functions as a scaffold to further bring in SFK, 
activated phosphatidylinositol 3 kinase (PI3K) and extracellular signal regulated kinase 
(ERK)/ mitogen activated protein kinase (MAPK).  The cytoskeleton remodeling and 
gene transcription are regulated by more complex downstream signaling.  To name a few, 
FAK activates Rho family small GTPases, including Rac1, Cdc42, and RhoA, which 
differentially control the cytoskeleton formation and myosin contractility in both leading 
edge and trailing edge – the regulation of cell adhesion and migration.  The Rac-
RelA/NF-κB also influences gene transcription, promoting cell survival and proliferation.   
At the same time, PI3K-Akt and Ras-ERK linkages also induce transcription for survival 
and proliferation – the mechanism of FA signaling is required to initiate apoptosis when 
the cell does not adhere to the ECM. 
 
As important as FA signaling activation, the deactivation of FA signaling helps 
cells detach from the adhesion and promotes cell motility by activating focal adhesion 
disassembly at the trailing edge.  However, as the mechanism of FA activation just starts 
to unveil; how FA is deactivated remains even more mysterious.  Rac plays an important 
role in FA disassembly, either directly through its effector p21-activated kinase (PAK), 
and/or indirectly through antagonizing Rho.  One mechanism involves the recruitment of 
PAK by GIT into the FA.  Activated PAK can catalyze the disassembly of actin stress 
fibers and has been found to be the central player for FA disassembly.12-15 
 
 
1.2.3.3 FA as a mechanosensor 
 
During FA maturation, the focal complex transforms into a more stable focal 
contact by crosslinking and clustering more integrins.  It has been shown that local 
tension can reinforce the focal contacts and external forces can stimulate the growth of 
focal contacts.16,17  The size of the focal contact is proportional to the contraction force 
applied on the FA.18  Thus, in addition to detect the chemical composition of the ECM, 
FA can sense the mechanical features of the ECM too.  This is of importance for cells to 
be able to adhere and migrate successfully.  The reason is simple – only a rigid surface 
can provide cells enough force for movement.  If the integrin happens to bind a piece of 
ECM component that is floating in the solution, the ECM can not provide enough tension 
when cell myosin contracts.  Without the signal of tension, or in another word the 
confirmation of a rigid ECM surface, no further integrin clustering can occur.  So, the 
focal complexes can not mature into robust focal contacts.  Instead, the focal complexes 
will disassemble and those transient attachments are released. 
 
The mechanism for the mechanosensor function is not very clear.  One model 
states that for a molecular aggregate with external pulling tension, the new subunits tend 
to incorporate at the direction of force applied.19  The tension applied at the existing 
focal complexes can then promote the formation of new actin filaments, which then help 
crosslink more integrin, like during the formation of focal contacts. 
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1.2.3.4 Synergistic role of FA 
 
In addition to function as ECM chemosensor and mechanosensor, focal adhesion 
also plays synergistic role to many growth factor receptors.  It has been demonstrated that 
FA signaling is required for the potent efficient signaling of epidermal growth factor 
receptor (EGFR),20 the vascular endothelial growth factor receptor (VEGFR),21 and the 
platelet-derived growth factor receptor (PDGFR).22  The association of β3 integrin with 
those growth factor receptors is critical for their functions.  As illustrated in Figure 1-2, 
FA signaling shares two major downstream pathways with these growth factor signaling: 
the Ras/Raf-ERK/MAPK pathway and the PI3K-Akt pathway.23  Both of them are 
critical for anti-apoptosis and cell proliferation.  The activated ERK/MAPK promotes 
survival via both direct and indirect mechanisms – directly influencing the activity of the 
cytoplasmic apoptosis regulator bcl-2;24 or indirectly change the level of survival proteins 
p53 and bax.25  On the other hand, the activated PI3K-Akt pathway suppresses apoptosis 
by activating Mdm2 or inactivating Bad, Caspase9 or FKHR.  It also promotes growth by 
mTOR or regulates the cell cycle by GSK3.  
 
 
1.3 Focal adhesion components 
 
 
1.3.1 Integrin 
 
Integrin is a family of important transmembrane receptor proteins.  They form 
obligate heterodimers of an α and β subunits.  To date, there are 18 α subunits and 8 β 
subunits in humans.26  The heterodimer pairing is limited to certain type of subunits; the 
total number of available heterodimers is limited to 24 (Figure 1-3).  Depending on cell 
type, each cell will generally express 8 to 12 different heterodimers.  Since each α or β 
subunit is transcribed by an independent gene, the density and type of heterodimer pairs 
on a cell is determined by the transcription level of both genes.  The ligand specificity is 
determined together by both α and β subunits.   
 
Both α and β subunits are large transmembrane proteins, each of which consists 
of a large extracellular ligand binding domain, a single transmembrane domain and a 
small intracellular signaling domain (20-50 amino acids).  Currently, there are 12 integrin 
heterodimer structures available in the protein data bank (PDB) database (I checked the 
PDB online database on Jan. 19, 2008).  All of them are fragments of the extracellular 
ligand binding domain.  Among all the integrin structures, the crystal structure of integrin 
αVβ3 is by far the most complete one, which covers almost the entire extracellular 
domain (PDB ID: 1JV2, 27).  As illustrated in Figure 1-4, the entire extracellular domain 
is deeply bended, reflecting the inactive state.  The N terminal segments of both subunits 
form an ovoid “head”.  The “tail” of αV consists of three β-sandwich domains, while the 
tail of β3 consists of four EGF domains.  So far, no structure of the transmembrane 
domain and intracellular domain reported.  The reason for the difficulty in obtaining a 
structure of the intracellular domain is because of the high flexibility of this domain.   
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Figure 1-2 The synergistic role of FA and growth factor receptors. 
FA plays a synergistic role with growth factor receptors (receptor tyrosine kinases) 
through the PI3K pathway and Ras pathway.  At the same time, some receptor tyrosine 
kinases can also interact with FAK and promote the Rac pathway.  The activation of all 
the three pathways regulates genes to promote cell survival and proliferation.   
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Figure 1-3 All the 24 possible integrin heterodimer pairs.  
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Figure 1-4 The crystal structure of the extracellular domain of integrin αVβ3. 
The structure of the extracellular domain of integrin αVβ3 (1JV2, 27) illustrated by 
software Pymol.  The α and β subunits are colored green and blue respectively.  The 
schematic view of domain orientation is also colored this way.  The α subunit consists of 
the β-propeller head domain, the Thigh domain and two Calf domains.  The β subunit 
consists of the βA-domain, Hybrid domain, 4 EGF motifs and the βTD.  An oval head is 
formed by the β-propeller head domain from the α subunit βA-domain and the Hybrid 
domain from the β subunit.  The overall domain structure is deeply bent, reflecting the 
inactive state. 
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The regulation of integrin activation is discussed in section 1.2.3.  During activation, the 
bent structure opens up around the hinge region between the first and the second β-
sandwich domains of αV.  The conformational change exposes substrate binding sites 
that allow the association of integrin with its ECM target.   
 
 
1.3.2 Paxillin 
 
Identified over a decade ago,28 paxillin is one of the most important adaptor 
proteins in the focal adhesions.  Although containing no signaling activity, paxillin 
functions as a signaling hub by recruiting other proteins to integrate and disseminate 
signaling from integrins and other growth factor receptors.  It also physically participates 
in the FA-cytoskeleton connections through the interaction with actin binding protein 
vinculin and actopaxin.   
 
The N terminus of paxillin consists of five LD motifs that function as protein 
docking sites for many binding partners (Figure 1-5a).29  There are four LIM domains 
(named after Lin-11, Isl-1, Mec-3) in the C terminus that mediate protein interactions 
too.30  The LD motifs and LIM domains are modular protein interaction sites that are 
connected by flexible disordered sequences in between.  Thus the whole protein has a 
very flexible beads-on-the-string architecture.  The LD motifs are the consensus leucine-
rich LDXLLXXL sequences found to repeat five times at the paxillin N terminal half 
(Figure 1-5b).  With diverse binding specificity, the LD motifs mediate the interaction of 
paxillin to a range of target proteins (Table 1-1).  It has been demonstrated that the LD 
motifs forms amphipathic α-helices and all the leucines are exposed to one side to create 
a large hydrophobic interface.31,32  The LIM domains are tandem zinc finger motifs, 
which contains two antiparallel β-sheet pairs and a short α-helix at the C terminus.  
Cooperatively, the LIM2 and LIM3 domains mediate the localization of paxillin to FA 
and the serine/threonine phosphorylation of the two LIM domains regulates paxillin FA 
localization and cell adhesion.33,34 
 
Paxillin is conserved from yeast to vertebrates; and the higher eukaryotes express 
three paxillin splice isoforms.  While the α isoform is more ubiquitously expressed, the β 
and γ isoforms are more strictly expressed.35  The human paxillin sequences are the same 
except for an insertion of 34 or 48 amino acids right after LD4 motif for isoform β or γ.  
The protein interactions are different for the splice isoforms, for example, isoform β 
bound to FAK but weakly to vinculin; however isoform γ bound to vinculin but weakly to 
FAK.35  Since both FAK and vinculin interactions are mediated by the paxillin LD4 motif, 
the interaction differences might be caused by the insertions.  Since the paxillin-GIT1 
interaction is also mediated by LD4 motif, this interaction might also be different.  Before 
this dissertation, no study has investigated the effect of paxillin splice isoforms on the 
GIT1 interaction.     
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Figure 1-5 The domain structure of full length paxillin. 
(a) Paxillin α consists of 5 N terminal LD motifs and 4 C terminal LIM domains.  The 
sequence of paxillin β and γ are the same as the α splice variant except for an insertion 
of 34 and 48 amino acids right after the LD4 motif.  (b) the sequence alignment of human 
paxillin LD motifs.  
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Table 1-1 Summary of LD motif binding partners. 
 
LD motifs Binding partner 
LD1 Actopaxin 36 
 Intergrin-linked kinase (ILK) 37 
 Vinculin 38 
 Protein E6 from papillomavirus 39 
LD2 Vinculin 38 
 FAK 31,33 
LD3 No binding partner identified 
LD4 Actopaxin 36 
 GIT1 38 
 FAK 33 
 PAK3 40 
 Clathrin 38 
LD5 No binding partner identified 
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1.3.3 FAK 
 
The focal adhesion kinase FAK is one of the most important signal “integrators” 
in the FA.  Since its identification in 1992, FAK has been found to play critical roles in 
different physiological functions, including embryo development, immunoresponse, cell 
adhesion and cell motility.41  Also, an elevated FAK level has been linked with the 
invasion and metastasis phenotype of many malignant cells.42   
 
FAK is an ubiquitously expressed protein tyrosine kinase; about 1050 amino acids 
long and 125 KDa in molecular weight.  There are four major domains in FAK: the N 
terminal protein interaction FERM domain (protein 4.1, ezrin, radixin and moesin), the 
central tyrosine kinase domain, two proline rich regions (PRRs) and a C terminal focal 
adhesion targeting (FAT) domain (Figure 1-6).  The FERM domain mediates the 
interaction with EGFR, PDGFR, ETK and ezrin,43 which is how FAK can integrate the 
signal from both integrin and growth factor receptors and output in the FA control.  The 
central kinase domain is essential for phosphorylating many critical tyrosines in 
activating both its targets and FAK itself.  The PRRs function as SH3 binding sites for 
proteins like p130CAS, GRAF and ASAP1.  The C terminal FAT domain promotes the 
localization of FAK into FA, through the interaction with integrin binding proteins 
paxillin and talin.41   
 
Among FAK domains, the FAT is of special interests to this dissertation, because 
it shares many similarities with our target GIT1 PBD (section 1.3.4).  The FAK FAT 
domain is a four-helix bundle protein that binds paxillin through both LD2 and LD4 
motifs.31  The LD2 and LD4 motifs bind to FAT at the H2/H3 face and H1/H4 face 
cooperatively.44,45 
 
 
1.3.4 GIT 
 
The G-protein coupled receptor (GPCR)-kinase (GRK) interacting protein (GIT) 
is an important scaffold as well as a signaling protein in the FA.  It plays a critical role in 
 
 
 
Figure 1-6 The domain structure of FAK and its interacting proteins. 
The auto-phosphorylation of tyrosine 397 activates FAK and creates binding site for SH2 
proteins, like Src and Grb.   
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controlling FA disassembly.  It also controls the cytoskeleton dynamics and membrane 
trafficking between endosome and plasma membrane.  At the same time, GIT has been 
linked to Huntington’s disease and HIV infection.46-48  In all mammals and birds studied, 
there are two GIT family members: GIT1 and GIT2.  The GIT proteins are highly 
conserved within the orthologs, especially for the N terminal and C terminal regions.49  
GIT has been found to locate in membrane ruffles, focal adhesions and recycling 
endosomes. 49   
 
As shown in Figure 1-7, GIT is a multi-domain protein that contains distinct 
activities in individual domains.  The N terminal Arf GTPase activating protein (Arf-
GAP) domain exhibits GAP activity for Arf1, Arf2, Arf3, Arf5 and Arf6.50-53  By 
interacting with vesicle surface proteins and phospholipid metabolizing enzymes, GIT 
regulates membrane traffic and receptor recycling.  Then there are three ankyrin repeats 
which mediate the interaction with the endosome.54,55  Following the ankyrin repeats is 
the Spa2-homology domain (SHD).  The SHD is a tandem repeat that mediates the 
binding to many proteins, for example, the p21-activated kinase interacting exchange 
factor (PIX), MEK1 and phospholipase C γ (PLCγ).56-58  The coiled-coil domain mediates 
GIT protein homo- or heter-dimerization by a putative leucine zipper motif.59  The C 
terminal paxillin binding domain (PBD) is highly conserved.49  It mediates the interaction 
with paxillin and is required for the FA localization of the GIT complex.54,60,61  A 
structure model of GIT1 PBD was derived from small-angle X-ray scattering (SAXS) and 
homology modeling based on the FAK FAT domain.62  To date, a high-resolution 
structure of the GIT1 PBD is unavailable and the mechanism of the paxillin–GIT 
interaction remains unclear. 
 
Through the work in this dissertation, I tried to characterise the atomic structure 
of GIT1 PBD and understand the paxillin –GIT interaction, with methodology like NMR 
and Biacore surface plasma binding assay.    
 
 
 
Figure 1-7 The domain structure of full length GIT and its interacting proteins.
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CHAPTER 2.  METHODS 
 
 
2.1 Nuclear magnetic resonance (NMR) 
 
 
2.1.1 Overview of NMR spectroscopy 
 
Nuclear magnetic resonance (NMR) is a physical phenomenon describing the 
behavior of certain atoms in the presence of external magnetic fields.  In 1946, Felix 
Bloch and Edward Purcell independently discovered the nuclear magnetic resonance 
phenomenon and shared the Nobel Prize in Physics in 1952.   NMR spectroscopy was 
originally developed by Richard Ernst and Weston Anderson as pulsed Fourier transform 
NMR spectroscopy.  With this contribution, Ernst was awarded the Nobel Prize in 
Chemistry in 1991.  After six decades of work, scientists have developed NMR 
spectroscopy into a widely used technique in studying the chemical and physical 
properties of small and macro molecules.  In 2002, Kurt Wüthrich was awarded the 
Noble Prize in Chemistry for his contribution in the development of NMR to study 
biological macromolecules such as proteins.  At the same time, NMR also found an 
important application in biomedical imaging, a technique called magnetic resonance 
imaging (MRI).  In 2003, Paul Lauterbur and Peter Mansfield were jointly awarded the 
Nobel Prizes in Physiology and Medicine based on their discoveries that lead to the 
development of MRI.   
 
In the early 1980s, Prof. Wüthrich first provided the idea of sequential assignment, 
which provided the foundation for the study of biological macromolecules by NMR 
spectroscopy.  It opened a new page for its applications in Structural Biology.  Since then, 
numerous new methods and pulse sequences have been developed.  Now, NMR 
spectroscopy is one of the major techniques used in Structural Biology.  To date, there 
are 7115 structures in the protein data bank (PDB) solved by NMR spectroscopy, 
accounting for 14.4% of all structures (Table 2-1). 
 
 
Table 2-1 PDB statistics. 
Data source:  RCSB website (http://www.rcsb.org/pdb/statistics/holdings.do, accessed 
on March 4, 2008).63  Permitted to reprint. 
 
Molecule type  
Proteins Nucleic acids 
Protein/NA 
complexes Other Total 
X-Ray 39082 1018 1791 24 41915 
NMR 6168 803 137 7 7115 
EM 114 11 42 0 167 
Other 88 4 4 2 98 
Experiment 
methods 
Total 45452 1836 1974 33 49295 
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Currently X-ray crystallography and NMR spectroscopy are the two main 
techniques used in Structural Biology.  These are the only methods that are capable of 
determining biological macromolecule structure at atomic level resolution.  A 
comparison between them can help us have a better understanding of the techniques 
available to structural biologists (Table 2-2).   
 
In general, X-ray crystallography can solve a larger structure with better 
resolution.  However, this structure is static, packed in the crystal, which is like a 
snapshot of a moving object.  Sometimes, the crystal packing can artificially alter the 
structures.  On the other hand, NMR spectroscopy is capable of observing molecular 
dynamics and associated conformational equilibrium in solution. NMR spectroscopy is 
able to obtain a lot of molecular parameters, such as individual angles, distances, 
chemical shifts, coupling constants and tumbling rates. At the same time, this makes it 
difficult to interpret NMR data, since these parameters are normally observed as a mixed 
(average) signal of thousands of individual signals from a macromolecule.  Because of 
the complexity of the NMR derived data, it normally takes more time to solve a structure 
by NMR compared to X-ray crystallography.  In general, the size of a structure one can 
solve by using NMR spectroscopy is smaller than X-ray crystallography.  There are two 
reasons why NMR spectroscopy is limited by the molecule size: 1. the signal overlapping 
makes unambiguous assignment impossible; 2. the large molecule has a slower tumbling 
rate, which makes the signal decay too fast to detect (small T2). 
 
 
2.1.2 Physics behind NMR spectroscopy 
 
 
2.1.2.1 Spin 
 
Spin describes a property of subatomic particles, like electrons, protons and 
neutrons.  Each unpaired particle possesses a spin of ½.  Since they come with plus or 
minus sign, they can normally pair up and cancel out the NMR observable signal.  
However, for certain atom types, the spin of particles can not pair up, resulting in net spin.  
It is these unpaired nuclear spins that are of importance for NMR detection. 
 
Each spin possesses a micro magnetic field, which can be considered as a tiny 
magnetic moment vector.  In the absence of an external magnetic field, these micro 
magnets are randomly distributed and the total magnetic effect is canceled out.  There is 
only one energy level for the entire population.  In the presence of an external magnetic 
field, the energy distribution of the nuclei will be split into two or more levels, depending 
on how many unpaired spins. (Figure 2-1)  The population in the lower energy level (N+) 
is slightly larger than the population in the higher energy level (N-).  The ratio between 
the two populations is determined by the energy difference and temperature.  This is 
described by the Boltzmann statistics, where E is the energy difference; K is Boltzmann’s 
constant (1.3805x10-23 J/Kelvin) and T is the temperature in degrees (Kelvin). 
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Table 2-2 The comparison of NMR spectroscopy and X-ray crystallography. 
 
 NMR spectroscopy X-ray crystallography 
Sample 
preparation 
Purified stable protein in high 
concentration in a solution ideally 
with low ionic strength 
Purified protein forming single 
crystal.  Need to screen the best 
condition, which is the most 
difficult step 
Sample labeling Depends on application.  Sample 
can be 15N or 13C labeled or both.  
Deuterium labeling is required for 
some applications 
Selenium-methionine labeling is 
necessary for MAD based 
phasing 
Observing All proton atom signals Diffraction pattern of all heavy 
atoms 
Structure 
solving 
Calculated structure based on the 
distance (NOE) restraints 
Observe the 3-D position of 
heavy atoms from the electron 
density map 
Molecule size 
limit 
Normally smaller than X-ray 
method 
Can solve larger structures 
Resolution Lower Higher 
Molecule 
dynamics 
Easy to observe  More difficult to observe.  Only 
by B-factor 
Binding study Can obtain binding kinetics, 
binding affinity and binding site 
information from simple titration 
experiments 
Can only obtain the binding site 
information from solving a 
complex structure 
Number of data 
sets 
Can obtain multiple data sets from 
one sample with different pulse 
sequences.  Can be used for cross 
validation 
One data set from one crystal  
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Figure 2-1 Spin energy splitting in an external magnetic field. 
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Thus, in the presence of an external magnetic field, there is a difference in the 
spin population of different energy states.  The magnetic moment vectors can not cancel 
each other out, which results in a net magnetic moment vector.  The energy gap is 
determined by the gyromagnetic ratio, γ and the strength of the external magnetic field, 
B0.  In the following equation, h is the Planck’s constant (h=6.626x10-34 J s). 
 
E=h γ B0                                           Equation 2-2 
 
Each NMR detectable atom has a characteristic spin frequency, Larmor frequency.  
It is different according to the magnetic field strength.  The Larmor frequency is defined 
by the magnetic field strength B0 and the gyromagnetic ratio γ: 
 
ν= γ B0                                                                 Equation 2-3 
 
The actual frequency for one atom is modulated by the chemical environment of that 
atom.  It is the actual frequency that NMR spectroscopy utilizes to study the chemical 
environment of each individual atom. 
 
 
2.1.2.2 NMR signal and Fourier Transform (FT) 
 
In the presence of external magnetic field B0, the net magnetic moment vector is 
aligned with B0.  This vector can be flipped down to the plane perpendicular to B0 by 
another magnetic pulse B1.  The flipped vector will then relax back to its original position 
through a spiral processing trace.  During the relaxing, the spinning vector generates 
electron magnetic waves that can be detected by coils located in the perpendicular plane.  
Due to the vector relaxation, the detected signal decays exponentionally, generating the 
raw data called free induction decay (FID).   
 
For biological NMR, a proton is the most common atom that is directly detected.  
Each proton processes at a special frequency, because it is modulated by its unique 
chemical environment, including atoms via direct bonding and electrostatic interactions 
through space.  The FID recorded by an NMR spectrometer is a mixture of the relaxation 
signal of all the protons in the sample.  Thus thousands of individual frequencies are 
mixed and represented as the time domain data FID.  Then a mathematical operation 
called Fourier transform (FT) is used to extract the frequency data out of an FID (Figure 
2-2).   
 
FT is a mathematical method for converting time domain data to frequency 
domain data.64  An FT is defined by the function: 
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Figure 2-2 Fourier transform converts time domain data to frequency domain 
data. 
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After FT, the FID is transformed into readable frequency data, in which each peak 
corresponds to a frequency.  As the atom frequency is a function of external magnetic 
field, it is difficult to compare frequency directly if two results are coming from different 
magnetic fields.  In practice, an internal reference is used to normalize the frequencies.  
The normalized frequency is called chemical shift (δ) in the unit of ppm.   
 
610×= −
REF
REFυ
υυδ                                Equation 2-5 
 
 
2.1.2.3 NMR spectrometer and pulse sequence 
 
NMR spectroscopy is a very complex system.  This diagram is simplified to 
illustrate the most essential components in an NMR spectrometer (Figure 2-3).  A strong 
magnetic field B0 is generated by a superconducting coil in an outer shell of the 
spectrometer.  The sample is inserted into the center of B0.  It is wrapped by receiver 
coils and radio frequency (RF) coils.  A central consol controls RF pulses that manipulate 
the spins through the frequency synthesizer and RF transmitter.  When the spins in the 
sample relax back to the equilibrant state, they can release energy in the form of radio 
frequency that is detected by the receiver coils.  The analog signal is then amplified and 
converted to a digital one by the amplifiers and analog digital converter (ADC).  The 
control console passes the digitized FID to the terminal computer, allowing it to be 
converted to the frequency domain data.  The data processing and presentation are also 
accomplished in the terminal computer.   
 
Besides the above components, there are many other critical subsystems.  The 
homogeneity of the magnetic field is critical for modern high resolution NMR 
spectroscopy.  A set of small shimming coils are placed between the sample and the main 
magnetic field.  By altering the current in those coils, the field inhomogeneity can be 
compensated.  For the same reason, the magnetic field is also required to be stable over 
time.  The lock system continuously monitors the signal (frequency) of certain nuclei, 
normally deuterium in the sample.  A drift of the observed deuterium frequency is 
considered as a drift of the magnetic field.  Then the magnetic drift is corrected by 
another coil in the main magnet, in a feed-back manner.  Since most chemical and 
physical properties are influenced by the temperature, a stable sample temperature is also 
important.  The temperature is precisely regulated by a heated gas system.   
 
A computer controls the spectrometer through programmed RF pulses called 
pulse sequences.  A typical pulse sequence consists of preparation, mixing and  
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Figure 2-3 Components of an NMR spectrometer. 
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acquisition time (Figure 2-4).  In the preparation, the spins are excited, preparing them to 
evolve during the following mixing stage.  Depending on the specific pulse sequence, the 
mixing time may be present or absent.  During the mixing time, different spin terms are 
allowed to evolve under the control of pulses.  At the end of the mixing time, normally a 
‘read’ pulse is used to prepare the spins for detection.  During the acquisition, the signal 
from the spins is detected by the coils in the plane perpendicular to the main magnetic 
field.  The detected raw data is the FID that can be converted to the frequency domain 
data.   
 
A multi dimensional pulse sequence is based on the simple one dimensional 
sequence (Figure 2-4b).  The difference is that for the multi dimensional sequence there 
is a mixing time that is variable for each scan.  The mixing time increases equally during 
the course of a multi dimensional NMR experiment.  It allows the coherence transfers to 
the acquisition stage to be recorded.  For each variable mixing time, the same pulse 
sequence is executed to record multiple FIDs.  This will generate an array of 1D NMR 
spectra that is modulated by the length of the mixing time.  The coherent information is 
extracted by another Fourier transform along the array of the frequency domain data.   
 
 
2.1.3 Protein structure determination by solution NMR 
 
 
2.1.3.1 Overview 
 
In principle, NMR based structure determination uses experimentally derived 
constraints, including distance, angle and torsion angle constraints, to build a structure 
model that agrees with all the constraints while energy is minimized.  In order to 
determine the constraints, all the resonances have to be specifically assigned.  Depending 
on the size of the target, different strategies can be used for spin assignment (Figure 2-5). 
 
A sequential assignment strategy is best for small proteins.  For sequential 
assignment, correlation spectra are analyzed to identify individual spin systems (amino 
acids).  Then the complete sequential assignment is achieved by sequential NOE analysis.  
Further analysis is needed to resolve more long range NOEs toward a global folding.  
This strategy works well until the target reaches a size limit, where the overlapping 
signals make unambiguous sequential assignment practically impossible.  For this reason, 
this strategy is currently used for peptides or very small proteins. 
 
Currently, a main chain directed strategy is widely used for larger protein 
assignment.  First, the main chain assignments and sequential connections are achieved 
by comparing pairs of backbone specific spectra.  Then correlation spectra are analyzed 
to yield side chain assignment of individual residues.  Similar to the sequential 
assignment strategy, long range NOEs need to be identified for structure calculation.  
This method simplifies sequential assignment by dealing with backbone only for the first 
step.  Larger proteins are required to be assigned in this manner.  It has become the main 
strategy used for protein structure determination.   
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Figure 2-4 Example of a simple pulse sequence. 
(a) Example of simple one dimensional pulse sequence.  (b) Schematic view of the two 
dimensional NMR spectrum.   
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Figure 2-5 Flow chart of structure determination by NMR. 
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Spectrum peak overlapping is a major problem for unambiguous assignment.  The 
use of three-dimensional or four-dimensional heteronuclear spectra greatly reduces peak 
overlapping.  Comparing to the two-dimensional homonuclear experiment, the three-
dimensional heteronuclear experiment resolves the resonances in an additional dimension 
based on the coupling from an additional atom, through bond or space.  Those multi-
dimensional spectra greatly simplify the assignment, but they take much more time to 
acquire.  Thus, a more concentrated sample is required to reduce scan number for each 
data point.  Normally, the minimum protein concentration is about 1 mM/L for multi-
dimensional experiment based structure determination.   
 
For best spectra compliance, all the experiments for one structure determination 
project are acquired at the same solution condition and temperature.  Normally, the 
sample temperature is between room temperature to 37 °C.  The higher temperature is 
preferred, because molecules move and tumble faster in higher temperatures, which 
results in sharper and narrower peaks.  Sharper peaks are preferable because it increases 
signal to noise ratio and decreases the chance of overlapping. 
 
In order to take advantage of multi-dimensional heteronuclear experiments, the 
protein sample should be 15N and 13C doubly labeled.  In the case of some large proteins, 
deuteron labeling is also utilized in addition to the double labeling.  Because of the 
requirement for high sample concentration and temperature, the protein solubility and 
stability are critical for sample preparation.  Normally, a lot of effort is needed to screen 
different constructs and solution conditions.   In the ideal condition, the protein should be 
a stable monomer at high concentration.  There are other conditions contributing to an 
ideal sample solution: a low salt concentration for a better signal to noise ratio acquiredby 
cryo-probes; a pH value between 6.0 and 7.0, to avoid deprotonating at higher pH or 
destabilizing at lower pH.   
 
Since the structure determination in this dissertation is based on the main chain 
directed strategy, it will be discussed in more detail below.    
 
 
2.1.3.2 Backbone assignment 
 
For the main chain directed strategy, the first step is to obtain the assignment for 
the backbone atoms and their sequential connections.  The scheme of the assignment 
strategy is to obtain the backbone atom chemical shift assignment for individual spin 
systems and link them into a continuous polypeptide chain.  With the development of 
NMR pulse theory, several pairs of three-dimensional experiments are currently available 
to provide sequential connectivity.  
 
First, spin systems are built up based on each peak in the 15N HSQC spectrum.  
An 15N HSQC spectrum gives the correlation between each amide proton and the 
connected amide nitrogen atom.  Except for proline, each amino acid has one amide pair 
in the backbone.  So in principle, each and every residue in the protein should have a 
peak in the 15N HSQC spectrum.  Thus, each peak in the 15N HSQC spectrum 
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corresponds to a residue, although the assignment is still unknown.  Based on the peaks 
in an 15N HSQC spectrum, the strips are built up for three-dimensional nitrogen 
correlation spectra (Figure 2-6).   
 
For backbone assignment, the most common three-dimensional spectra include 
HNCACB/CNCA(CO)NH pair, HNCA/HN(CO)CA pair and HNCO/HN(CA)CO pair.  
In each pair, the former experiment provides the backbone chemical shift for both the 
current residue and the previous residue.  The later experiment provides the backbone 
chemical shift for the previous residue only.  By comparing the pairs, we should be able 
to differentiate the peaks from the current residue or the previous one.  Now, for each and 
every spin system (residue), the backbone chemical shift is known for both itself and the 
previous residue, but the connectivity is still unknown.   
 
To connect individual spin systems, the backbone chemical shift values are 
compared to find a match for its predecessor (Figure 2-7).  For example, the 
HNCA/HNCOCA pair gives us the information that the CA chemical shift value for the 
predecessor of spin system X is 60.52 ppm.  We then looked through all the spin systems 
and found that only spin system Y has CA chemical shift value of 60.52 ppm.  We can 
link spin system Y and X as a dual-residue peptide piece.  Then we can try to find the 
predecessor of residue Y and continue until reaching the N terminus.  In the ideal 
situation, the entire polypeptide chain can be linked, which finishs the sequential 
assignment by filling in the residue type with corresponding sequence.  In the real 
situation, the sequential linkage may not be complete from the N terminus to the C 
terminus, because of proline residues (no peak in the 15N HSQC spectrum), or missing or 
overlapping peaks.  Normally, fragments are first built up and their assignment may be 
unambiguously determined through some anchoring residues.  Since glycine, serine and 
threonine have characteristic CA and CB chemical shift, their type may be identified 
independent of other information.  Sometimes, there may be unique combinations of the 
3 residues in the sequence, thus the assignment of the residues and the linked fragment 
can be uniquely anchored.  From the anchored fragment, more linkage can be found 
toward both ends.  The ultimate goal of the backbone assignment is to try to link all the 
spin systems and have them uniquely assigned.   
 
What has just been described is the manual assignment, which is complicated, 
tedious and difficult.  With the development of automatic linking algorithms, some of the 
backbone assignments can be easily done by computer.  Among the few automatic 
backbone assignment softwares, Autolink is one of the best in accuracy and speed.65  
Developed by Masse and Keller, Autolink is an extension to the NMR spectrum analysis 
software CARA.66  It utilizes the chemical shift value for a spin system and its 
predecessor to calculate a most possible sequential assignment.  The central idea of the 
algorithm is to calculate the link possibilities and score the linkage in trying to maximize 
the linked residue numbers while minimize the total score.  It also takes into account the 
secondary structure and uses the experimental database to further fine tune the scoring 
function.  For small proteins (about 100 residues), the program can achieve very good 
accuracy and speed.  For larger proteins, it also dramatically helps assignment with 
relatively good accuracy.  However, the result from the calculation should always be 
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Figure 2-6 Example of 3D nitrogen correlation spectrum and 3D strips. 
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Figure 2-7 Example of backbone connection by backbone walk. 
The backbone walk by the HNCACB and CBCAcoNH pair.  Each CBCAcoNH strip has 
two peaks (red): One for the CA peak of the current residue and one for the CA peak of 
the predecessor.  Each HNCACB strip has four peaks: two CA (positive, in red) and two 
CB (negative, in blue).  The larger CA and CB peaks are from the current residue and the 
smaller CA and CB are from the predecessor. 
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manually verified to insure accuracy.  Normally, the gaps between major fragments have 
to be finished manually.  The best strategy is to use the program to help do most of the 
easy but tedious backbone assignment and manually verify the results.  If used correctly, 
Autolink can help dramatically increase assignment efficiency and accuracy.   
 
 
2.1.3.3 Side chain assignment 
 
The next step is to obtain the side chain proton assignments for individual 
residues.  The side chain protons include mostly methyl, methylene and aromatic protons.   
Normally, this is on the basis of completed backbone assignment, but sometimes the side 
chain assignment can also help backbone assignment by identifying residue types.  
Currently, no mature automatic side chain assignment software available, so it is still 
done manually.   
 
For small proteins, the combination of two dimensional Total Correlation 
Spectroscopy (TOCSY) and Correlation Spectroscopy (COSY) should be sufficient for 
side chain assignment.  The TOCSY provides the correlation between all the methyl and 
methylene protons within a spin system (Figure 2-8).  The COSY provides the correlation 
between two protons connected by two adjacent carbon atoms.  The COSY gives 
redundant information of TOCSY, so it is used for validation and supplement for 
overlapping TOCSY regions.  For large proteins, the 2D spectra normally suffer from 
heavily overlapping methyl and methylene regions.  To help reduce overlapping, the 
combination of 3D HCCH-TOCSY and 3D NOESY-HSQC are used.  Like 2D TOCSY, 
 
 
 
Figure 2-8 TOCSY correlation scheme for Leucine.  
Take proton H1 for instance, the TOCSY can display the resonance of all the protons 
from H2 to H9, in principle.  The correlation is mediated by CA and other carbon atoms 
in the residue.   
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the 3D HCCH-TOCSY also reveals the correlation between all the methyl and methylene 
protons within a spin system (Figure 2-8).  It resolves the 2D TOCSY with an additional 
carbon dimension.   
 
To make side chain assignment, strips are built based on the proton-carbon 
correlation plane which is the same as a 2D carbon HSQC spectrum.  Based on the HA, 
CA, HB, CB chemical shift value obtained from backbone assignment, the α proton and 
β proton peaks can be located in the proton-carbon plane.  For example, we build a strip 
based on the α proton shift of a particular residue, all the protons that have correlation to 
the α proton should resolve as a peak in the third proton dimension.  Thus, by this means 
we should be able to assign all the proton peaks within each spin system.  The 3D 
NOESY-HSQC and 3D HCCH-COSY are used as a supplement to the 3D HCCH-
TOCSY.   
 
 
2.1.3.4 NOE assignment and determination of distance restraint 
 
To determine the distance restraints for structure calculation, the NOE peaks have 
to be unambiguously assigned.  For a regular sized protein, the NOE spectrum can be 
heavily overlapped, because any proton pairs that are close enough (smaller than 5 Å) in 
space can have a peak.  This problem can be partially solved with the 3D 15N NOESY-
HSQC and 3D 13C NOESY-HSQC that resolve the 2D NOESY spectrum in the third 
nitrogen dimension or carbon dimension (Figure 2-9).  Currently, besides manual 
assignment, some NOE assignment can be done automatically with software.  Both 
approaches will be introduced below.  
 
 
 
Figure 2-9 2D NOESY is resolved in the third carbon dimension. 
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The manual approach employs an iterative strategy.  Since most aliphatic protons 
are dispersed in a 5 ppm chemical shift range, there are some protons having the same or 
very similar chemical shift values, which means one NOE peak can be attributed to more 
than one proton.  It can be challenging to unambiguously assign the NOE peaks without 
any structure information.  So, NOE assignment is coupled with structure calculation in 
several iterative steps.  The initial assignment only applies to those unambiguously 
resolved NOE peaks and that can be determined from known structure or structure 
models.  The initial structure will be calculated based on the partial assignment.  This 
structure could be a very loose bundle (not enough distance restraints) with high 
violations (some mis-assigment).   
 
Based on the preliminary structure, we can check the violations for incorrect 
assignments.  We can also make additional assignments, because the unambiguity is now 
greatly reduced since only the protons within the 5 Å radius can give NOE cross peaks.  
Based on the new distance restraints, we can calculate the new structure, which is used to 
refine the NOE assignments in the next iteration.  Thus, the NOE assignment and 
structure calculation are repeated several times until reaching a satisfying final structure.  
The criteria for a satisfying structure are defined by small values for target function and 
RMSD. 
 
Similar to the manual approach, most automatic NOE assignment protocols also 
exploit the iterative strategy.  CYANA is the most commonly used software for automatic 
NOE assignment.  CYANA is a structure-calculation software that integrates the 
automatic NOE assignment module CANDID.67,68  The input data for CANDID are the 
chemical shift values for all the NOE peaks as well as the chemical shift values for all the 
assigned protons, including the amide protons and aliphatic side chain protons.  With the 
same iterative strategy, CANDID makes the NOE assignment and structure calculation in 
7 cycles.  The result is normally very reliable for most small proteins, giving enough 
proton chemical shift completeness.  To further automate the de novo NOE assignment 
and structure calculation, CANDID was integrated with the automatic NOE peak pick 
program ATNOS.69,70  The input data for ATNOS/CANDID is only the proton chemical 
shift list and the NOE spectra.  Thus, it greatly boosts the efficiency of structure 
determination by NMR.  For a successful automatic NOE assignment calculation, there 
are some prerequisites.  Firstly, the proton assignment should be more than 80% 
completed.  Secondly, a reasonable structure must be reached after the first cycle.  
Thirdly, the NOE spectra should be carefully calibrated to the proton list.   
 
The purpose of NOE assignment is to identify corresponding NOE peaks and 
convert the peak intensity into distance restraints.  For a rigid two-spin system, the NOE 
peak volume is proportional to inverse sixth power of distance and overall tumbling. 
 
)(61 τfV
ijrij
×=      Equation 2-6 
 
Where Vij is the volume of the NOE cross peak between proton i and j; rij is the distance 
between the two protons.  A weighting function is needed to convert the peak volume 
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into distance restraints.  In CYANA, the module CALIBA helps calibrate the NOE 
intensity with distance restraints.  It has different calibration functions for backbone, side 
chain and methyl groups.  Normally, the NOE derived distance is treated as upper 
distance limit restraint in the calculation.  While the lower distance limit restraint is set to 
the sum of van der waal radii of two proton by default.   
 
 
2.1.3.5 Structure calculation 
 
NMR can provide multiple restraints from different angles towards an accurate 
3D structure.  The most important restraint is the inter-proton distance restraints derived 
from NOE experiments.  The scalar coupling constant provides torsion angle restraints 
and hydrogen bond distance restraints.  Chemical shift provides secondary structure 
information and disulfide bridge possibility.  Residual dipolar coupling (RDC) provides 
H-N and H-C bond orientation information.  Although 3D structures can be derived from 
only the NOE distance restraints, the additional information is able to improve the 
structure accuracy and precision.  Thus, always try to collect as many restraints as 
possible before structure calculation.    
 
Although many programs are available for 3D structure calculation, they are all 
based on two common approaches: distance geometry 71 and restrained molecular 
dynamics (rMD).72  The distance geometry algorithm samples all the possible inter-
proton distances in a geometric matrix and reaches structure solutions satisfying all the 
experimental derived distance restraints.  Software employing distance geometry include 
DISGEO and DG2.73  The restrained molecular dynamics approach solves the 3D 
structure based on the classic mechanics and Newton’s equation of motion.  A standard 
force field defines the chemical properties of all the amino acids from experimental 
knowledge.  NOE derived structure information is treated as pseudo force field (pseudo 
energy terms) that is specific to describe the structure.  By rMD, a 3D structure is folded 
up from random conformers guided by both standard force field and the NMR derived 
pseudo force field.  Currently, rMD can be performed in both Cartesian space and torsion 
angle space.  Because of fixed bond length, the later is about ten times faster than the 
former, thus it is widely used in most structure calculation softwares, e.g. DYANA, 
CYANA, X-PLOR and CNS.    
 
In practice, we use CYANA as structure calculation tool.67  CYANA employs 
torsion angle dynamics simulated annealing for structure calculation.  It integrates the 
module CANDID for automatic NOE assignment as well as automatic structure 
calculation from the spin peak list and a list of NOESY peak positions.  The automatic 
structure calculation has been described in the previous section.  Besides the automatic 
way, CYANA can calculate structures directly from various restraints too, the classic 
manual structure calculation.  Conventional manual structure calculation is an iterative 
process that involves calculation of an initial structure followed by many steps of 
refinements and re-calculations.  The refinement steps are critical because they improve 
structure by identifying more NOE assignments and eliminating incorrect NOE 
assignments based on the preliminary structure.   
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The current version of CYANA can not use residual dipolar coupling data.  The 
most common restraints are the upper distance limit restraint and the torsion angle 
restraint.  The upper distance limit restraint is calculated from the intensity of NOE peaks 
(Equation 2-6).  The torsion angle restraint provides the range of rotation angle of each 
rotable bond.  The backbone torsion angles can be predicted from the chemical shift 
value of HA, CA, CB, CO and N resonances, by the software TALOS.74  Based on the 
database of chemical shift values and sequence homology, TALOS predicts the torsion 
angle range for the backbone phi and psi angles with good accuracy.74  The use of torsion 
angle restraint greatly reduces the conformational space to sample and increases the 
calculation efficiency dramatically.   
 
During NMR structure calculation, distances can not be uniquely determined 
because NMR derived distance restraints usually describe a range of distance instead of 
one fixed value.  Thus, the experimental restraints describe an ensemble of structures 
instead of one exact structure.  So structure determined by NMR is usually reported as a 
bundle of 20 conformers with the best target function.  There are three major criteria for 
evaluating the quality of NMR structure.  The target function measures the deviation 
between the structure model and the experimental data.  It illustrates the accuracy of the 
structure.  The root mean square deviation (RMSD) measures the distance deviations 
within the 20 conformers.  It illustrates how tight the bundle is and describes the 
precision of the structure.  The Ramachandran plot visualizes the conformation by 
plotting the backbone phi and psi angle value of each residue.  Based on the statistics, it 
reports the percentage of residues that are in favorable conformation or disfavored 
conformation.  Usually, the residues in disfavored conformation are the result of incorrect 
assignment.  It describes the structure conformation from statistics and points out the 
suspicious assignment for further investigation.     
 
 
2.1.4 NMR as a tool to study protein interactions 
 
 
2.1.4.1 Overview 
 
In addition to structure determination, the other powerful aspect of NMR is to 
study the interaction between a protein and another protein, peptide, nucleic acid and 
small molecules.  NMR detects the spin relaxation from RF excitation and the signal is 
modulated by the environment of the spin.  It makes NMR very sensitive to any changes 
in the chemical and physical environment, including temperature, solution conditions and 
ligand binding.  The binding of a ligand can locally change the chemical environment of 
the interface atoms or change the tumbling rate of the protein, which are easily detectable 
by NMR.  A simple titration experiment can provide very wealthy information regarding 
the interaction.  In addition, NMR studies protein interactions in the solution, which is 
closer to the physiological condition compared to the X-ray crystallography.  The 
advantages make NMR the prime tool to study protein interactions, especially for those 
weak or transient interactions.   
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Although very versatile, NMR still has its own weakness in studying protein 
interactions.  One of the major disadvantages is that the system it can study is limited by 
the protein size, which is normally smaller than the limit of other methods.  The other 
limitation is the requirement for backbone sequential assignment, although the titration 
experiment is relatively easy.  Further, the chemical shift perturbation is composite 
changes, which may make data interpretation difficult if more than one event (e.g. two 
binding sites or binding plus conformational change) occurs in the mixture.  And the 
binding is studied in high protein concentration, which may limit the value of the results.   
 
NMR is capable of providing different levels of information regarding protein 
interactions.  Among all the applications, the most powerful ones are binding interface 
mapping, binding affinity measurement and complex structure determination.   
 
 
2.1.4.2 Binding interface mapping 
 
Many NMR methods can help map the protein interaction interface.  A chemical 
shift perturbation (CSP) titration experiment is the most powerful and easy one.  It 
mainly monitors the environment change of individual amide protons upon titrating 
ligand into protein, by a heteronuclear single quantum coherence (HSQC) titration 
experiment.  For a 15N labeled protein, its 15N HSQC spectrum should give a peak for 
each amide proton (Figure 2-10a, b).  Except proline, each amino acid has one amide 
proton in the backbone.  So each residue in the protein can be assigned to one peak, the 
position of which is directly modulated by the local chemical environment of the 
corresponding residue.  Upon titration with ligand, some peaks will change position due 
to the perturbation of the local environment by the ligand binding.  Then the shifted peaks 
can be easily identified by overlay of the spectra taken before and after adding the ligand 
(Figure 2-10c).  Now if the peak assignment and protein structure is available, the 
binding interface can be mapped (Figure 2-10d).   
 
Compared to other methods, CSP titration experiments are very fast and accurate.  
It takes only 20 minutes to acquire a 15N HSQC spectrum at 400 µM/L sample 
concentration.  CSP titration experiments are widely used also because of their capability 
to detect very weak and transient interactions.  However, CSP titration experiments are 
prone to false positives.  Because it only monitors the variation of the local chemical 
environment, anything that alters the environment should be detected as positive.  This 
includes a change of solution pH, ionic strength or sample temperature.  Even when those 
conditions are carefully controlled, there could still be peak shifts caused by 
conformational change.  There are two common false positive scenarios that can be 
identified: 1.If shifted peaks are not clustered, it could be non-specific binding; 2. if the 
majority peaks shift, it could be protein unfolding or aggregation.     
 
Besides a CSP titration experiment, cross saturation or saturation transfer (SAT) 
is another widely used interface mapping technique.75  SAT is based on the idea that 
when two proteins have interaction, the RF excitation can be transferred from one protein 
to the other through the binding interface.  The two proteins are differently labeled: the  
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Figure 2-10 Binding site mapping by chemical shift perturbation titration. 
Example of binding site mapping by CSP titration experiment. (a) The 15N HSQC 
spectrum of protein alone; (b) the HSQC spectrum of protein with 1:1 unlabeled ligand; 
(c) spectra overlay reveals shifted peaks; (d) on the structure, the shifted peaks mapped 
to a cluster of residues, which are colored in red. The wider the tube the larger the 
chemical shift perturbation.   
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“donor” protein is unlabeled and the “observer” protein is perdeuteratued and 15N labeled.  
The amide deuterons in the observer are then exchanged back to protons in the H2O 
solution, in order to be observable by 15N HSQC experiment.  Through a cross-relaxation 
mechanism, the donor protein is saturated and it attenuates the signal in the interface of 
the observer protein.  Hence, the binding interface on the observer can be identified by 
the signal intensity change.  Compared to CSP titration, SAT is more resistant to the false 
positive caused by conformational change.   
 
A Proton-Deuterium exchange experiment is capable of mapping the solvent 
exposed surface residues.  The protein-protein interaction shields the solvent from the 
interface residues, so it can be identified by the variation of solvent exposure areas.  For 
15N HSQC experiment, an amide proton is visible but an amide deuterium is not.  In the 
solution, the amide proton can exchange with the solvent proton if exposed to solvent.  If 
a protein is dissolved in D2O, some of the amide protons should be substituted by 
deuterium through solvent exchanging.  Reflected in the spectrum, some peaks should 
disappear over time.  Since only solvent exposed residues are able to exchange with 
deuterium, the disappearing peaks are the solvent exposed residues.  Now if some peaks 
are protected upon binding, the protected residues can be mapped as the binding interface.  
 
 
2.1.4.3 Binding kinetics 
 
In addition to binding site mapping, NMR is also capable of studying binding 
kinetics.  Interactions can be categorized into fast exchange, intermediate exchange and 
slow exchange in the NMR timescale (Figure 2-11).   
 
 
 
 
Figure 2-11 Schematic view of different binding kinetics. 
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Depending on the binding affinity, the receptor is in equilibrium between free and 
bound forms.  Because of different resonance frequency, the receptor free and bound 
forms should correspond to two distinct peaks in the spectrum.  However, when the two 
states are interchanging too fast to be distinguished by NMR, the two peaks average into 
one single peak.  The position of the average peak is between the two component peaks 
and determined by the equilibrium.  This situation is often typical for weak binding 
where the ligand associates and disassociates from the receptor very fast, usually in 
submilliseconds.  It is called fast exchange in the NMR timescale (around a second).  In 
contrast, if the interaction is so strong that the ligand disassociates in more than a second, 
two distinct peaks should exist simultaneously.  The ratio of the peak integral is 
determined by the ratio of the two species in the equilibrium.  This situation is called 
slow exchange in the NMR timescale.  Interactions with intermediate disassociate rates 
exhibit a broad peak at the average position, which is called intermediate exchange in the 
NMR time scale.    
 
Thus, binding kinetics is observable by resonance behavior upon ligand titration.  
The binding affinity can also be compared, since binding affinity is directly correlated 
with exchange rate.  
 
 
2.1.4.4 Binding affinity 
 
Besides binding affinity comparison by kinetics behavior, NMR is able to directly 
measure the binding affinity too.  As shown in Figure 2-12, during a series of titration 
experiments, peaks in fast exchange should have a series of movement until they reach an 
ultimate position, which corresponds to the complete bound form.  Each peak is the 
average resonance of free and bound form at that particular ligand receptor ratio.  The 
plot of chemical shift difference against ligand receptor ratio should result in a standard 
binding curve that approaches a plateau when ligand/receptor ratio reaches maximum.  It 
can be fitted with standard two parameter nonlinear least square fit one site binding 
function or this function if considering the dilution effect during titration.76 
 
( ) ( ) ⎥⎦⎤⎢⎣⎡ −++−++Δ=Δ ++ RRR dd KLP LRPKLP LRPcomposite 411 2max21 00 0000 00δδ      Equation 2-7 
 
Where Δδcomposite is the composite chemical shift distance for each titration point; R is the 
ligand to protein concentration ratio; P0 and L0 are the initial concentration for protein 
and ligand stock.  The fitting should derive the value for Δδmax and Kd.   
 
For 15N HSQC based CSP titration experiment, the chemical shift difference is 
normally calculated as composite chemical shift difference by the equation: 
 
2
)2.0( 22 nitrogenproton
composite
δδδ Δ×+Δ=Δ              Equation 2-8 
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Figure 2-12 Example of binding affinity determination by NMR CSP titration.  
(a) For a fast exchange binding, peak moves continuously until reaching an ultimate 
position, which corresponds to completely occupied receptors.  (b) The composite 
chemical shift perturbation can be plotted with ligand concentration to fit a standard 
binding curve, from which the Kd and Ymax are derived.   
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Where Δδproton is the chemical shift difference in the proton dimension and Δδnitrogen is the 
chemical shift difference in the nitrogen dimension. 
 
Since normally there is more than one peak experiencing chemical shift 
perturbation, the overall binding affinity is usually derived as the average of several 
peaks in the binding site.  The overall binding affinity can also be globally fitted from 
several individual data sets.   Compared to the Kd value measured by isothermal titration  
calorimetry (ITC) and surface plasmon resonance (SPR), NMR derived Kd values are 
usually larger (weaker) by about one to two orders of magnitude.  The reason for this 
might be that NMR always measures the average position, which dilutes the effect of 
binding.  Nevertheless, the relative binding affinity value should be correct and thus can 
be compared to other Kd values measured by NMR.    
 
 
2.1.4.5 Complex structure determination  
 
Complex structures can provide very rich information regarding protein-protein 
interactions.  It is the most direct way to study protein interactions, especially in studying 
signal transduction, regulation and enzymatic functions.  Currently, most complex 
structures are still determined by X-ray crystallography.  However, NMR is playing a 
more and more important role in studying weak and/or transient interactions, which are 
very difficult for X-ray crystallography.  There are two categories of complex structures 
that NMR contributes to: 1. full complex structure determination based on NOEs; 2. 
NMR-driving docking or modeling. 
 
For full complex structure determination, different strategies were developed over 
the past decade.  The most common one is using intermolecular NOEs detected by 
15N/13C-filtered/edited NOESY experiments.  This method works best when the 
interaction is strong or under condition of slow exchange.  If possible, residual dipolar 
coupling data is also used to provide relative orientations.   If the binding affinity is weak 
or under condition of fast exchange, a transfer NOE experiment is able to provide 
intermolecular NOEs.  Also, the RDC data can be combined for structure determination.   
When the binding site and relative orientation is known for a protein-protein complex, 
sometimes it is possible to combine the two components by designing a flexible amino 
acid linker.  This way, the complex can be treated as one single protein with a flexible 
region.  It is usually necessary to check if the linking introduces conformational changes 
or altered interactions.   
 
For NMR-driving docking or modeling, there are some prerequisites: 1. structures 
of the individual components are known; 2. the binding interface is identified by NMR; 3. 
no major conformational change upon binding.  NMR is very capable of mapping a 
binding interface, as introduced in the previous section.  However, the interface 
information can be obtained not only by NMR, but also by mutagenesis, or 
bioinformatics analysis.  The docking integrates the interface information with known 
individual structures to achieve the complex structure with atom level resolution.  
Normally, the complex structure will be validated by independent data for reliability.  
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The validating data includes NMR cross saturation data, H/D exchange data, chemical 
cross-linking, RDC data and more mutagenesis.  Of all the NMR-driving docking 
software, HADDOCK is commonly used because of its accuracy and efficiency.  It will 
be discussed in more details in the next section. 
 
 
2.2 Data driving complex modeling by HADDOCK 
 
 
2.2.1 Overview 
 
Protein-protein complex structure is critical in understanding protein interaction, 
regulation and enzymatic functions.  Despite its importance, there are only a small 
number of protein complex structures available.  The main reason for the limited number 
is that the complex structure determination is much more difficult than solving protein 
structure alone.  At the same time, more and more structures of binding partners are 
determined and their interactions are characterized by various biochemical and 
biophysical approaches.  To solve the problem, Dominguez et al developed the docking 
software HADDOCK (High Ambiguity Driven biomolecular DOCKing).77   
 
In general, computational docking uses a similar protocol – translate and rotate 
one binding partner around the other partner and each pose is scored by various terms, 
which include electrostatic interaction, van der Waals and surface complementarities.  
The problem is that the conformational space to sample becomes very large with the 
increase of target size.  As a result, those docking protocols may not be able to find the 
correct pose or provide unique resolution.  Different from other docking software, 
HADDOCK makes use of known binding data to help maximize docking accuracy and 
efficiency.  Any information describing the binding site on any binding partner can be 
used as input data, which includes NMR chemical shift perturbation data, NMR H/D 
exchange data, NMR cross saturation data, biochemical mutation binding study and 
bioinformatics sequence analysis.  Described as AIRs (Ambiguous Interaction Restraints), 
the information is defined as ambiguous distance restraints used to drive the docking 
process. 
 
HADDOCK integrates ARIA script with CNS.78,79  The core structure calculation 
is executed by CNS, but the accuracy and efficiency is greatly improved with 
experimentally derived restraints.  Because of the accuracy, more and more studies have 
been carried out with HADDOCK and the targets were also extended from protein-
protein complex to protein-DNA, protein-RNA and protein-polysaccharide complexes. 
 
 
2.2.2 Definition of AIRs 
 
In HADDOCK, the binding site residues are grouped into “active” and “passive” 
residues based on NMR titration experiments or mutation experiments or any other 
experimental information.  For NMR titration data, the “active” residues are defined as 
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significantly shifted residues with high solvent accessibility (>50%).  The “passive” 
residues are defined as all other shifted residues and/or the surface neighbors of the 
“active” residues, with high solvent accessibility (>50%).     
 
The AIR is defined as the inter-atomic distance restraint that has a maximal value 
of 3.0 Å.  For a complex formed with A and B, AIRs consider all the distances between 
any atom in the “active” residues in A to all atom in the “active” and “passive” residues 
in B; and any atom in the “active” residues in B to all atom in the “active” and “passive” 
residues in A.  In this definition, the “passive” residues do not participate in the AIR to 
the partner, but can satisfy the AIR from the “active” residues in the partner.  The 3 Å 
maximal distance value is the best representation for hydrogen/hydrogen and heavy 
atom/heavy atom van der Waals distance.   
 
The great advantage for introducing AIR is that the number of possible 
conformational spaces to sample is dramatically reduced during docking procedure.  This 
simplification is guided by experimental information describing the binding interface, so 
the chance of introducing error is minimized.  With greatly reduced conformational space 
to sample, the docking can afford more time consuming but accurate energy 
minimization steps.  This also helps promote the unique docking solution.   
 
 
2.2.3 Docking protocols 
 
HADDOCK uses CNS as the core module for docking and structure calculation.  
There are three steps in the docking protocol.   
 
1. Randomize the orientation and rigid body energy minimization.  The two binding 
partners are initially placed 150 Å away in space.  They are allowed to translate 
and rotate while rigid body energy minimization is performed.  Under the restraint 
of AIRs, the orientations of the binding partners are sampled to optimize the 
contacts.  This step determines the pose and orientation for the complex, leaving 
local energy minimization to the next step.   Normally, this step is relatively fast. 
 
2. Semi-rigid body simulated annealing in torsion angle space.   Residues in the 
binding interface are allowed to move in order to optimize side chain contact.  
The binding interface residues are defined as all the “active” and “passive” 
residues and 2 residues in extension to both ends.  Three stages of simulated 
annealing refinements are performed, in which the flexibility in the interface 
increases gradually.  This step provides the basis for final water refinement and 
scoring.  In general, it is the most time consuming step among all three steps. 
 
3. Refinement in Cartesian space with explicit solvent.  An 8 Å shell of TIP3P water 
box is added before actual molecular dynamics refinement.  This is a rather gentle 
refinement.  No significant movement will occur in this step.  Although small, the 
movement is necessary to optimize the energetics in the binding interface.  Then, 
all the poses are scored with average interaction energy and average buried 
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2.2.4 Results analysis 
 
Current scoring functions can rank the binding energy more accurately if all the 
binding poses are similar.  However, HADDOCK is driven by highly ambiguous restraint, 
so there will be more than one docking solution generated.  Thus, the data analysis 
strategy is to cluster and compare scores within the cluster.   
 
HADDOCK provides scripts for complex structure clustering.  The complex 
RMSDs are defined by superimposing the interface backbone atoms of protein A and 
calculating the RMSD of the interface backbone atoms of protein B.  The complex 
structures are then clustered by this complex RMSDs based on a user defined cut off 
value.  By fine tuning the cut off value, all the complexes can be clustered into several 
groups (less than 5, ideally).  The top ranked complex solutions in each group should be 
carefully inspected.  The best model should satisfy the following conditions: 1. Having 
one of the lowest binding energies; 2. Clustered in one of the largest groups; 3. satisfying 
all the experimental data.   
 
For most cases, this docking and analysis protocol should yield a reasonable 
complex structure.  However, in some difficult situations, a good model may be difficult 
to obtain.  For trouble shooting and re-docking, careful analysis is needed to fix the 
problem.  If there are too many clusters even for a small RMSD cut off value, the 
complexes are too diverse.  The main reason for the large diversity is insufficient AIRs to 
restrain the binding into a limited number of poses.  More experimental data is needed to 
gather enough restraints.  If docking results in a positive binding energy or is not be able 
to reach a solution, there might be some error in the structure or the AIRs or both.  
Careful experiments are needed to map the binding interface and rule out the possibility 
of binding induced conformational change.   
CHAPTER 3.  THE GIT1 PAXILLIN BINDING DOMAIN IS A FOUR-HELIX 
BUNDLE AND IT BINDS TO BOTH PAXILLIN LD2 AND LD4 MOTIFS *  
 
 
3.1 Introduction 
 
Cells attach and communicate with the extracellular matrix (ECM) through 
membrane peripheral proteins that form focal adhesions (FAs).80,81  Cell motility is 
regulated through the alternating assembly and disassembly of FAs and cytoskeletal 
proteins.82  The dynamics of FAs is controlled by the signaling of different adhesion 
molecules such as focal adhesion kinase (FAK), paxillin, the G protein-coupled kinase 
(GRK)–interacting (GIT) protein, and p21-activated kinase (PAK),52,83-85 whereas 
cytoskeletal remodeling is regulated by small GTPases of the Ras and Rho family, such 
as Rac1, Cdc42, and RhoA.86-88   
 
GIT proteins play an important role in initiating the disassembly of FAs.12,89  Both 
members of the GIT protein family, GIT1 and GIT2/p95-PKL, have an N-terminal Arf 
GTPase-activating protein domain (Arf-GAP), a Spa2-homology domain (SHD), a 
coiled-coil (CC) domain, and a C-terminal paxillin-binding domain (PBD).  Previous 
studies have shown that the SHD binds the PAK–PIX complex and the PBD binds 
paxillin.12,38,61,62  GITs, functioning as scaffold proteins, target the PAK complex into 
FAs by binding with paxillin via their PBDs.12,38,56  GIT PBDs span about 130 amino 
acids and are highly conserved among species.49  Recently, a low-resolution structural 
model for the GIT1 PBD was derived from small-angle X-ray scattering (SAXS) and 
homology modeling, based on the structure of FAK focal adhesion targeting (FAT) 
domain, which is a four helix bundle protein.62  Mutagenesis studies suggest that paxillin 
binds the GIT1 PBD through the putative helices 1 and 4.62  However, a high-resolution 
structure of the GIT1 PBD is unavailable and the mechanism of paxillin–GIT interaction 
remains unclear. 
 
Paxillin is one of the major binding partners of GIT proteins in FAs, functioning 
as an elongated adaptor protein that links actin filaments with integrin.90  It contains 
multiple docking sites for different signaling and structural proteins in FAs and comprises 
five N-terminal LD motifs and four C-terminal LIM domains.29,30 The LD motifs are 
named after their consensus sequence LDXLLXXL and bind with multiple proteins, 
including FAK, GIT, vinculin, actopaxin, and integrin-linked kinase (ILK).33,36-38  
Structural studies have shown that the LD2 motif and the bound form of the LD4 motif 
form amphipathic α-helices, with several leucines forming a large hydrophobic patch.31,91  
FAK interacts with paxillin on both LD2 and LD4 motifs.33,92  Unlike FAK, the 
interaction between GIT1 and paxillin is reported to be mediated by the LD4 motif 
only.38,61 
 
* Reproduced with permission from Zhang ZM, Simmerman JA, Guibao CD and Zheng 
JJ.  GIT1 paxillin-binding domain is a four-helix bundle and it binds to both paxillin LD2 
and LD4 motifs.  J Biol Chem (2008).  Copyright © 2008 by American Society for 
Biochemistry and Molecular Biology. 
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In this study, we determined the solution structure of the PBD of rat GIT1 
(residues 640–770) by nuclear magnetic resonance (NMR) spectroscopy.  Using 
synthesized LD peptides, we also studied the interaction between the GIT1 PBD and 
paxillin LD motifs.  Our finding reconciles some controversial observations of earlier 
studies and provides a clearer picture of the role of GIT proteins in focal adhesion 
regulation.   
 
 
3.2 Experiment procedures 
 
 
3.2.1 Protein purification and peptide synthesis 
 
Full-length rat GIT1cDNA was a gift from Dr. Edward Manser, Institute of 
Molecular and Cell Biology, Singapore.  The sequence of rat GIT1 is identical to human 
GIT1 sequence except one substitution (P644L) in the N terminal unstructured region.  
We subcloned the GIT1 PBD (residues 640–770) into the pET28 vector (EMD 
Biosciences, San Diego, CA).  The protein was over expressed in Escherichie coli strain 
BL21(DE3). 13C/15N labeled sample was prepared by growing the cells in 3-(N-
morpholino)propanesulfonic acid (MOPS) buffered medium containing 15NH4Cl (1 g/L) 
and 13C6-glucose (3.6 g/L).93  Proteins were purified using a Ni2+-charged His-Bind 
Resin (EMD Biosciences, San Diego, CA) according to the manufacturer’s protocol.  The 
6XHis tag was removed by thrombin cleavage (EMD Biosciences, San Diego, CA) at 
room temperature for 4 hours.  The digested protein was dialyzed in 20 mM potassium 
phosphate (pH 6.5), 5 mM 1,4-dithiothreitol (DTT), and 5 mM EDTA then further 
purified by gel filtration on a HiLoad 26/60 Superdex 75 HR column (GE Healthcare, 
UK).  Human paxillin LD2 (residues 140–161), LD4 (residues 261–282) and the LD4 
peptide phosphorylated at the S272 position were chemically synthesized and purified by 
HPLC at the Hartwell Center of Bioinformatics and Biotechnology, St. Jude Children’s 
Research Hospital, Memphis, TN.   
 
 
3.2.2 NMR spectroscopy 
 
The 15N/13C double-labeled GIT1 PBD sample used for structure determination 
was approximately 400 μl at a concentration of 1.2 mM in 20 mM potassium phosphate 
buffer (pH 6.5), 5 mM deuterated EDTA, 5 mM deuterated DTT, and 5% (v/v) D2O.  All 
NMR spectra for structure determination were acquired at 37°C with either a Bruker 
Avance 600 MHz spectrometer or a Bruker Avance 800 MHz spectrometer, both 
equipped with a cryoprobe.  To determine the residues exposed to the solvent, a 15N-
labeled GIT1 PBD sample was first lyophilized in a Labconco FreeZone Plus 6 freeze dry 
system (Labconco Corp., Kansas City, MO) and dissolved in the same volume (400 μl) of 
D2O. 15N heteronuclear single-quantum coherence (HSQC) spectra were collected at 
25°C every 10 min by the Bruker 600 MHz spectrometer.  Spectra were analyzed by the 
software Sparky.94   
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3.2.3 NMR data analysis and structure calculation 
 
All NMR spectra were processed with NMRPipe 95 and analyzed with CARA.66  
Backbone assignments were obtained based on CBCA(CO)NH, HNCACB, HNCA, and 
HN(CO)CA experiments.  Side-chain assignments were obtained by using HCCH-
TOCSY, HCCH-COSY, HBHA(CO)NH, CC(CO)NH, and HCC(CO)NH spectra.  
Dihedral angle range was predicted by TALOS.74  For structural determination, the NOE 
distance restraints were derived from 13C-NOESY and 15N-NOESY spectra.  NOE 
spectra were first analyzed by an automatic algorithm with the software 
ATNOS/CANDID 69,70 and the results were then manually inspected and modified.  
Structure calculation and refinement were carried out by using the software CYANA 
2.1.68  The final structures were checked and validated by PROCHECK.96  Structure 
figures in this paper are generated by Molmol.97  For electrostatic potential map, the 
figure was generated by Pymol, based on the electrostatic potential generated by 
GRASP.98  Structure superposition and structure based sequence alignment are generated 
by the Swiss-Pdb viewer.99 
 
 
3.2.4 Chemical shift perturbation titration 
 
All NMR titration experiments were performed at 25°C under the same 
conditions: 15N-labeled GIT1 PBD at a concentration of 400–450 μM in 20 mM 
potassium phosphate (pH 6.5), 5 mM deuterated EDTA, 5 mM deuterated DTT, and 5% 
(v/v) D2O.  All peptide stocks were prepared in the same buffer and their pH was 
readjusted to 6.5 before titration.  Titrations were made by adding ligand at the following 
ratios: 1:0.5, 1:1, 1:2 and 1:5.  A series of 15N HSQC spectra were taken on a Bruker 
Avance 600 MHz spectrometer with cryoprobe and data were analyzed with Sparky.94 
 
 
3.2.5 Biacore binding assay 
 
Synthesized LD peptides with the N-terminal biotin tag were attached to a 
NeutrAvidin-covered gold surface (CM5 chip; Biacore, GE Healthcare, UK).  Kinetic 
studies were performed at 20°C with a BIACORE 3000 (Biacore, GE Healthcare, UK).  
The purified GIT1 protein (in 20 mM phosphate buffer (pH 6.5), 150 mM NaCl, 5 mM 
EDTA, 0.1 mg/mL BSA, and 0.005% P20 surfactant) was injected to flow through the 
chip and Kd was derived by fitting the data from three injections.  The association and 
dissociation were observed at a flow rate of 50 μL/min in a concentration range of 1.4–
110 μM.  Binding affinities were determined by the program Scrubber 2 (Version 2.0b, 
BioLogic Software).  The experiment was repeated with chips covered with both high- 
and low-density peptides and the results were found compatible. 
 
 
 
 
 
47 
 
 
3.2.6 Circular dichroism (CD) spectroscopy 
 
All CD spectra were obtained with an Aviv 62DS CD spectrometer (Aviv, 
Lakewood, NJ).  CD spectrum of the PBD was taken at 25°C in 50 mM potassium 
phosphate (pH 6.5) and 1 mM EDTA.  The protein thermo stability was determined by 
monitoring the CD signal of the PBD sample at 222 nm while increasing the sample 
temperature. 
 
 
3.3 Results 
 
 
3.3.1 Solution structure of the GIT1 PBD is a four-helix bundle 
 
The PBD of rat GIT1 (residues 640–770, Figure 3-1a) was expressed in E. coli as 
a soluble protein, and CD spectroscopy showed that the protein is predominantly helical; 
and the PBD started to denature only at about 45 ºC (Figure 3-2).  The solution structure 
of the PBD was determined by heteronuclear multidimensional NMR spectroscopy.  
After backbone and side-chain assignments, the Nuclear Overhauser Effect (NOE) 
constraints were obtained from both 15N-edited 3D-NOESY and 15N/13C-edited 3D-
NOESY spectra.  The structure of the PBD was determined based on 2440 NOE distance 
constraints and 189 dihedral angle constraints.  The structures were calculated by 
CYANA, and 20 structures with the lowest target function value were selected and 
superimposed (Figure 3-1b).  Table 3-1 gives the final structural statistics.  All 
experimental NMR constraints are satisfied, the average target function of the 20 
structures selected is 0.7, and no NOE constraint violation is more than 0.2 Å.  Most 
residues (81%) have dihedral angles in the most favored region of the Ramachandran plot, 
and 10.9% residues are in the additionally allowed region.  The only residue in the 
disallowed region is D643, which is located in the unstructured N terminus.  The solution 
structure is of high precision.  The average root mean square deviations (RMSDs) of the 
20 structures from the average structure for backbone atoms and all heavy atoms of 
residues 643–767 are 0.39 Å and 0.77 Å, respectively.  The Coordinates and the structure 
factors of the GIT1 PBD have been deposited in the Protein Data Bank (PDB) with 
accession codes 2JX0. 
 
The GIT1 PBD forms a compact rod-shaped protein with a well-defined C 
terminus and a slightly floppy N terminus.  The C terminal end is in proximity to the N 
terminus, a feature common to many functional independent domains.  The PBD 
structure forms a four-helix bundle with a right-handed up-and-down topology, about 58 
Å in height and 26 Å in diameter (Figure 3-1c). There are many NOEs observed between 
helix turns.  The four helices form an antiparallel bundle, with an average axis angle of 
19.1º between neighboring helices.  The hydrophobic side chains from all helices 
interlace to form a network of hydrophobic interactions that dramatically stabilize the 
bundle (Figure 3-1b and c).  Extensive interhelical NOEs were observed, resulting in well 
defined side chains of the residues located in the interhelical regions (Figure 3-1c). 
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Figure 3-1 Structure of the paxillin-binding domain (PBD) of rat GIT1. 
(a) Sequence alignment based on structures of the rat GIT1 PBD, the chicken FAK FAT 
domain (1KTM), and the H2 to H5 of chicken vinculin Vt domain (1QKR).  The sequence 
of human GIT2, FAK2/PYK2, and vinculin are also aligned based on the structure-based 
sequcence alignment.  Residues that are significantly perturbed on binding of LD 
peptides are indicated by red dots.  The hydrophobic core is composed of residues 
marked by black diamonds.  Hydrophobic residues are marked by filled diamonds and 
the two polar Ts are marked by empty diamonds.  The absolutely conserved residues are 
highlighted in yellow.  The example of the hydrophobic network in Figure 3-3 is 
represented by black-line connections.  (b) Stereo view of the backbone trace of the 
ensemble of the 20 best structures.  The side chain of the hydrophobic core is shown.   (c) 
Ribbon representation of the GIT1 PBD structure.  H1 through H4 are shown in blue, 
green, yellow, and red, respectively.  Side chains of the interlaced core are also 
presented. (d) Representation of the H/D exchange experiments.  The unambiguously 
observed non-proline amide proton atoms are represented as small balls in the structure.   
After the first 15 min, the solvent-exchanged amide proton atoms are colored in blue 
whereas the protected amide protons are colored in yellow.  The atoms that remain 
protected after 380 min are colored in red. 
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Figure 3-2 CD spectra of purified GIT1 PBD. 
(a) CD spectrum of the GIT1 PBD at 25°C in 50 mM potassium phosphate (pH 6.5) and 
1 mM EDTA.  (b) Molar ellipticity measured at 222 nm while temperature was changed 
from 25°C to 95°C and back to 25°C.   
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Table 3-1 Statistics of the GIT1 PBD structure determined by nuclear magnetic 
resonance (NMR) spectroscopy.  
 
Distance restraints Numbers 
Total number of NOE restraints 2440 
Intraresidue  574 
Sequential  750 
Medium range  718 
Long range  398 
Restraints per residue 18.07 
  
Dihedral angle restraints  Numbers 
Total number of restraints 189 
Phi angle restraints 93 
Psi angle restraints 96 
  
Ramachandran plot Percentage 
Residues in most favored regions  88.1% 
Residues in additional allowed regions  10.9% 
Residues in generously allowed regions  0.5% 
Residues in disallowed regions 0.4% 
  
RMSD (residue 643-767) Values 
Average backbone RMSD to mean 0.39 ± 0.09 Å  
Average heavy atom RMSD to mean 0.77 ± 0.07 Å 
  
Target function 0.70 ± 0.04 
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The PBD fold was confirmed by the solvent-exposed surface mapped by the 
hydrogen/deuterium (H/D) exchange experiments.  Fast 15N HSQC spectra were taken 
immediately after dissolving the lyophilized 15N-labeled PBD in D2O.  After the first 15 
min, approximately 57% of amide peaks had disappeared because of H/D exchange.  All 
the protected peaks are in the helical regions, whereas most peaks that vanished belong to 
the residues in the loop regions and the termini (Figure 3-1d).  Some peaks were 
protected even after 6 hours; they are all within the core of the four-helix bundle.  The 
H/D exchange data validates the 81 pairs of H-bonds in the structure, most of which were 
between Oi and HNi+4 from individual helices.   
 
Of the four helices in the PBD structure, H4 (30 residues) is slightly longer than 
helices H1 (23 residues), H2 (21 residues) and H3 (22 residues).  The H3/H4 loop is 
longer than the H1/H2 loop, which may explain why H3 and H4 appears longer than H1 
and H2 in the low resolution SAXS model.62  The GIT1 PBD had 11 prolines; all locate 
in the loops or at the end of helices.  The rigid backbone and hydrophobic side chain of 
proline make the loops less flexible, allowing us to observe extensive NOE connections 
between the loops and the rest of the protein.  The PBD also has three cystines; the 
chemical shifts of Cβ of all three cystines are less than 32 ppm, indicating that they are in 
the reduced states.100  This might be caused by the presence of 5 mM DTT in the NMR 
sample buffer.  In the solution structure, C683 and C725 are closely located in helices H2 
and H3 and the distance between the Cα atoms of the two residues is 8.7 Å.  A small 
degree of rotation of the C683 side chain or a slight change in the packing of the helices 
can bring the two cysteine side chains close enough to form a disulfide bond.  
Considering the high thermo stability of the PBD, we cannot rule out the possibility of a 
disulfide bond bridge between the two cysteines. 
 
A sequence comparison of the GIT1 PBD with those of two other four-helix 
bundle domains – the FAT domain of FAK and the vinculin Vt domain – revealed that 
the hydrophobic residues in the core regions are well conserved among all the three 
sequences (Figure 3-1a).  The best example of the hydrophobic residues is the L721 in 
helix H3, wherein  the side chain of the residue makes hydrophobic contacts with side 
chains of L668, I687, V746, and C749 (Figure 3-3).  In the structural-based sequence 
alignment, not only is L721 conserved among the three domains, but the residues that had 
hydrophobic contacts with this leucine are well conserved too.  Although different in 
surface residues, the three domains share a conserved central hydrophobic network that 
holds the bundle together.  The overall folding of the GIT1 PBD is very similar to that of 
the FAT domain of FAK (RMSD value of 1.65 Å) and helices H2 to H5 of the vinculin 
Vt domain (RMSD value of 1.68 Å calculated and averaged on Cα pairs; Figure 3-4). 
The vinculin Vt domain is a five-helix bundle, with the first helix attached to the groove 
between helices H2 and H5.  The distance between Vt H2 and H5 is slightly more than 
that between GIT1 H1 and H4, probably because Vt H1 is attached to the groove. 
 
It has been demonstrated that FAK FAT domain features helix H1 swapping 
dynamics and dimer formation.91,101  However, it was not determined whether the dimer 
is of biological importance in the context of full length FAK.  Different from FAK FAT 
domain, no evidence showed similar H1 swapping dynamics or dimerization  
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Figure 3-3 The conserved hydrophobic core of the PBD. 
The L721 side chain is enclosed by the side chains of L668, I687, V746, and C749.  See 
the Figure 3-1 legend for color coding details. 
 
53 
 
 
  
Figure 3-4 Superposition of the structures of GIT1 PBD, FAK FAT, and vinculin 
Vt domains. 
Superimposition of GIT1 PBD, FAK FAT (1KTM), and vinculin Vt domains (H2 to H5) 
(1OKR) are shown in blue, red, and green respectively.  H2, H3, and H4 are relatively 
well overlaid whereas Vt H2 is more apart from the bundle.  Structures are aligned by 
the Swiss-Pdb viewer and the ribbon represented in MolMol. 
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phenomenon for GIT1 PBD.  The change of sample temperature from 37°C to 13°C 
resulted in a series of spectra showing all peaks with unchanged intensities.  It suggested 
there is no local line broadening in the protein, including the loop between H1 and H2 
(Figure 3-5).   The GIT1 PBD seems to be more resistant to H1 dynamics than FAK FAT 
domain.  The reason might be that the loop between H1 and H2 has a sequence of EFKH 
for the PBD and PAPP for the FAK FAT domain.  The three prolines in the FAT domain 
make the loop more rigid, probably introducing the conformational strains that cause 
FAT H1 swapping.   
 
 
3.3.2 The PBD and the FAT domain are similar on the H1/H4 surface but different 
on the H2/H3 surface 
 
Forming four amphipathic helices, the GIT1 PBD buries most of its hydrophobic 
side chains in the bundle core.  There is only one major hydrophobic patch on the surface.  
As shown in Figure 3-6, side chains from H1 and H4 form two positive-charged ridges 
sandwiching an elongated hydrophobic groove, which covers about two thirds of the 
bundle length.  To the center of the H1/H4 surface, positively charged K663, K755, K758, 
and polar residue T662, Q666, Y751 enclose a well-defined hydrophobic pocket 
composed of I665, A754, and A757 at the bottom.  These residues are conserved between 
GIT1 and GIT2 in all organisms for whom sequences are available.  Among them, K663, 
K758, A754, and A757 are also conserved with the FAK FAT domain, with a conserved 
I665/V936 substitution (Figure 3-1a).  This surface makes an ideal binding site for 
paxillin, as confirmed by chemical shift perturbation titration experiments. 
 
When the GIT1 PBD was compared with the FAT domain of FAK, the latter has 
two major hydrophobic grooves located at both the H1/H4 and the H2/H3 faces, which 
correspond to the LD2 and LD4 motif binding sites, respectively (Figure 3-6).32  Both 
grooves have a surface setting similar to that of the H1/H4 site of the PBD: a 
hydrophobic groove with surrounding polar and positive-charged ridges. Superimposition 
of the structures of the PBD and the FAT domain revealed that K663GIT1/K934FAK and 
K758GIT1/K1033FAK were in the same position, which is another indication of 
functional similarity arising from structural similarity.  The electrostatic interaction 
between the side chain of FAK K1033 and the conserved D146 in the LD2 motif might 
be important in determining binding specificity.  Thus, we speculated that the analogous 
K663 and K758 in GIT1 might also greatly contribute to paxillin binding; this prediction 
was confirmed by the studies described in the next section.   
 
The FAT surface has two hydrophobic surfaces that serve as LD motif binding 
sites, but the GIT1 PBD has only one such surface (Figure 3-6).  In the FAT domain, 
helices H2 and H3 form a second hydrophobic surface, and at the center of the FAT 
H2/H3 site, the bottom of the hydrophobic pocket is composed of G959 and A996 on H2 
and H3, respectively.  However, the equivalent position on GIT1 PBD is occupied by 
bulky H688 and Y719 which effectively close the pocket.  Moreover, the positively 
charged H2 ridge in the FAT domain is also eliminated by the substitutions of K956 and 
R963 in FAK by E685 and T692 in GIT1.  Interestingly, we found that the vinculin Vt  
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Figure 3-5 15N HSQC spectra of the GIT1 PBD measured at different 
temperatures. 
Blue: 37°C; cyan: 31°C; green: 25°C; gray: 19°C; red: 13°C.  All peaks in the spectra 
showed similar intensities at different temperatures, indicating that there was no floppy 
region in the PBD.   
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Figure 3-6 Electrostatic surfaces of PBD and FAT domains. 
Positive charge is shown in blue and negative charge in red.  Equivalent residues are 
marked in both structures.  The figure was generated by Pymol, based on the electrostatic 
potential generated by GRASP. 
57 
 
 
domain is more similar to FAK; for example, FAK K956 is conserved as K1021 in the Vt 
domain, whereas FAK G959 is substituted with a small residue A1024 in Vt.  This 
suggests a possible paxillin-binding site on the H2/H3 surface of the vinculin Vt domain. 
 
 
3.3.3 Paxillin LD4 motif binds to the PBD at the H1/H4 face  
 
The binding between the GIT1 PBD and paxillin is essential to localize the PAK–
PIX–GIT complex to the focal adhesion.60  Although the interaction between the paxillin 
LD4 motif and GIT proteins had been proposed,12,38,61 the details about the binding 
remained unknown.  Therefore, we analyzed the interaction between the GIT1 PBD and 
the paxillin LD4 motif by chemical shift perturbation experiments. In the experiments, 
we used a peptide comprising the LD4 motif of paxillin (residues 261–282, designated 
LD4 peptide, Figure 3-7c) to titrate the 15N-labeled PBD, and found that the LD4 peptide 
binds to the PBD on the H1/H4 surface.  The binding site locates to the central region of 
the H1 and H4 solvent-exposed surface, corresponding to the two clusters of largely 
shifted peaks in the perturbation plot (Figure 3-8a).  Although the two clusters seem to be 
remote in the sequence, they are actually in close contact in the 3D structure, forming the 
two ridges and the hydrophobic pocket mentioned previously (Figure 3-6a).  
 
Most of the shifted peaks affected by the bound LD4 peptide are in the 
intermediate exchange time scale.  Additionally, the cluster in H4 is higher than that in 
H1 in average, indicating a slightly stronger association with H4 than H1 (Figure 3-8a).  
The solvent-exposed T662, K663, Q748, Y751, D752, K755, and K758 exhibited 
significant perturbations (K633, Y751, K758 had the largest perturbations as shown in 
Figure 3-7a and d). The residues between them, which are buried between the helices, 
showed only moderate changes.  This indicates that the large shift is not due to a binding-
induced conformational change.  The cluster in H1 corresponds to the paxillin binding 
sequence 2 (PBS2) proposed by sequence analysis.38 Compared with H1/H4, residues in 
the H2 and H3 had only minimal or moderate shifts on LD4 peptide titration.  A closer 
inspection of the shifted peaks in H2 and H3 showed that most peaks are residues at the 
interface with H1 or H4, and among those, buried residues showed more perturbation 
than exposed ones, indicating that the perturbation was due to proximity to the H1/H4 
binding site.  Similarly, recent mutagenesis data showed that mutations on H2/H3 did not 
influence paxillin binding, while mutations on H1/H4 decreased paxillin binding, 
especially the K663 and K758 mutations substantially decreased paxillin association.62  
 
 
3.3.4 The effect of paxillin S272 phosphorylation on the binding of GIT1 PBD 
 
It was reported that paxillin S272 (S273 in the chicken sequence) phosphorylation 
promoted GIT1 focal adhesion localization in cells,89 and so we wanted to investigate the 
interaction with GIT1 and phosphorylated paxillin.  We studied the interaction between 
purified GIT1 PBD and synthesized LD4 peptide with S272 phosphorylation by NMR 
chemical shift perturbation experiments.  Different from the previous ITC data,62 we 
found the GIT1 PBD spectra titrated with phosphorylated LD4 peptide (LD4p) was very  
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Figure 3-7 The interaction between the PBD and LD peptides. 
(a,b) Overlay of GIT1 PBD spectra titrated with LD4 and LD2 peptides, respectively 
(Blue: GIT1 PBD alone; Cyan: adding 0.5 eq. of ligand; Green: adding 1 eq. of ligand; 
Gold: adding 2 eq. of ligand; Red: adding 5 eq. of ligand.  Arrows mark significantly 
perturbed resonance and dashed arrows mark perturbation with intermediate exchange 
rate.  (c) Sequence alignment of human LD2 and LD4 peptides used in this study.  
Identical residues are marked with asterisks and the LDXLLXXL motif is showing in bold.  
Conventional nomenclature is used; the first L is Φ0 and other residues are named as in 
the figure. 
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Figure 3-8 Analysis of the interaction between the PBD and LD peptides. 
(a,b) Composite chemical shift perturbation plotted against residue number for LD4 and 
LD2, respectively.  Composite chemical shift perturbation was calculated by the equation 
Δδ composite = (ΔδNH2 + ΔδN2 /25)½.  K663, K758, Y751 and Q748 are labeled and they are 
among those dramatically shifted peaks.    
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similar to that of the PBD titrated with the same ratio of LD4 peptide (Figure 3-9), 
indicating that the two peptides bound to the PBD with similar affinities.  Superimposing 
the 15N-HSQC spectra of the PBD mixed with 5 equivalents of the two peptides revealed 
that most perturbed peaks could be overlaid (Figure 3-10a), suggesting the two peptides 
bind to the PBD in similar fashions.  However, there were clear differences between the 
two spectra.  For example, comparison with the peaks in the spectrum of apo-PBD 
showed that some peaks were perturbed more by the LD4 binding (Figure 3-10b and e), 
while others were perturbed more by the LD4p peptide (Figure 3-10d).   In addition, the 
two peptides also shifted some peaks in different directions (Figure 3-10c and f).  In both 
cases, neither peptide produced a consistently larger chemical shift perturbation 
throughout the PBD binding site than the other, further indicating that the two peptides, 
LD4 and LD4p, have similar binding affinities for the PBD.  These observations suggest 
that unlike the interaction between the FAT domain of FAK and LD4p,45 in the complex 
of PBD bound to LD4p peptide, the phosphate group in the peptide has some contacts 
with the PBD, and those contacts might compensate for the entropy lost due to the 
phosphorylation.45 
 
 
3.3.5 The binding between the paxillin LD2 peptide and the GIT1 PBD 
 
Because the only hydrophobic patch on the GIT1 PBD corresponds to the LD2 
motif binding site on the FAT domain of FAK, we investigated whether the LD2 motif 
also participates in GIT1 binding.  Synthesized LD2 peptide (human paxillin 140-161, 
Figure 3-7c) was titrated into uniformly 15N-labeled GIT1 PBD.  Surprisingly, we found 
that the LD2 peptide also dramatically perturbed the PBD spectrum (Figure 3-7b).  The 
LD2 and the LD4 binding perturbed the same set of residues and they shifted in similar 
directions and distances (Figure 3-7).  Like LD4 peptide, when the LD2 peptide was 
titrated into the solution of GIT1 PBD, we found that while some peaks remained at the 
same position, many peaks shifted during the titration; some peaks had large shifts and 
some even showed intermediate exchange phenomena.  Thus, the LD2 peptide perturbed 
the GIT1 PBD spectrum to a similar extent as the LD4 peptide.  Additionally, both 
peptides perturbed the same set of peaks, and their binding sites overlapped on the H1/H4 
surface (Figure 3-6a). 
 
To determine how the binding occurs with both LD motifs present, we performed 
competitive titration experiments, in which up to 5 equivalents of LD2 peptide was 
titrated into 15N-labeled PBD in the presence of 5 equivalents of LD4 peptide and vice 
versa. The competitive experiments agreed with the single-peptide titration data, 
confirming that each peptide was able to further perturb the spectrum in the presence of 
equal concentration of the other peptide (Figure 3-11).  The two final spectra overlaid 
well, indicating that the binding reaches equilibrium regardless of the order in which the 
peptides were added.  It is likely that both peptides compete for the same binding site 
with similar affinity.  The concentration of available LD motifs may dynamically 
determine the equilibrium state.   
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Figure 3-9 Binding of the GIT1 PBD to the LD4p peptide. 
Overlay of GIT1 PBD spectra titrated with the LD4(S272)p peptide. Blue: GIT1 PBD 
alone; Cyan: adding 0.5 eq. of ligand; Gold: adding 2 eq. of ligand; Red: adding 5 eq. of 
ligand).  The result was very similar to the LD4 peptide titration, indicating the S272 
phosphorylation does not greatly influence the binding. 
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 Figure 3-10 Comparison of PBD spectra titrated with 5 eq. of LD4 or LD4p 
peptides. 
(a) Full spectra overlay.  Gray: GIT1 alone; Blue:GIT1 PBD+LD4; Red:GIT1 
PBD+LD4p.  While most peaks in the spectra of PBD bound with the two peptides could 
be overlaid well, some peaks exhibited difference.  (b)-(f) examples of different peaks in 
the spectra of PBD bound with the two peptides: (b) like the example showed, the 
bindings of the two peptides had similar effects to the most peaks in the spectra of PBD; 
(c) and (f) some peaks moved to different directions due to the bindings; (d) and (e) other 
peaks moved to the same direction, but the magnitudes of shift were different.  Some 
shifted more due to the LD4 peptide binding while others shifted more due to the LD4p 
binding. 
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 Figure 3-11 Competitive binding study of the GIT1 PBD to LD2 or LD4 peptide. 
(a) 15N HSQC spectra of GIT1 PBD with 5 eq. of the LD4 peptide (blue) and of the same 
sample with another 5 eq. of the LD2 peptides were added (red).  (b) 15N HSQC spectra 
of GIT1 PBD with 5 eq. of the LD2 peptide (blue) and of the same sample with another 5 
eq. of the LD2 peptides were addes (red).  The titration data showed that each peptide 
could further perturb the spectrum of the PBD in the presence of the same concentration 
of the other peptide, indicating that the two peptides had similar binding affinities to the 
GIT1 PBD.   
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To test the binding between PBD and paxillin, we titrated the PBD with up to 5 
equivalents of chicken paxillin 133-288, which contains both LD2 and LD4 motifs.  The 
spectrum of PBD titrated with 5 equivalents of paxillin 133-288 overlaid well with the 
PBD spectrum titrated with 5 equivalents of both LD2 and LD4 peptides, exhibiting an 
average of binding from both LD motifs (Figure 3-12).  It also showed that the LD3 motif, 
which was also present in the paxillin construct, does not interact with GIT1 PBD.   
 
 
3.3.6 Examining the interactions between LD peptides and GIT1 PBD by Biacore 
binding studies 
 
To further characterize the binding properties of the two paxillin peptides to the 
PBD, we measured the binding affinities between the LD peptides and the PBD by the 
Biacore binding assay.  In the experiments, the LD peptides were synthesized with an N-
terminal biotin tag connected with a flexible GGSG linker.  The peptides were 
immobilized on a NeutrAvidin coated chips and run through the purified GIT1 PBD 
protein.  As summarized in Table 3-2, the PBD binds to the LD4 peptide with a Kd of 7.2 
μM, which is close to the reported Kd of 10 μM.62  The LD2 peptide showed a slightly 
higher Kd of 25.1 μM.  Because the LD2 peptide binds to GIT1’s PBD with a Kd only 
about three times weaker than the LD4 peptide, the two peptides should be able to 
compete for the ligand binding site on the surface of the PBD, and indeed this conclusion 
is in agreement with our NMR experiments.  Also consistent with our NMR studies, the 
LD4p peptide exhibited only a slight increase in Kd value (Kd=10.2 μM).  
 
 
3.4 Discussion 
 
The solution structure of the GIT1 PBD is a stable four-helix bundle, which is 
similar to the structures of the FAT domain of FAK and the vinculin Vt domain.  The 
structure was validated by the solvent exposure surface mapped by the H/D exchange 
experiment.  The PBD forms an up-and-down helix bundle with an average axis angle of 
19.1º, which is close to the ideal antiparallel helix packing angle of 20º.102  The PBD, the 
FAT domain of FAK and the vinculin Vt domain share a well conserved hydrophobic 
core, but their surface residues exhibit more diversity.  This explains the very similar 
overall folding of the three domains as well as their distinct binding specificity. 
 
Both the PBD and the FAT domain interact with the LD2 and LD4 motifs of 
paxillin and are responsible for targeting GIT1 and FAK to focal adhesions.  However, 
there are distinct differences between the two domains.  First, in solution, the FAT 
domain forms a dimer by swapping the H1 between the two protomers,91 whereas the 
PBD is a well-folded monomer.  Second, the LD2 and LD4 motifs of paxillin interact 
with the FAT domain simultaneously at two opposite faces of the four-helix bundle,44 
whereas the LD2 and LD4 motifs of paxillin bind to the PBD at the same site, the H1 and 
H4 site.  These functional differences between the FAT domain and the PBD are rooted 
in the difference of their sequences. 
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 Figure 3-12 Spectrum of GIT1 PBD titrated with paxillin 133-288. 
Overlay of the spectra of the GIT1 PBD in the presences of 5 eq. of paxillin 133-288 and 
5 eq. of both the LD2 and LD4 peptides respectively.  Blue: GIT1+LD4; Cyan: 
GIT1+LD4+LD2 (in order); Gold: GIT1+LD2+LD4 (in order); Red: GIT1+LD2; 
Green: GIT1+paxillin 133-288.  (a) The whole spectrum of GIT1.  The black box showed 
the peak of T662, which was magnified in (b).  The paxillin 133-288 titration shifted the 
peaks of PBD to the average positions of the spectra of the PBD bound to the LD2 and 
LD4 peptide respectively. 
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Table 3-2 Binding affinities between GIT1 PBD and LD peptides measured by 
Biacore binding assay. 
 
Interaction KD (µM) Rmax (RU) 
GIT + LD2 25.1 (±0.2) 91.0 (±0.2) 
GIT + LD4 7.0 (±0.2) 53.3 (±0.4) 
GIT + LD4p 9.4 (±0.2) 87.7 (±0.4) 
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The previously reported  interaction between the LD4 motif of paxillin and the 
GIT1 PBD was confirmed in our studies.12,38,61  The binding site mapped by NMR was 
also in agreement with the recent mutation study,62 in which all residues critical for LD4 
binding exhibited strong chemical shift perturbation.  The LD4 motif binds to the H1 and 
H4 site of the PBD, unlike the complex of LD4 with the FAT domain of FAK, where it 
binds to the H2 and H3 surface.  This variation may also explain another difference 
between the two complexes: while S272 phosphorylation within the LD4 motif decreases 
the LD4 binding to the FAT domain,45 the LD4p peptide interacts with the PBD similarly 
to the LD4 peptide.  
 
In this study, the LD4 S272 phosphorylation interacted with PBD similarly to 
LD4 peptide.  The NMR showed that the spectrum of PBD titrated with LD4 S272p 
peptide overlaid well with the spectrum titrated with LD4 peptide.  The Biacore also 
showed that there is only a slight decrease in binding affinity by S272 phosphorylation.  
This result is different from the recent report, in which S272 phosphorylation decreased 
LD4 binding by 12 folds.62  The reason for the difference is still under investigation.  One 
possibility we noticed is that the author might have used a shorter LD4 peptide, since we 
found that GIT1 PBD binds very weakly to the phosphorylated LD4 peptide if it ends at 
the D275 (Figure 3-13). 
 
It has been proposed that paxillin S272 phosphorylation is an important event in 
focal adhesion regulation.12,45,89  In a working model, FAK and GIT1 compete for 
paxillin binding, and, in turn, the two proteins compete for FA localization.  When 
paxillin S272 is dephosphorylated, paxillin prefers binding to FAK, because FAK binds 
both the paxillin LD2 and LD4 motifs cooperatively with a higher affinity.  Once S272 is 
phosphorylated, the affinity between LD4 and FAK is weakened, causing the 
disassociation of FAK–LD4.45  However, the phosphorylation of S272 in LD4 does not 
affect the interaction between paxillin and GIT1.  Therefore, paxillin S272 
phosphorylation shifts the balance of the paxillin interaction with FAK versus GIT1 in 
favor of GIT1 and causes an increase in the paxillin–GIT1 complex.  This would 
decrease FAK while increasing PAK (through GIT1) in the FAs.  Since FAK has been 
linked to FA assembly and PAK can promote FA disassembly,12,45,89 this balance shift 
may promote regulated FA assembly and the disassembly cycle. 
 
The FAT domain of FAK binds to paxillin by interacting with both the paxillin 
LD2 and LD4 motifs simultaneously using its H1/H4 and H2/H3 sites.44,103  With two 
binding sites, FAT should have a much stronger binding affinity with paxillin than the 
GIT1 PBD since the PBD has only one LD binding site, the H1/H4 site.  This concern 
can be alleviated by another novel finding in this work – the paxillin LD2 motif also 
interacted with the GIT1 PBD.  Since the LD2 motif binds to the PDB as well, GIT1 
might achieve a binding affinity comparable to FAK by interacting with both the LD2 
and LD4 motifs of paxillin.  Indeed, in our studies, we not only showed that the LD2 
motif of paxillin could bind to the GIT1 PBD, but in one experiment we also found that 
the spectrum of the PBD bound with paxillin 133-288, which contained both the LD2 and 
LD4 motifs, was an average of the spectra of the PBD bound with the LD2 and LD4 
peptides (Figure 3-12).  Furthermore, such observation did not change even when the  
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Figure 3-13 GIT1 PBD spectra titrated with shorter LD4p peptide. 
PBD titrated with up to 10 eq. of the short LD4p peptide.  The peptide is 7 residues short 
at the C terminus and has a sequence of SATRELDELMASpLSD.  Blue: GIT1 PBD 
alone; Red: adding 2 eq. of ligand; Green: adding 10 eq. of ligand.  Different from the 
longer LD4p, the shorter LD4p bound to PBD very weakly, with only small perturbation 
at K755 and K758.     
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paxillin concentration was increased to five times that of the PBD, indicating that the two 
LD motifs have similar affinity to the PBD and bind GIT1 simultaneously.  In other 
words, it suggests that one paxillin can bind two GIT1 proteins.  In consistent with the 
observation, GIT1 can dimerize in solution through its central coiled-coil domain.104  
Considering the length of the flexible linker between the LD2 and LD4 motifs, it is 
possible that two GIT1 proteins in a dimer can bind to one paxillin molecule 
simultaneously, through both the LD2 and LD4 motifs.  Indeed, GIT1 is found primarily 
as an oligomer together with PIX,59,104 and the oligomerization is essential for GIT1 FA 
localization.105,106 
 
 
CHAPTER 4.  AN NMR STUDY OF GIT1-PAXILLIN INTERACTION AND THE 
DATA DRIVING COMPLEX STRUCTURE MODELING 
 
 
4.1 Introduction  
 
Cell attachment and migration are critical for embryogenesis, tissue repair, 
inflammatory response, tumor invasion and metastasis.1  Cell peripheral protein complex 
focal adhesion (FA) plays central role in cell attachment and migration.  FA mechanically 
couples cell membrane attachments with cytoskeletons and integrates signals in 
controlling the assembly and disassembly of adhesions.  The temporal and spatial 
distribution of FA is regulated by multiple proteins, e.g. Focal Adhesion Kinase (FAK), 
G Protein Coupled Receptor (GPCR) Kinase (GRK) Interacting proteins (GITs), p21-
activated kinase (PAK), paxillin and small GTPases.52,83-88 
 
GIT family proteins are multi-domain adaptors that consistent of an N terminal 
Arf GTPase-activating protein (Arf-GAP) domain, a central Spa2-homology domain 
(SHD), and a C terminal paxillin-binding domain (PBD).  GIT SHD interacts with PAK 
through the p21-activated kinase interacting exchange factor (PIX).53,56  GIT and PIX can 
dimerize by themselves and oligomerize to form high molecular weigh 
complexes.12,59,61,104,106,107   GIT PBD binds to paxillin and recruits the GIT complex into 
FA.12,38,54,60  GIT1 PBD forms a four-helix bundle that resembles the structure of FAK 
focal adhesion targeting domain (FAT).62,108  It interacts with both paxillin LD2 and LD4 
motifs through the same binding site on the H1 and H4 surface.108  Although the GIT1 
PBD structure and its interaction with paxillin were characterized,108 the atomic complex 
structure remained undetermined.   
 
Paxillin is a scaffold protein that binds multiple targets through its five N terminal 
LDXLLXXL motifs (LD motifs) and four C terminal LIM domains.90,109  Previous 
studies indicated the LD4 motif was the GIT1 binding site,12,38 but we demonstrated that 
both LD2 and LD4 motifs can bind GIT1 with comparable binding affinities.108  
Although the GIT1 titration experiment with unlabeled paxillin 133-288 suggested a 
simultaneous interaction between paxillin LD2, LD4 motifs and a PBD dimer,108 there 
was no study directly observing the binding of both LD motifs.  
 
There are three splice variants for human paxillin.  The only sequence difference 
is in the central region right after the LD4 motif.  Isoform β and γ differ from the isoform 
α with an insertion of 34 or 48 residues after the K277.   It has been shown that the splice 
isoforms bind differently to FA proteins, for example, isoform β binds stronger to FAK 
than to vinculin; however isoform γ binds stronger to vinculin than to FAK.35   Since the 
binding to FAK or vinculin are mediated by the LD4 motif, the insertion might help 
determine the specificities to FAK or vinculin.  One hypothesis is that the different 
sequences after the LD4 motif may influence the interaction between the LD4 motif and 
its binding partners, which may play a regulatory role.  In our recent study, we 
demonstrated that the GIT1 PBD was able to interact with paxillin isoform α LD4 
peptide (human paxillin α 261-282).  Since the splice isoforms are different after K277, 
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their interactions to GIT1 PBD are still unknown for the isoform β and γ.  The function of 
the splice variants right after the LD4 motif remains unidentified.   
 
To understand the function of the paxillin splice isoforms, we tested GIT1 PBD 
interaction with different LD4 peptides that derived from the isoforms.  We also tested 
GIT1-paxillin binding by directly observing the 15N labeled paxillin 133-288 construct.  
The complex structures determined by data driving HADDOCK modeling reconciled 
existing data and explained the binding specificities of paxillin-GIT1 interaction versus 
paxillin-FAK interaction.  
 
 
4.2 Materials and methods 
 
 
4.2.1 Protein purification and peptide synthesis 
 
15N labeled rat GIT1 PBD (640-770) was expressed and purified as described 
before.108  The sample condition for all the NMR titration experiments were: 400 uM of 
purified GIT1 PBD in the solution of 20mM potassium phosphate (pH 6.5), 5 mM 1,4-
dithiothreitol (DTT), 5 mM EDTA and 5% (v/v) D2O.  Chicken paxillin 133-288, which 
covered both the LD2 motif and the LD4 motif, was expressed with pET28b vector in E. 
coli strain BL21(DE3).  It was purified with the same Ni-affinity chromatography 
protocol and further purified with HPLC.  The paxillin NMR sample was prepared in the 
same buffer condition: 20mM potassium phosphate (pH 6.5), 5 mM 1,4-dithiothreitol 
(DTT), 5 mM EDTA and 5% (v/v) D2O.  All the human LD peptides were chemically 
synthesized and purified by HPLC at the Hartwell Center of Bioinformatics and 
Biotechnology, St. Jude Children’s Research Hospital, Memphis, TN.  The corresponding 
sequences were presented in Table 4-1.  
 
 
4.2.2 NMR chemical shift perturbation titration experiments 
 
All the titration experiments were performed at 25 °C on either a Bruker Avance 
600 MHz NMR spectrometer or a Bruker Avance 800 MHz NMR spectrometer, both 
equipped with cryoprobes.  All the peptides were dissolved in the same buffer as the 
protein: 20mM potassium phosphate (pH 6.5), 5 mM 1,4-dithiothreitol (DTT), 5 mM 
EDTA and 5% (v/v) D2O.  The pH was adjusted back to 6.5 before titration.  For the 
natural abundance 15N HSQC of the LD peptides, unlabeled LD2 peptide and LD4_S1 
peptide (used LD4_S1 instead of LD4α for solubility reason) were dissolved in the above 
buffer with final concentration of 8mM.  1024 scans on a Bruker Avance 600 MHz NMR 
spectrometer yielded good signal to noise ratio.  All the NMR spectra were processed 
with NMRPipe and analyzed with Sparky.94,95  Structural analysis and all the structure 
figures in this paper were generated with MolMol and Pymol.78,97 
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Table 4-1 The peptide used in the study and Kd value derived from Biacore 
SPR.  
 
Peptide Sequence Kd by Biacore SPR (μm) Rmax (RU) 
LD4α  SATRELDELMASLSDFKFMAQG 7.0 ± 0.2   53.3 ± 0.4 
LD4β SATRELDELMASLSDFKIQDLE 6.5 ± 0.2 50.3 ± 0.5 
LD4γ SATRELDELMASLSDFKGSWPL 6.5 ± 0.1 78.0 ± 0.3 
LD4 _S1 SATRELDELMASLSDFK 12.8 ± 0.2 28.4 ± 0.1 
LD4 _S2 SATRELDELMASLSD Not detectable / 
LD4 _S2p SATRELDELMAJLSD Not detectable / 
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4.2.3 Biacore surface plasmon resonance (SPR) binding assay 
 
LD peptides used in this study were the same sequence to the ones for NMR CSP 
titrations except that a GGSG linker joined a biotin tag at the N terminus.  The peptides 
were attached to a NeutrAvidin-covered (Pierce) gold surface (CM4 chip; Biacore, GE 
Healthcare, UK).  Kinetic studies were performed at 20°C with a BIACORE 3000 surface 
plasmon resonance instrument (Biacore, GE Healthcare, UK).  The purified GIT1 protein 
(in 20 mM potassium phosphate buffer, pH 6.5, 150 mM NaCl, 5 mM EDTA, 0.1 mg/mL 
BSA, and 0.005% P20 surfactant) was inject to flow through the chip and the Kd was 
derived by fitting the data from three injections.  The association and dissociation were 
observed at a flow rate of 50 μL/min in a concentration range of 1.2–100 μM.  Binding 
affinities were determined by the program Scrubber 2 (Version 2.0b, BioLogic Software).  
Triplicate injections were made and the average was reported. 
 
 
4.2.4 Circular dichroism spectroscopy 
 
All CD spectra were obtained with an Aviv 62DS CD spectrometer (Aviv, 
Lakewood, NJ).  The peptide samples were prepared so that the final concentrations were 
about 50 µM in a solution of 10mM potassium phosphate at pH 6.5.  Experiments were 
carried at 25 °C and a blank was used to eliminate solution influence.   
 
 
4.2.5 Complex structure modeling 
 
Complex structures were modeled with the software HADDOCK V1.3.77  The top 
20 GIT1 PBD structures with lowest target function were taken for complex modeling.  
The structure of LD2 and LD4 peptides were made as an ideal α-helix by Swiss-
Pdbviewer,99 according to the CD data and the LD2 structure solved before.31  The 
peptide structures were further energy minimized by 10000 steps of conjugated gradient 
method, in Sybyl V7.3 (Tripos, St Louis, MO).  The AIR restraint files were generated 
according to the previous LD2 and LD4 peptide titration data.108  The docking was 
performed on a Linux cluster with 16 CPUs.  The top 200 best models were clustered and 
the complex with best intermolecular energy was chosen as our model for further analysis.  
 
 
4.3 Results 
 
 
4.3.1 Comparison of paxillin splice variants for GIT1 PBD interaction.  
 
Using magnetic resonance spectroscopy (NMR) and Biacore binding assay, we 
tested the interactions between GIT1 PBD and three LD4 peptides derived from the 
splice isoforms (For sequences refer to Table 4-1).  
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NMR chemical shift perturbation (CSP) titration experiments were performed so 
that the binding interface and binding affinity can be compared.  The three LD4 peptides 
were chemically synthesized and titrated into 15N labeled GIT1 PBD.  The peptides were 
in the same length and only different in the C terminus.  Similar to the GIT1 PBD titrated 
with LD4α peptide,108 the LD4β and LD4γ peptide titrations dramatically perturbed the 
GIT1 PBD spectrum too.  The same set of residues was moved in the same directions 
with the same intermediate exchange phenomena (Figure 4-1).  In fact, the final spectra 
of GIT1 PBD titrated with 5 equivalences of LD4α, LD4β and LD4γ peptides were 
overlaid reasonably well (Figure 4-2).  The shifted peaks mapped to the same binding 
interface – the groove between helix H1 and H4.  The similar shifted distance and 
intermediate exchange phenomena indicated similar binding affinities.  Thus, from NMR 
CSP titrations, we were able to conclude that the LD4β and LD4γ peptides interacted 
with GIT1 PBD in a manner very similar to the LD4α peptide. 
 
Biacore SPR binding assay was used to compare the overall binding affinities 
between GIT1 PBD and the LD4 peptides.  As summarized in the Table 4-1, GIT1 PBD 
bound to the three splice variants with very similar binding affinity (7.0 μm, 6.5 μm and 
6.5 μm, respectively).  It confirmed the observation by NMR titration experiments.  Thus, 
the overall binding affinity between GIT1 PBD and the three splice variants were very 
close.   
 
 
4.3.2 Definition of minimal LD4 peptide length for the GIT1 PBD interaction 
 
With the aim of defining the minimal LD4 peptide length, we tested the binding 
of GIT1 PBD and LD4 peptides with different lengths.  The Biacore SPR showed that the 
peptide ended at K277 (designated LD4_S1) retained the similar binding affinity while 
the peptide ended at D275 (designated LD4_S2) didn’t have detectable binding signal 
(Table 4-1).  Also, the interaction between GIT1 and S272 phosphorylation of LD4_S2 
was also too weak to be detected by SPR.   
 
Similarly, NMR CSP titration experiments indicated that the LD4_S1 had the 
same perturbation pattern with the three LD4 variants tested (Figure 4-2).  The final 
spectra also overlaid satisfactorily with the final spectra of the three LD4 variants, which 
indicated the 5 residues extension in the C terminus did not have direct interaction with 
GIT1 PBD.  NMR was able to detect the binding of LD4_S2, although the peak shifting 
is much weaker.  The LD4_S2 S272 phosphorylation interacted even weaker with only 
slight peak shifts for GIT1 residues Y751, K755 and K758 (Figure 4-3).  Therefore, 
paxillin K277 was the C terminal end of the minimal LD4 sequence for GIT1 binding.  
Comparing LD4_S1 and LD4_S2, the deletion of F276 and K277 dramatically decreased 
GIT1 binding.  The two peptides had very similar CD spectra (Figure 4-4), indicating 
similar secondary structure compositions.  Thus, the tighter binding of LD4_S1could not 
be attributed to a more helical structure.  We also compared the 15N HSQC spectra 
titrated with 5 e.q. of LD4_S1 or 5 e.q. of LD4_S2 peptides.  As shown in Figure 4-5a, 
most peaks shifted to the same directions by both peptides, with a much larger distance 
for LD4_S1 peptide.  However, some peaks moved in different directions.  This could be  
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Figure 4-1 NMR CSP titrations with LD4 peptides derived from isoform β and γ. 
NMR CSP titrations observing 15N GIT1 PBD.  GIT1 PBD: LD4 peptide color coded as 
Blue –  1:0; Cyan – 1:0.5; Green – 1:1; Gold – 1:2; Red - 1:5  (a) GIT1 + LD4 isoform β. 
(b) GIT1 + LD4 isoform γ.   
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Figure 4-2 GIT1 PBD titrated with 5 equivalences of LD4α, LD4β and LD4γ 
peptides.       
All spectra overlaid well. Blue - LD4α; Gray - LD4β; Green - LD4γ; Red – LD4_S1.  
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Figure 4-3 The LD4_S2 S272p interacted very weakly to GIT1 PBD. 
Binding only caused slight shifts to GIT1 residues Y751, K755 and K758.  Blue-GIT1 
alone; Green-GIT1+1:2 LD4_S2p; Red-GIT1+1:10 LD4_S2p. 
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Figure 4-4 The CD spectra of LD4S1 and LD4S2 were very similar. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79 
 
 
 Figure 4-5 The comparison of GIT1 PBD titrated with LD4_S1 and LD4_S2 
peptide. 
(a) PBD spectrum titrated with either LD4_S1 or LD4_S2 peptides.  Gray – PBD alone; 
Blue – PBD+LD4_S1; Red – PBD+LD4_S2.  (b) The difference mapped to the PBD 
structure.  All the little balls represent the amide protons that have composite shift larger 
than 0.06.  The blue balls are peaks shifted in the same direction upon either LD4_S1 
titration or LD4_S2 titration.  The red balls are peaks shifted in different directions upon 
the two peptide titrations.  Since the CSP direction difference can be attributed to the 2 
residues difference at the C terminal end of LD4 peptide, it seems the LD4 C terminus 
interacts with the upper half of the H1/H4 surface. 
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accounted as the additional attachment site for F276 and K277, besides the overall tighter 
interaction.  Those peaks were mapped to the upper half of the H1 and H4 when the N 
and C termini pointed down (Figure 4-5b).  Peaks in H2 and H3 were shifted much less 
than those in H1 and H4, so they might be caused by the proximity or binding induced 
conformational change.  Hence, the F276 and K277 might create an additional attachment 
at the upper half of H1 and H4.  The observation was further confirmed with the complex 
model driven by independent data set. 
 
 
4.3.3 Both LD2 and LD4 motifs interacted with GIT1 PBD in the context of paxillin 
 
We have demonstrated that the 15N GIT1 PBD titrated with unlabeled paxillin 
133-288 was an average of LD2 and LD4 peptide titrations.108  In order to directly 
investigate the paxillin-GIT1 interaction, we did titration experiment the opposite way.  
By NMR, we compared the 15N HSQC spectra of 15N labeled paxillin 133-288 in the 
absence and presence of unlabeled GIT1 PBD.   
 
In the absence of GIT1 binding, paxillin gave a spectrum with most amide proton 
peaks clustering in the center within 1ppm range in proton dimension, which indicated 
lack of a well defined structure.  In the presence of 0.8 e.q. of GIT1, the paxillin spectrum 
is greatly perturbed (Figure 4-6a).  While more than half of the residues remained 
unchanged, about 20 peaks were largely shifted and some new peaks appeared in the 
more dispersed region.  The addition of more GIT1 up to 2.4 e.q. resulted in a spectrum 
very similar to that with only 0.8 eq. of GIT1 (Figure 4-6b).  Thus, it seems GIT1 PBD 
strongly bound to paxillin and the binding changed the conformation of part of the 
paxillin.  A defined structure in a certain region was stabilized by the GIT1 binding.   
 
In order to map the perturbed region in paxillin, at least the backbone resonance 
assignment was required.  However, as a disordered protein, it was prohibitively difficult 
to make the unambiguous assignment.  Previously, we had experimentally determined the 
structure of LD2 peptide and obtained its backbone assignment.31,44  In addition, LD2 and 
LD4 peptides natural abundance 15N HSQC spectra appeared to superimpose well with 
the spectrum of paxillin 133-288 (Figure 4-7).  Thus, the partial assignment of paxillin 
133-288 was obtained by adapting the assignment of the LD2 peptide,31 based on the 
assumption that the ordered LD motifs were relatively independent and the synthesized 
LD peptides can represent the LD motifs in the paxillin.  The peaks from the LD4 motif 
were also identified.   
 
The partial paxillin assignment made it possible to identify the GIT1 binding site 
by directly mapping the GIT1 titration data.  As shown in Figure 4-6, peaks from both 
LD2 and LD4 motifs experienced dramatic shifts.  It directly exhibited the interactions 
between GIT1 PBD and both LD2 and LD4 motifs in the context of paxillin.  Most 
shifted peaks were from either the LD2 or LD4 motif, excluding the possibility of LD3 
motif as a binding site.  Also, peaks other than from the LD2 and LD4 motifs kept at the 
same position, which ruled out the possibility of a wrapped loop between LD2 and LD4 
motifs, as predicted for paxillin-FAK interaction.31,44  Otherwise, we should expect to  
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Figure 4-6 15N paxillin titrated with unlabeled GIT1 PBD. 
Blue – 1:0; Red – 1:0.8; Cyan – 1:1.6; Green – 1:2.4. 
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Figure 4-7 Superposition of the spectrum of paxillin 133-288 with the natural 
abundance HSQC spectra of LD2 and LD4 peptides. 
The spectra overlaid well, allowing the partial assignment of paxillin.  Blue – paxillin 
133-288; Red – LD2 peptide; Green – LD4 peptide. 
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see remarkable chemical shift perturbations for most of the peaks, because the wrapping 
around was a huge conformational change for most of the residues in the paxillin 133-288.   
 
 
4.3.4 NMR driving HADDOCK complex modeling 
 
Although we have determined that both LD2 and LD4 bound to GIT1 PBD on the 
H1/H4 surface, the interaction details were still unclear without a complex structure.  By 
NMR, we determined the solution structure of GIT1 PBD as a 4-helix bundle.108  We had 
also solved the solution structure of LD2 peptide as a single α-helix.31  CD spectrum 
suggested LD4 peptide was also an α-helix in solution (Figure 4-8).  The binding site on 
GIT1 PBD had been precisely mapped by NMR CSP titrations experiments.108  Thus, we 
try to model the complex structures by HADDOCK.77  For GIT1, the active and passive 
residues were defined according to the NMR CSP titration data and solvent exposure 
surface data.108  For the peptides, the CSP based binding site mapping was not applicable, 
because all the peaks experienced shifts.  Thus, paxillin sequence conservations were 
used to define the active and passive residues.  
 
Figure 4-9 showed the complex models with the best intermolecular energy out of 
200 poses calculated by HADDOCK with explicit solvent refinement.  Both LD2 and 
LD4 peptides attached to the GIT1 H1/H4 groove as an additional helix to the bundle.  
The complex models for both peptides were very similar, in both distances and helix axis 
angles (Figure 4-10).  Both interactions were dominated by hydrophobic interactions 
between the hydrophobic GIT1 groove and the hydrophobic LD side chains, e.g. the 
residues at Ø-3, Ø+0, Ø+3, Ø+4, Ø+7 and Ø+10 (colored yellow in Figure 4-9).  It might 
explain the reason why both LD2 and LD4 peptides could interact with the GIT1 H1/H4 
face in a very similar manner.108   
 
 
 
Figure 4-8 CD spectrum suggested LD4 α peptide was an α-helix in solution. 
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Figure 4-9 Complex structures of GIT1 PBD bound with LD2 peptide or LD4 
peptide. 
Both peptides bound to the hydrophobic groove between H1 and H4.  The GIT1 PBD 
surfaces were colored according to surface charge, with blue for positive and red for 
negative.  The hydrophobic residues from LD peptides were colored in yellow.  (a) GIT1 
PBD + LD2 peptides; (b) GIT1 PBD + LD4 peptides. 
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Figure 4-10 The overlay of GIT1 PBD complex structures bound with LD2 or LD4 
peptides. 
The two complex structures were very similar.  Red – GIT1 PBD + LD2 peptide; Green - 
GIT1 PBD + LD4 peptide. 
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Besides hydrophobic interactions, there were some well defined salt bridge and 
H-bond connections between the LD peptides and the two polar and positive charged 
ridges.108  The conserved D146 and D267 (Ø+1) formed a salt bridge with GIT1 K758 for 
both LD peptides.  Similarly, this salt bridge is conserved between FAK K1032 and 
paxillin D146 (Ø+1) in the FAK-LD2 complex structure.32  There were H-bonds between 
GIT1 E659 and paxillin N141 (LD2 Ø-4) or S261 (LD4 Ø-5).  For GIT1-LD4 complex 
structure, a network of salt bridges and H-bonds was built by the E265Pax-K663GIT1-
E268Pax-Q666GIT1-S272Pax connections (Figure 4-11).  Experimentally, these GIT1 
residues were among those mostly shifted upon both LD peptide titrations.108  However, 
in GIT1-LD2 complex structure, the network was broken by the substitution of E268 
(LD4 Ø+2) with R147 (LD2 Ø+2), leaving only E144Pax-K663GIT1 and Q666GIT1-
E151Pax (Figure 4-11).  The breaking of a well defined H-bond network might contribute 
to the observation that LD4 peptides bound to GIT1 slightly stronger than the LD2 
peptide.108  The binding affinity difference was also supported by the slightly larger 
buried surface areas (1474.64 Å2 for LD4 compared to 1417.26 Å2 for LD2) and 
intermolecular energy calculations (-446.162 Kcal/Mol for LD4 compared to -315.141 
Kcal/Mol for LD2).   
 
With the complex structures, we would like to answer why the H1/H4 surface of 
GIT1 can bind both LD2 and LD4 peptides, while the analogous FAK surface binds only 
LD2 peptides.31,44,110  As shown in Figure 4-12, overall the two surfaces were similar as 
both featured a hydrophobic groove sandwiched by two polar and positive charged ridges.  
However, FAK had an additional positive charged patch at the upper end of helix 4, 
formed by K1018 and K1019.  The analogous position on GIT1 was T743 and Q744, 
which is in proximity to the positive charged LD4 K277 in our GIT1-LD4 complex 
structure.  Different from LD4, the same position in LD2 peptide was Q156, which 
should not cause charge repulsion.  Therefore, it might be possible that the binding 
specificity of FAK H1/H4 site is determined by the positive charged patch at the upper 
half of H4.   
 
There were no contacts between GIT1 PBD and the last 5 residues in LD4 peptide, 
which explained why LD4α, LD4β, LD4γ and LD4_S1 peptides behaved very alike in 
both NMR CSP titrations and Biacore SPR binding assays.  However, the paxillin F276 
and K277 made extensive contacts with the H1 and H4, correspondingly.   It explicated 
the huge difference between LD4_S1 and LD4_S2 peptides and confirmed our 
hypothesis that the binding affinity change was the result of additional contacts. 
 
The complex structures were validated by the recent mutation experiment, in 
which GIT1-paxillin binding was weakened to different extent by mutations such as 
K663E, K758E, I747E, T662E and Q666E.62  Those residues were right in the binding 
interface in both complex structures.  Our model also explained the reason why Y751F 
mutation didn’t affect binding was that the main interaction here was the hydrophobic 
stacking of the tyrosine aromatic ring against the side chain of paxillin L152 and 
V155(for LD2 complex) or L273 and F276 (for LD4 complex). 
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Figure 4-11  The side chain salt bridge and H-bond network. 
(a) The complex structure of GIT1 PBD and the LD2 peptide.  (b) The complex structure 
of GIT1 PBD and the LD4 peptide. 
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Figure 4-12 H1/H4 surface of GIT1 PBD and FAK FAT. 
Surfaces were colored according to the charge, with blue for positive and red for 
negative.  (a) GIT1 PBD bound with LD4 peptide.  The LD4 K277 is in proximity to GIT1 
T743 and Q744.  (b) FAK FAT domain surface map.  The two Lys create a large positive 
charged patch that may prevent LD4 binding by repelling LD4 K277.  
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4.4 Discussion 
 
Both NMR CSP titrations and Biacore SPR binding assay revealed that there was 
no significant difference between the three paxillin LD4 peptide variants and the shorter 
LD4_S1.  They interacted with the same interface on GIT1 with similar binding affinity.  
It disproved the hypothesis that paxillin splice variants might bind GIT1 differently. 
However, their interaction to other proteins, e.g. FAK and vinculin, should also be tested 
in order to conclude if the specificity is determined by the LD4 proximal sequences.  
Since there was no sequence homology in the last 5 residues, the study also confirmed 
that the last 5 residues were not directly involved in GIT1 interactions. 
 
Comparing the LD4_S1 and the LD4_S2, the deletion of the last two residues 
dramatically decreased the GIT1 interaction.  Why were the two residues were so 
critical?  There were two possible reasons: 1. the two residues capped the peptide C 
terminus and made the peptide more helical (more ordered); 2. the two residues made 
additional attachments to GIT1. The more ordered peptides should bind stronger than the 
less ordered ones because of the entropy loss upon binding.  The CD data disfavored the 
first hypothesis by showing that the two residues did not change the overall secondary 
structure.  So the stronger binding was not the result of increased helicity by the C 
terminal capping.  In contrast, both NMR CSP titration and complex modeling supported 
the second hypothesis.  The GIT1-LD4 complex even showed extensive contact between 
GIT1 and F276/K277.  Thus, it is likely the two residues made additional contacts that 
dramatically increased the binding affinity.   
 
The CSP titration with 15N labeled paxillin 133-288 substantiated our previous 
study that both paxillin LD2 and LD4 were able to interact with GIT1 PBD.108  It also 
confirmed our observation that the two LD motifs bound PBD with a similar affinity,108 
since peaks from both motifs experienced perturbation when there were more LD motifs 
than PBD (LD2:LD4:PBD=1:1:0.8 for the first point titration).  With only partial 
assignment, we were able to differentiate paxillin 133-288 resonance from either LD2 
motif, LD4 motif or the rest of the protein.  GIT1 PBD perturbed both LD2 and LD4 
motifs and those were the only region perturbed.  So it is likely GIT1 PBD interacts with 
both LD2 and LD4 motifs but not at the same time.  There was no wrap-around for the 
linker region, supporting the hypothesis that one paxillin interacts with two copies of 
PBD simultaneously.  Since GIT1 can dimerize through the coiled-coil domain,104 it is 
highly possible the dimer interacts with paxillin through both LD2 and LD4 motifs 
concurrently, achieving comparable affinity as the FAK-paxillin interaction.   
 
We deemed the complex models reliable.  The reason included: 1. It was a small 
system and there were no conformational changes upon binding;108 2. The top lowest 
binding energy models were classified to the largest groups for both dockings; 3. The 
models were validated by mutation data.  Our GIT1-LD2 complex structure resembled 
the FAT-LD2 peptide complex structure (1OW8 chain A,D, 32), with an overall backbone 
RMSD of 1.38 Å.  A close analysis found that FAT-LD2 binding was mainly 
hydrophobic interactions too, with side chain salt bridges and H-bonds.  Most of the side 
chain interactions were even conserved between FAT and GIT1.  This, along with the 
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supporting experimental data, demonstrated the reliability of our complex structure 
models.  For the GIT1-LD4 complex structure, the lack of contacts between GIT1 and the 
last five residues in LD4 explained the similarities within LD4 splice variants and 
LD4_S1 peptides.  The binding surfaces overlapped more than 90% for LD2 peptide and 
LD4 peptides, excluding the possibility of simultaneous LD2 and LD4 interactions.   
 
Most importantly, our complex structures suggested that FAK K1018 and K1019 
might be the determinant for its binding specificity in favor of LD2 to LD4 on the H1/H4 
surface.  Without this positive charged patch, GIT1 is able to interact with both LD2 and 
LD4 on the H1/H4 surface.  Further mutation experiments are needed to confirm this 
conclusion.  Thus, the complex models provide structural insight for the GIT1-paxillin 
interaction and are presented as a starting point for applications such as structure based 
ligand screening.   
 
 
CHAPTER 5.  CONCLUSION AND DISCUSSION 
 
 
5.1 The NMR structure of GIT1 PBD  
 
 
5.1.1 The accuracy and quality of the structure 
 
The accuracy of the NMR derived PBD structure was supported by the H/D 
exchange experiment.  As seen in Figure 3-1d, all the solvent accessible amide protons 
(blue) were mapped to the 3 inter-helix loops and the 2 ends.  So the flexible regions 
identified by the H/D exchange experiment correspond well to the loops in the structure.  
The protected peaks were mapped exclusively to the center of all 4 helices, which 
approved the accuracy of the structure.  Also, the low target function value (0.70) also 
indicated the good correlation between the structure and NOE data.  In addition, the PBD 
structure is very close to the previously reported GIT1 PBD homology model.62  Thus, 
the accuracy of the GIT1 PBD presented in this dissertation is supported from more than 
three independent data sources.   
 
The quality of the GIT1 PBD structure is elucidated by the final structure 
statistics.  As seen in Table 3-1, the structure was derived from a total of 2440 NOE 
distance restraints and 189 dihedral angle restraints.  Among them, there are 398 long 
range NOE restraints, most of which were inter-helix NOE correlations.  On average, 
there are 18.07 NOE restraints per residue.  So the structure was supported by a good 
number of restraints.   
 
The NMR structure bundle is of good precision too.  The overall backbone RMSD 
value is 0.39 Å and the heavy atom RMSD value is 0.77 Å.  In the Ramachandran plot, 
88% of residues are in the most favored region and only 1 residue is in the disallowed 
region.  It was the D643 which located at the very N terminal end in an unstructured 
region.   
 
Thus, all the statistics support that the structure presented in this dissertation is a 
high quality NMR structure.   
 
 
5.1.2 Structure analysis 
 
Overall, GIT1 PBD is a rod shaped molecule, about 58 Å in height and 26 Å in 
diameter.  The molecule shape was validated by an analytical ultra-centrifugation (AUC) 
experiment, which derived an f/f0 value of 1.24.  At the same time, the SAXS model also 
matched well to our structure in overall shape.62  The low resolution SAXS model 
showed that H3 and H4 appeared to be longer than H1 and H2, which can be explained 
by the fact that the H3/H4 loop was longer than the H1/H2 loop in our structure.   
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The solution structure of GIT1 PBD is a 4 helix bundle with right handed up-and-
down antiparallel topology.  The individual helices form an average axis angle of 19.1º, 
which is very close to the ideal antiparallel helix packing angle of 20º.102  This suggests a 
well organized inter-helix side chain network.  Actually, a well conserved hydrophobic 
side chain network has been identified from GIT1 PBD, FAK FAT and vinculin Vt 
domain.   
 
The GIT1 PBD is a well folded monomer in solution, which is different from the 
dimeric FAK FAT domain.91,101  The GIT1 PBD spectra taken at different temperatures 
revealed that all the peaks have similar intensity upon temperature change.  It is an 
indication of the absence of local regions with higher mobility.  However, the FAK FAT 
domain had local line broadening in the loop region between H1 and H2.  The 
comparison explained the reason why FAT can dimerize by swapping the H1.  The 
H1/H2 loop of PBD has the flexible sequence of EFKH comparing to the PAPP found in 
FAT.  We proposed that the conformational strain introduced by the proline rich loop is 
the cause of the higher dynamics of FAT H1 and the related dimerization behavior.   
 
 
5.1.3 The comparison to FAK FAT domain 
 
GIT1 PBD, the FAT domain of FAK and the vinculin Vt domain share a well 
conserved hydrophobic core, while the surface residues of the three domains exhibit more 
diversity.  This ensures the three domains to have a very similar overall fold while 
keeping distinct binding specificity.  There are more common points within the three 
domains: 1. they are all independent helix bundle proteins; 2. they share a conserved 
inter-helical side chain network; 3. they can all bind to the paxillin LD motifs and are 
responsible for focal adhesion targeting.  Thus, the three protein domains are very similar 
in both structure and function.  This suggests a common ancestor for the three domains.   
 
However, there are many differences between GIT1 PBD and FAK FAT.  
Although they can both bind to paxillin at LD2 and LD4 motifs, PBD binds them at the 
same site – the H1/H4 face, while FAT binds them simultaneously at H1/H4 face and 
H2/H3 face.  The binding specificity can be elucidated by comparing the surface residues 
of PBD and FAT.   
 
 
5.1.3.1 The H1/H4 face 
 
Both GIT1 PBD and FAK FAT can bind paxillin LD2 motif at the groove surface 
between H1 and H4.  There are many similarities at this surface.  They are hydrophobic 
grooves sandwiched by positive charged and polar ridges.  Both of the hydrophobic 
grooves are elongated with similar size, accommodating the same set of hydrophobic side 
chains from the LD2 motif.  The two positive charged Lys residues (one at each ridge, 
see Figure 3-6) locate exactly at the same positions on both PBD surface and FAT 
surface.  In the complex structures, the two Lys residues function as attachment points to 
anchor the same two negative charged residues in the LD2 motif.  More specifically, the 
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K663GIT1 or K934FAK forms salt bridge with D146 in the LD2 motif.  The K758GIT1 
or K1033FAK form another salt bridge with E144 in the LD2 motif.  Besides the two 
conserved salt bridges, there are more conserved hydrogen bond pairs between LD2 and 
the polar residues from the ridges.  Thus, we can conclude that the H1/H4 surface is 
highly similar between GIT1 PBD and FAK FAT.  This perfectly explained the reason 
why the paxillin LD2 motif can bind to both GIT1 PBD and FAK FAT.   
 
 
5.1.3.2 The H2/H3 face  
 
The FAK FAT domain can bind to LD4 at its H2/H3 face, but the GIT1 PBD can 
not bind to any LD motif at its H2/H3 face.  The different binding specificity is rooted in 
the distinct surface residues.  Although both surfaces have a hydrophobic groove, the 
residues at the ridges are different.  On the H2/H3 surface of GIT1 PBD, the hydrophobic 
groove is closed by two bulky residues, the H688 and Y719, at the center of the groove.  
Differently, the two positions are occupied by two small residues (G959 and A996) on 
the FAT surface.  So FAT does not have the problem of a closed groove.  In addition, the 
positive charged residues (K956 and R963) on FAT ridge are also substituted by 
negativly charged ones (E685 and T692).  Since the positive charged surface patch may 
be responsible for the anchoring of the two negative charged residues in the LD4 motif, 
the lack of those positive charged residues might be another reason why GIT1 PBD 
cannot bind to the LD4 peptide.  Thus, there is major difference comparing the H2/H3 
surface of PBD and the FAT domain. 
 
 
5.1.4 Other 4 helix bundle proteins in FA 
 
GIT1 PBS shares the 4-helix bundle structure with both FAK FAT and vinculin 
Vt.  Besides, based on the high sequence homology, we also predict the same folding for 
FAK2 (PYK2) and GIT2 (PKL) C terminal paxillin binding domain.   It appears that this 
is an evolutionarily preferred structure for the binding of paxillin LD motifs.  In addition, 
there are more 4-helix bundle protein domains existing in focal adhesion components, e.g. 
p130CAS (1Z23 111), Talin VBS2 (1U89 112) , VBS3 (2B0H 113) and α-Catenin (1H6G 114).  
They are all bundles composed of 4 amphipathic helices in a right handed up-and-down 
topology.  All the helices were bundled up with 4 anti-parallel helices at an average inter-
helix angle of 20º.   
 
The reason for the concentration of so many 4-helix bundle proteins in focal 
adhesions remains unclear.  Some features of the helical bundle may contribute to the 
answer:   
 
1. 4-helix bundle proteins tend to be small and stable.  The up-and-down topology 
enables the forming of a bundle with minimal loop residues.  Besides, this also 
helps to increase the stability by aligning helix dipole moment so that opposite 
charged ends are against each other.    
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2. Although small in size, the stability allows them to expose a relative large binding 
surface (between helices), which results in a large binding energy. 
 
3. The bundle offers 4 faces, which makes it possible for the existence of multiple 
binding sites. 
 
4. The bundle often binds α helix parallel to its elongated groove, which may help 
fix the angle between the two binding partners.  This is of more importance for 
scaffold proteins to be able to bring its binders into proximity with the right 
distance and orientation. 
 
Thus, four-helix bundle protein domains have the features suitable for functioning 
at the focal adhesion.  It may be the reason why so many four-helix bundle proteins exist 
in the FA.   
 
 
5.2 The GIT1-paxillin interaction studies 
 
The GIT1-paxillin interaction has been studied extensively in this dissertation.  
With 15N labeled GIT1 PBD, we studied the interaction between PBD and different LD 
peptides, including LD2, LD4, LD4 S272p, LD4 splice variants, and LD4 shorts.  The 
studies mapped the binding site and compared the binding affinities.  More quantitatively 
comparison of binding affinity has also been made by Biacore surface plasma resonance 
binding assays.  With 15N labeled paxillin, we studied the interaction the other way, in 
which the GIT1 binding site on the paxillin was also mapped. 
 
 
5.2.1 Binding site on GIT1 
 
The binding of LD peptides perturbed the 15N HSQC spectrum of GIT1 PBD and 
allowed mapping the binding site on GIT1.  Both LD2 and LD4 peptides perturbed the 
same set of GIT1 spectra, which mapped to the groove between H1 and H4.  The binding 
site for both LD2 and LD4 is on the H1/H4 surface.  This observation corresponds well 
with the SAXS data that the LD4 peptide bound to GIT1 PBD at the H1/H4 surface.62 
  
The perturbations focused at the center of the H1/H4 groove, in which many 
residues experienced long range shifts and intermediate exchange phenomena.  Residues 
in the H2 and H3 experienced small shifts too, but the small shifts were the results of 
proximity to the H1/H4 site.  The reason includes: 1. the shifts were very small compared 
to residues at the H1/H4 site; 2. the buried H2/H3 residues had longer shifts than the 
exposed residues.  This exactly showed that it is the proximity to the H1/H4 that caused 
those shifts.  The GIT1-LD interactions were not at the surface of H2/H3, since the 
H2/H3 solvent exposed residues had less perturbation.   
 
Recently, in order to pinpoint the paxillin binding site on GIT1, a series of PBD 
point mutations were made and their ability to bind the full length paxillin were 
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examined.62  The mutation data perfectly matches our results, providing more 
biochemical support.  The residues that are critical to paxillin/GIT1 binding are mapped 
to the H1 and H4 site, while most mutations on H2 and H3 have minimal effect.  In the 
study described before, perturbed residues also cluster in H1 and H4, with minimal 
changes in H2 and H3.  Furthermore, while both K663E and K758E mutations abolished 
paxillin binding, both the Ks were among the most dramatically perturbed residues in the 
titration experiments.   
 
Also, among different species, H1/H4 has higher sequence identity than H2/H3.  
So from the evolutionary point of view, H1/H4 seems to be more important than H2/H3.  
Since the function of GIT1 PBD is paxillin binding, it is likely that the paxillin binding 
site is located to the more conserved H1/H4 surface.   
 
Thus, many evidences converge to identify that the GIT1 paxillin binding site is 
in the hydrophobic groove between H1 and H4.  The conclusion is supported by data 
from NMR CSP titration experiments, biochemical mutagenesis experiments, SAXS and 
sequence analysis.   
 
The binding of LD2 and LD4 peptides resulted in a very similar chemical shift 
perturbation pattern.  This is the direct evidence that the LD2 peptide and LD4 peptide 
bind GIT1 in a very similar manner.  The observation was confirmed by the complex 
structure modeling.  In the complex structures, the LD2 peptide and the LD4 peptide 
interact with GIT1 at the same angle and distance in the same pocket.  Most of the side 
chain interactions are even conserved, for example, the salt bridges between the two 
anchoring Lys on GIT1 to the Glu and Asp residues on the LD2 and LD4 peptides.  More 
details about the complex structure are discussed in section 5.3.   
 
 
5.2.2 Binding site on paxillin  
 
In order to discover the GIT1 binding site on the paxillin, NMR CSP titration 
experiments were performed from two directions.  Firstly, the experiments with 15N 
labeled GIT1 PBD identified LD2 and LD4 motifs as the binding site.  Secondly, the 
experiment with 15N labeled paxillin confirmed that both LD2 and LD4 motifs participate 
in GIT1 binding.  It also excluded the possibility of LD3 as a binding site.   
 
 
5.2.2.1 Studies from 15N labeled GIT1 
 
Using 15N labeled GIT1 PBD, we tested the interactions to peptides derived from 
paxillin LD2 and LD4 motifs.  The NMR CSP titration experiments discovered a PBD-
LD2 interaction, in addition to confirming the PBD-LD4 interaction.  Both paxillin LD2 
and LD4 peptides were able to dramatically perturb the NMR spectra of GIT1 PBD.  
Thus either LD2 or LD4 or both motifs could be the GIT1 binding site.   
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To determine which LD motif is the real GIT1 binding site, their binding affinity 
needed to be compared.  The competitive NMR titration experiments were used to 
directly compare the binding affinity.  The experiments showed that LD2 peptide could 
further perturb the spectrum in the presence of equal molar amounts of LD4 peptide.  
Similarly, the LD4 peptide could further perturb the spectrum in the presence of equal 
molar amount of LD2 peptide.  And the peaks from the two competitive experiments 
moved to a central position between the positions of single peptide titration (Figure 3-12).  
So it is clear that the two peptides bind to GIT1 PBD at very similar binding affinities; 
otherwise if one peptide binds significantly stronger than the other, only the stronger one 
can further perturb the PBD spectrum.  The observation was confirmed by the Biacore 
surface plasma resonance binding assay.  It showed the Kd values for PBD-LD2 and 
PBD-LD4 interaction were different by only three folds, which is close enough for them 
to compete if equal molar concentrations co-exist. 
 
The CSP titration with 15 N labeled GIT1 and unlabeled paxillin 133-288 further 
confirmed that the LD2 and LD4 motifs both interact with GIT1.  The PBD spectrum 
titrated with paxillin 133-288 was the average of PBD spectrum titrated with equal molar 
of both LD2 and LD4 peptides (Figure 3-12).  It means the GIT1 responds to paxillin the 
same as to the LD2 and LD4 peptides together.   
 
Thus, all the evidences above support that the paxillin GIT1 binding site is both 
the LD2 and the LD4 motifs.  Why did previous studies find that only LD4 is required for 
GIT binding? One noticeable difference is that we are studying GIT1 protein, while 
previous studies focus on GIT2 (p95-PKL).38,61  Although GIT1 and GIT2 have 65% 
sequence identity and 85% of similarity,49 they are different in many ways, e.g. GIT1 
exists mainly in full-length, but GIT2 is largely alternatively spliced;53 although GIT2 is 
uniformly distributed, GIT1 only expresses in certain cells;115  GIT1 binds paxillin with a 
much higher affinity than does GIT2 (p95-PKL);53 Src, FAK activity is required for GIT2, 
not GIT1, to localize to FA;116  GIT1, not GIT2, can localized to the FA with 
constitutively active PAK.60,107  The other difference is that we are studying protein 
interactions in the absence of other context proteins.  Since paxillin LD motifs are the 
binding sites shared with other proteins, e.g. FAK/PYK2, GIT1/GIT2, vinculin, 
Actopaxin or Clathrin, it is possible the LD2 motif is not always available for GIT1 
binding, probably due to masking or allosteric hindering by other proteins; and this could 
be an interesting way of regulation.  With this in mind, the current study provides a more 
direct observation that LD2 can actually interact to GIT1.  Since it is still unknown how 
paxillin dynamically interacts with multiple partners, this new finding may shed more 
light on the signal integration function of paxillin.   
 
 
5.2.2.2 Studies from 15N labeled paxillin  
 
The NMR CSP titrations observing the 15N labeled paxillin provided more direct 
information about the GIT1 binding site.  With the innovative approach, we were able to 
partially assign paxillin.  Using the partial assignment, the CSP titrations unambiguously 
identified the GIT1 binding site is both the LD2 and LD4 motifs.   
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Firstly, we want to discuss the correctness of the partial paxillin assignment.  The 
assignment was based on the comparison of the spectra of paxillin and its component LD 
motifs.  The paxillin 133-288 is a flexible protein, with folded LD motifs connected by 
unfolded linker sequences.  It can be described as “beads-on-the-string” model, in which 
the individual motifs are relatively independent and the HSQC peak positions are at the 
same positions as the HSQC peaks of individual motifs.  We found that the HSQC 
spectra of individual LD motifs matched well with the paxillin HSQC spectrum, which 
meant there were no interactions between the LD motifs and the rest of the protein.  The 
LD motifs in the paxillin construct folded and behaved the same as the isolated LD 
peptides.  This validated our approach to assign the paxillin by the assignment of the 
individual LD motifs.   
 
The partial assignment enabled us to identify which residues were from the LD2 
motif, which were from the LD4 motif and which were from the rest of the protein.  In 
the subsequent titration experiments, it directly showed which part of the paxillin was 
involved in the GIT1 binding. 
 
The titration of unlabeled GIT1 PBD into the 15N labeled paxillin 133-288 
perturbed all the peaks from both the LD2 motif and the LD4 motif.  Thus, this is the 
direct evidence that both LD2 and LD4 motifs are involved in GIT1 binding.  At the 
same time, all the peaks other than from the LD2 and LD4 motifs remains exactly at the 
same position.  So they are not involve in the GIT1 binding for the rest of the paxillin 
construct, including the LD3 motif and the linker sequences.  It excluded the possibility 
of wrapping around like the situation of the FAT-paxillin interaction, where the paxillin 
LD2 and LD4 motifs bind to two opposite face of the FAT and the sequences in between 
wrap around the FAT.  The data supports the model that the LD2 motif binds to a 
molecule of GIT1 and the LD4 motif binds to a second molecule of GIT1, because the 
residues in between do not have any perturbation.    
 
Thus, data from this part of study directly confirmed that the paxillin GIT1 
binding site is both LD2 and LD4 motifs.   
 
 
5.2.2.3 Model of GIT1-paxillin interactions 
 
The novel finding that the paxillin LD2 motif can also interact with GIT1 PBD 
opens a new window toward the understanding of FA signaling.  Current data supports 
the idea that FAK binds paxillin in the way that paxillin LD2 and LD4 motifs bind 
simultaneously to FAT in both the H1/H4 face and the H2/H3 face.44  With two binding 
sites, it seems the FAT should have much stronger affinity than GIT1 PBD if the LD4 
motif is the only binding site for PBD.  With the LD2 motif as another binding site, GIT1 
might achieve the comparable binding affinity by interacting with the two LD motifs 
simultaneously.  However, both LD motifs share the same binding site; it seems not 
possible for them to bind PBD at the same time.  This is true until we consider the fact 
that GIT1 can dimerize through its coiled-coil domain.104  Thus, we propose that GIT1 
interacts with paxillin as a dimer, with one protomer binds the LD2 motif while the other 
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binds the LD4 motif at the same time.  The two LD motifs could belong to one paxillin or 
two copies of paxillin.  The former possibility could lead to similar binding affinity 
comparable to the FAK-paxillin interaction; the later possibility could result in the cross-
linking of paxillin molecules in the FA, which is even more exciting.  Indeed, GIT1 is 
found primarily as an  oligomer together with PIX,59,104 and the oligomerization is 
essential for GIT1 FA localization.105,106  Our hypothesis exactly explained the 
observations in that only the oligomerized GIT1 can provide multi LD binding PBDs that 
interact with a network of paxillins, locating themselves into the FA and clusterize the 
FA at the same time.  This may also explain why previous studies only found the LD4 
motif as the GIT1 binding site – the LD2 motif alone may not be strong enough for GIT1 
binding.   
 
 
5.2.3 The effect of paxillin S272 phosphorylation 
 
Since the paxillin S272 phosphorylation promotes GIT1 FA localization,89 the 
effect of S272 phosphorylation was also tested.  We found that the LD4 S272p peptide 
bound GIT1 PBD in a manner very similar to the same length of LD4 peptide.  The same 
set of residues had perturbation shifts in the same direction and distance.  The final 
spectra of the PBD titrated with either LD4 or LD4p can be overlaid.  Most peaks were in 
the same position, while a small number of peaks were in different positions.  However, 
neither peptide produced a consistently larger chemical shift perturbation throughout the 
PBD binding site than the other, indicating the two peptides had very similar affinity to 
PBD.  This notion was confirmed quantitively by the Biacore surface plasma resonance 
experiment.  The Kd value for PBD binding with LD4 or LD4p was very close (7.2 μM 
and 10.2 μM, respectively).   
 
There is phosphorylation induced LD4 helix unfolding in the interaction between 
LD4 and the FAT domain of FAK.45  The same phosphorylation might induce helix 
unfolding too in the GIT1 interaction.  Since GIT1 binds the same to LD4 and LD4p, 
there might be some other interaction to compensate for the entropy lost for LD4p.  The 
most plausible theory is that the phosphate group of LD4p created more contacts which 
compensated for the entropy lost.   
 
 
5.2.4 Paxillin splice variants and short LD4 peptides 
 
The three paxillin splice variant differ right after the LD4 motif, so we tested 
GIT1 binding with the three LD4 peptides, of which the sequence is the same in the N 
terminus and different in the C terminus.  Both NMR CSP titration and Biacore SPR 
showed that the three splice variants bound GIT1 PBD the same: same binding affinity, 
same binding site and same intermediate exchange phenomena.  This is different from a 
previous report that the splice variants bind differently to FA proteins.35  There are three 
reasons that might contribute to the discrepancy: 1. while the 3 spice variants bind the 
same to GIT1, they might interact differently to other paxillin LD4 binding FA proteins, 
e.g. FAK, actopaxin and PAK3; 2. the LD4 peptides might not be long enough to show 
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the difference; 3. the difference might be caused by conformational changes far into the 
insertions.   
 
By serial deletion of the LD4 peptide at the C terminus, we identified the minimal 
LD4 length for GIT1 binding.  The LD4 peptide ending at K277 is enough and sufficient 
to interact with GIT1 PBD.  The deletion of two residues at the C terminal end 
dramatically decreased GIT1 binding.  In the GIT1-LD4 complex structure, the two 
residues, F276 and K277, have extensive interactions with PBD.  However, there is no 
interaction between GIT1 and the residues beyond K277.  Thus the complex structure 
explained the reason why F276 and K277 are required for effective GIT1 binding and the 
reason why the LD4 splice variants did not exhibit any difference. 
 
 
5.3 The GIT1-LD complex structures 
 
 
5.3.1 The reliability of the complex structure models 
 
Although accurate, HADDOCK can still make mistakes in generating the 
complex structure models.  So the correctness of the model has to be validated before 
further analysis.  We deem the complex structures correct and reliable.  The reasons 
include: 
 
1. The complex structures were validated by mutation data.62  All the GIT1 
mutations that proved to be important for paxillin binding involved residues that 
had extensive side chain contacts in the complex structures.  All the GIT1 
mutations that proved to be non-important for paxillin binding involved residues 
that had no contacts in the complex structures.  
 
2. The binding site that was used to guide HADDOCK docking was obtained 
experimentally from the CSP titration experiments.  Extensive binding site 
information was obtained for GIT1 PBD. 
 
3. The structure of the binding partners, the GIT1 PBD and LD peptides, were 
experimentally determined by NMR, which is more accurate than homology 
models.  
 
4. There was no conformational change upon interacting with both LD2 peptide and 
LD4 peptide.  Since HADDOCK treats residues with very limited flexibility, this 
is an important prerequisite. 
 
5. Both complex structures were small systems that had a smaller number of 
possible conformations to sample, so it was less challenging for HADDOCK to 
find the best solution. 
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6. During post docking analysis, the top lowest binding energy models were 
classified to the largest groups.  In other words, the models were solutions that 
had the lowest binding energy and were similar to the majority of all the possible 
solutions.      
 
 
5.3.2 The reason why GIT1 PBD binds both LD2 and LD4 motifs 
 
The complex structures found that the sequence similarity of LD2 and LD4 motifs 
determined the ability for the two LD peptides to bind to GIT1 PBD.  The interactions 
were primarily mediated by hydrophobic interactions with specificity mediated by side 
chain salt bridges and H-bonds.   
 
The two LD peptides had well conserved hydrophobic side chains.  As aligned in 
Figure 3-8c, the side chains of Φ-3, Φ+0, Φ +3, Φ +4, Φ +7 and Φ +10 positions were 
highly conserved in both properties and positions in the helices.  In the complex 
structures, all of those residues were inserted into the hydrophobic groove between H1 
and H4.  So the conservation of the hydrophobic residues provided the basis for both LD 
peptides to bind to the PBD H1/H4 site.   
 
Besides the hydrophobic residues, the conservation of the charged and polar 
residues further contributed to the fact that both LD peptides can bind to GIT1.  For 
example, the Glu at Φ-1 and the Asp at Φ+1 had the conserved salt bridges to GIT1 K663 
and K758, respectively.  Also, the H-bond between GIT1 Q666 and paxillin LD Φ+6 
residue were conserved too.   
 
With the conservation of the large hydrophobic contacts, the well defined salt 
bridges and H-bonds, the LD2 and LD4 peptides were very alike.  Thus both LD2 and 
LD4 motifs can interact with GIT1 PBD at the H1/H4 site.  It also explained why the two 
peptides perturbed the same set of residues in a very similar manner in the CSP titration 
experiments.   
 
 
5.3.3 The specificity compared to FAT domain of FAK  
 
Since there are so many similarities between the two LD motifs, why does the 
H1/H4 site of FAK FAT domain only interact with the LD2 motif?  What determines the 
specificity of GIT1 PBD versus the FAK FAT domain?  
 
The answer might be the subtle difference of the H1/H4 surface.  Overall the two 
surfaces are very similar as both featured a hydrophobic groove sandwiched by two polar 
and positive charged ridges.  However, the FAK H1/H4 has an additional positive 
charged patch at the upper end of helix 4 (K1018 and K1019).  The same positions on the 
GIT1 surface are T743 and Q744 which accommodate well the LD4 K277 residue.  So 
this may explain why the LD4 motif can bind to the H1/H4 site of GIT1, but not the 
H1/H4 site of FAK FAT.   
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5.4 Implications for the understanding of FA disassembly  
 
Focal adhesion disassembly, or FA turn over, is important to ensure cells 
switching from stationary to motile.  It is as important as FA assembly if not more 
important.  However current research has focused more on the FA assembly.  The 
mechanism of FA disassembly is just starting to be unveiled.  More and more evidence 
indicates that PAK is one of the key regulators for FA disassembly,12,45,89  Combining 
previous knowledge and discoveries in this dissertation, we proposed a model of FA 
disassembly initiation (Figure 5-1). 
 
This model involves the switch of assembly activator FAK to the disassembly 
activator PAK, under the control of paxillin S272 phosphorylation.  Detailed discussion 
follows the Figure 5-1.   
 
1. FAK and GIT depend on paxillin for FA localization.  The interactions between 
paxillin LD motifs and the FAK FAT domain or the GIT1 PBD are critical for 
their FA targeting.  At the beginning of FA assembly, FAK is recruited to FA 
through paxillin.  The FAT domain of FAK binds paxillin LD2 and LD4 motifs 
simultaneously, with LD2 binding to the H1/H4 site and LD4 binding to the 
H2/H3 site.  The interaction is cooperative at two helix-helix interfaces, bearing a 
large binding energy.31,44  FAK is one of the master activators of FA assembly.  
The recruitment of FAK activates multiple downstream signaling, resulting in the 
FA assembly at cell leading edge as well as the cell survival and proliferation. 
 
2. The paxillin S272 (in the LD4 motif) phosphorylation is the major switch event to 
change FA assembly to FA disassembly.  The kinase that phosphorylates the S272 
is still unknown.  The phosphorylation of S272 leads to the dissociation of 
paxillin LD4 from the binding site at the FAT H2/H3 face.  The mechanism 
involves the unfolding of the LD4 motif by the S272 phosphorylation.45  Without 
the interaction at the LD4 motif, the cooperative binding at the LD2 motif may 
not be strong enough to compete with other paxillin binding partners, in particular, 
the GIT1.  
 
3. GIT1 PBD is capable of binding to either the LD2 or the LD4 motif with roughly 
the same affinity.  And the LD4 S272 phosphorylation does not influence the 
PBD interaction.  So, without FAK occupying the LD motifs, GIT1 is able to bind 
to paxillin, through either LD2 or LD4 or LD4p motifs.  Considering the fact the 
GIT1 is primarily found to be dimerized in the FA, we also propose that the 
interaction involves the one molecule of paxillin and a dimer of GIT1 (it could be 
a GIT1 homodimer or heterodimer with GIT2).  Thus, one copy of GIT1 binds to 
the LD2 motif and the other GIT1 binds to the LD4 motif, achieving a similar 
binding affinity as the FAK-paxillin interaction.  The recruitment of GIT1 into FA 
also brings in PAK and PIX via the interaction of GIT1-PIX-PAK.  PAK is one of 
the master activators to promote focal adhesion disassembly.  The PAK activity 
can activate downstream signaling to promote FA disassembly.  
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Figure 5-1 Model of focal adhesion disassembly initiation. 
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Thus, cell achieves FA assembly to the disassembly switch through the paxillin 
phosphorylation and the recruitment of different activation complexes.  The paxillin S272 
phosphorylation shifts the balance of paxillin interaction with FAK versus GIT1 in favor 
of GIT1.  This would decrease FAK while increasing PAK in the FA; the balance shift 
may promote regulated FA assembly and disassembly cycle.    
 
This model integrates existing data to provide a reasonable working theory for FA 
disassembly, a critical cell function.  However, there are still a lot of questions to be 
answered, for example, which kinase phosphorylates the S272 and which phosphatase 
reverses the S272p and at what time point?  Nevertheless, the structural and functional 
studies of GIT1 PBD presented in this dissertation shed more light on the function of GIT 
proteins in the integration of focal adhesion signaling.   
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APPENDIX A. A STRUCTURAL AND FUNCTIONAL STUDY ON THE 
INTERACTION BETWEEN EBNA2 AND NOTCH EFFECTOR CSL 
 
 
A.1 Introduction  
 
 
A.1.1 Notch signaling pathway 
 
Notch signaling is evolutionarily conserved and involves cell fate decision in 
metazoans through intercellular communications.117  This signaling pathway is widely 
used in organisms from C. elegans to human.  The interaction of trans-membrane 
receptor Notch with its ligand DSL (Delta, Serrate, Lag-2) on the neighboring cell 
surface activates the intracellular signaling pathway and controls binary cell-fate 
determination.117-119  Various cancers and developmental disorders have been found to 
relate to abnormal Notch signaling.120,121  
 
CSL is the collective name of CBF1/RBP-Jκ, Su(H), Lag-1 for mammalian, 
Drosophila melanogaster and Caenorhabditis elegans orthologs, respectively.  It is the 
central nuclear effector in the canonical Notch signaling pathway.  In the nucleus, CSL 
specifically binds to target DNA and acts as an expression switch in working with 
different co-regulators.  Without an activation signal, CSL binds co-repressor complexes 
and keeps its target gene silent.  Upon activation by the ligand DSL from the adjacent cell, 
receptor Notch is cleaved by presenilin-dependent proteolysis and the Notch intracellular 
domain (NICD) is released.122  In the nucleus, migrated NICD binds CSL and results in 
the displacement of co-repressors by co-activators, which then turns on transcription by 
chromatin remodeling.122  The products of CSL controlled genes belong to the basic 
Helix-Loop-Helix (bHLH) family of transcription repressors, including Hairy/Enhancer 
of Split (HES) and HES related repressor protein (HERP).123,124  HES and HERP are 
transcription factors themselves and further control downstream gene expression in 
different contexts.  Although there is evidence for CSL independent Notch signaling,125-
128 CSL is still believed to be the major effecter of the Notch pathway.117   
 
Notch signaling plays an essential role in development.  Take the vascular system 
for example, Notch components are found widely expressed in various vessels, including 
system artery, pulmonary artery and veins.129-133  In mice, mutation or knockout of 
different Notch components results in multiple system development disorders.  Most of 
the investigations found embryonic lethality with vascular development failure.130,134,135  
In humans, two diseases caused by Notch component deficiency were recorded to have 
cardiovascular system abnormality: Alagille syndrome (AGS) and Cerebral Autosomal 
Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) 
with Notch ligand Jagged1 and receptor Notch3 mutation, respectively.13,136,137  The 
current opinion on Notch function in vascular development is that it is dispensable in 
vasculogenesis, a process of forming the primary homogeneously sized vascular plexus, 
but essential for angiogenesis, a remodeling step following vasculogenesis.128 
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A.1.2 Epstein-Barr virus transforms B lymphocytes by hijacking the Notch pathway 
 
Epstein-Barr Virus (EBV) is a common human herpesvirus that is the major cause 
of infectious mononucleosis and is tightly associated with several cancers, especially B 
cell lymphomas in immunocompromised individuals.138  EBV achieves strong 
transforming potential by hijacking the Notch signaling pathway.  EBV Nuclear Antigen 
2 (EBNA2) is a latent viral gene product that interacts with the host Notch nuclear 
effector CSL.139-142  Three layers of evidence proved that the EBNA2-CSL interaction is 
essential for EBV associated B cell transformation: while an EBNA2 gene deleted EBV 
strain can not transform B cells;143 restorations of the EBNA2 gene restores 
transformation function.144  Furthermore, disruption of EBNA2-CSL interaction inhibits 
EBV induced growth proliferation.145   
 
Thus, both NICD and EBNA2 can bind the Notch nuclear effector CSL and both 
interactions have critical functions.  The crystal structure of C. elegans Lag-1 bound with 
DNA was determined by Kovall et al in 2004.146  Core Lag-1 comprises three 
subdomains among which the central beta-trefoil domain (BTD) was found to bind with 
NICD by native gel electrophoresis.146  Recent studies resolved crystal structures of CSL 
complexed with NICD and co-activator Mastermind (Figure A-1).100,147  The new 
complex structure revealed that Notch binds CSL BTD via the same stretch of residues as 
we used in the preliminary binding test.  Thus far, there is no CSL complex structure 
available to show how EBNA2 binds CSL.  Although some researchers believed the 
binding site for EBNA2 might be similar to that of NICD,146,147 some mutation data 
indicates that NICD and EBNA2 have distinct binding sites on CSL.148,149  In this project, 
we studied the interaction between CSL and EBNA2 and compared it with CSL-NICD 
interaction.   
 
 
A.2 Experimental procedures 
 
 
A.2.1 CSL construct and peptide synthesis 
 
The BTD of the human CSL179-333 was subcloned into a pET15 vector.  The 
protein was overexpressed in E. coli strain BL21(DE3) and 15N labeled by growing the 
cells in MOPS-buffered medium containing 15NH4Cl (1 g/L).93  Proteins were purified 
by the Ni2+-charged His-Bind Resin (Novagen, San Diego, CA) according to the 
manufacturer’s protocol.  The His tag was removed by thrombin cleavage (EMD 
Biosciences, San Diego, CA) at room temperature for 4 hours.  The digested protein was 
dialyzed in 50 mM potassium phosphate (pH 7.2), 50 mM NaCl, 5 mM 1,4-dithiothreitol 
(DTT), and 5 mM EDTA and further purified by gel filtration on a HiLoad 26/60 
Superdex 75 HR column (GE Healthcare, UK).  The EBNA2 peptide and NICD peptide 
were chemically synthesized and purified by HPLC at the Hartwell Center of 
Bioinformatics and Biotechnology, St. Jude Children’s Research Hospital, Memphis, TN.  
The CSL target DNA was synthesized as single strand DNA and annealed at 95 °C and 
cooled down to 25°C.   
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Figure A-1 Crystal structure of CSL bound with NICD. 
The Crystal structure of CSL bound with NICD (2FO1, 147)  CSL is composed of 3 
subdomains: N terminal domain(NTD) in blue, central beta-trefoil domain(BTD) in 
yellow and C terminal domain (CTD) in red.  The NICD binds to BTD through a stretch 
of residues from the RAM domain. (Magenta).   
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A.2.2 NMR chemical shift perturbation titration studies 
 
The 15N labeled CSL BTD sample was approximately 400 μl at a concentration of 
0.4 mM in 50 mM potassium phosphate buffer (pH 7.2), 50 mM NaCl, 5 mM EDTA, 5 
mM DTT, and 5% (v/v) D2O.  All peptide stocks were prepared with the same buffer and 
the pH was readjusted to 7.2 before titration.  All NMR spectra were acquired at 25°C 
with a Bruker Avance 600 MHz spectrometer equipped with cryoprobe.  NMR data was 
processed by NMRpipe and analyzed with the software Sparky.94   
 
 
A.3 Results and discussion 
 
Based on the Lag-1 structure and sequence alignment from different organisms,146 
we designed several constructs for the central beta-trefoil domain(BTD) of human CSL 
homologue CBF1/RBP-Jκ.  An optimal construct (hRBP-Jκ 179-333) and solution 
condition was obtained by extensive solubility screening and NMR analysis.  An 15N 
HSQC experiment was carried out for initial protein fold quality assessment.  As shown 
in Figure A-2, the protein is very sensitive to pH changes and our screening found that 
pH 7.2 is the best pH to balance stability and deprotonation at low pH.   
 
Using our CSL BTD construct and synthetic peptides from both hNotch1 and 
EBNA2, we were able to show that there is strong binding between CSL BTD and both 
peptides.  The data indicated that the adding of both peptides can dramatically stabilize 
the CSL BTD structure.  As shown in the 15N HSQC spectrum, there are only a few 
dispersed peaks when observing 15N-labeled CSL BTD alone (Figure A-4).  A large 
number of peaks are clustering in the center, which is an indication of poor folding.  
However, upon adding the unlabeled peptides, almost all the peaks show up and nicely 
dispersed (Figure A-5).  The experimental conditions were carefully controlled to insure 
the same solution environment, including pH, salt concentration, protein concentration 
and temperature.  The spectra ware collected and processed with the same set of 
parameters too.  The dramatic spectral change is a strong indication of protein- peptide 
interaction.  Our explanation is that by binding to CSL BTD, both peptides dramatically 
stabilized the protein structure.   
 
Interestingly, we noticed that there is significant peak shifting comparing hNotch1 
peptide bound form and EBNA2 peptide bound form (Figure A-6).  This abnormally 
large difference, as shown in the overlaid spectrum, led us to speculate that there might 
be different binding sites for the two peptides, which is consistent with the mutation 
data.148,149  The other possibility is that the binding of different peptides to the same site 
might induce different conformational changes, which could open a new door to the study 
of Notch signaling and the EBNA2 hijacking mechanism.   
 
At the same time, we also found that there was an interaction between CSL BTD 
and its target DNA sequence when it co-existed with, as we observed that the synthesized 
DNA fragment can further perturb the peaks from the EBNA2 peptide bound CSL BTD 
(Figure A-7).  This indicated that the CSL binding site for EBNA2 peptide and DNA 
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Figure A-2 CSL BTD fold is very sensitive to pH change.  
The pH screening found that pH 7.2 is the best balance point for protein stability and 
deprotonation effect.   
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Figure A-3 The alignment of EBNA2 and Notch sequence used in the study. 
The highlighted area is proposed as the CSL binding site.146 
 
 
 
 
Figure A-4 15N HSQC spectrum of CSL BTD. 
Peaks are poorly dispersed, which is an indication of poor folding. 
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Figure A-5 15N HSQC spectra of CSL BTD bound with different peptides. 
(a) CSL BTD + hNotch1 peptide (1:5);  (b) CSL BTD + EBNA2 peptide (1:5). 
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Figure A-6 Overlayed 15N HSQC spectra of CSLBTD bound with both peptides.  
Blue -- CSL BTD + hNotch1 peptide (1:5); Red  -- CSL BTD + EBNA2 peptide (1:5). 
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Figure A-7 The DNA target interacts with CSL BTD in the presence of EBNA2. 
Blue – CSL BTD + EBNA2 peptide (1:5) ; Red – CSL BTD + EBNA2 peptide (1:5) + 
DNA target (1:5).  It showed that the DNA can further perturb the CSL spectrum, 
indicating the binding sites for EBNA2 and DNA are not overlapping.   
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were not overlapping, and EBNA2 and DNA can bind CSL BTD simultaneously.  It 
supported the hypothesis that EBNA2 functions as a transcription regulator because 
EBNA2 binding did not exclude DNA binding.      
 
Studies had showed that EBV transformed B cells by hijacking Notch signaling 
with its latent protein EBNA2.  However, there was no detailed model on how EBNA2 
achieves its goal.  Although how NICD interacts with CSL has been elucidated,100,147 
conflict still remained regarding whether EBNA2 shared the same binding site.147-149  On 
basis of our preliminary data, we can conclude that EBNA2 might bind dramatically 
differently from NICD, either binding to a different site or inducing distinct 
conformational changes on CSL.  However the question can not be answered without the 
CSL-EBNA2 complex structure determination.  The complex structure can also help 
elucidate the mechanism by which EBNA2 hijacks Notch signaling.  Hence, the future 
direction of this project is to solve the complex structure of CSL/EBNA2.   
 
APPENDIX B. NMR DATA PROCESSING SCRIPTS  
 
NMRPipe script for processing 2D 15N-HSQC spectrum: 
 
FIN=ser 
OUT=hsqc.ft5 
bruk2pipe -in ./ser -bad 0.0 -aswap -DMX -decim 1920 -dspfvs 20 -grpdly 
68  \ 
  -xN              2048  -yN               256  \ 
  -xT              1024  -yT               128  \ 
  -xMODE            DQD  -yMODE  Echo-AntiEcho  \ 
  -xSW        9615.385   -ySW         1519.988  \ 
  -xOBS         599.913  -yOBS          60.796  \ 
  -xCAR           4.618  -yCAR         118.913  \ 
  -xLAB              1H  -yLAB             15N  \ 
  -ndim               2  -aq2D          States  \ 
|nmrPipe -fn CBF \ 
|nmrPipe -fn SOL -mode 1 -fl 7 -fs 3 -poly               \ 
|nmrPipe -fn SP -size 1024 -off 0.5 -end 0.98 -c 0.5  -pow 2   \ 
|nmrPipe -fn GM -g1 16 -g2 10 \ 
|nmrPipe -fn ZF -size 2048                                   \ 
|nmrPipe -fn FT                                              \ 
|nmrPipe -fn EXT -left -sw                                   \ 
|nmrPipe -fn PS -p0 102.6 -p1 -8.4 -di                       \ 
|nmrPipe -fn TP \ 
|nmrPipe -fn CBF \ 
|nmrPipe -fn LP -ord  8 -fb -after -x1 1 -xn 128 -pred 384     \ 
|nmrPipe -fn SP -size 512 -off 0.5 -end 0.95 -c 0.5  -pow 2     \ 
|nmrPipe -fn GM -g1 16 -g2 18 \ 
|nmrPipe -fn ZF -size 512                                   \ 
|nmrPipe -fn FT                                         \ 
|nmrPipe -fn PS -p0 87 -p1 0 -di                          \ 
|nmrPipe -fn TP -verb                                        \ 
 -ov -out $OUT 
 
NMRPipe script for processing 3D 15N-NOESY HSQC spectrum: 
 
FIN=ser 
OUT=ph.ft 
 
bruk2pipe -in $FIN   \ 
  -DMX -decim 2080 -bad 0.0 -dspfvs 20 -aswap  -grpdly 68      \ 
 -xN    1024       -yN     98         -zN     128        \ 
 -xT    512             -yT     49         -zT     64        \ 
 -xMODE DQD     -yMODE  Echo-Antiecho -zMODE  States-TPPI   \ 
 -xSW   5699.088        -ySW    9956.353        -zSW    5699.088      \ 
 -xOBS  599.9128226     -yOBS   150.8532966     -zOBS   599.9128226   \ 
 -xCAR  4.705       -yCAR   38.500         -zCAR   4.705      \ 
 -xLAB  H1         -yLAB   C13        -zLAB   H1        \ 
 -ndim  3          -aq2D  States-TPPI                 \ 
|nmrPipe -fn SP -size 512 -off 0.44 -end 1 -c 0.5 -pow 2           \ 
|nmrPipe -fn ZF -size 1024                                    \ 
|nmrPipe -fn FT                                           \ 
|nmrPipe -fn EXT -x1 10.0ppm -xn 0.0ppm -sw                  \ 
|nmrPipe -fn PS -p0 14 -p1 0 -di              \ 
127 
 
 
|nmrPipe -fn TP                                           \ 
|nmrPipe -fn SP -size 49 -off 0.44 -end 1 -c 0.5    \ 
|nmrPipe -fn ZF -size 98       \ 
|nmrPipe -fn FT                                           \ 
|nmrPipe -fn PS -p0 -90 -p1 0 -di      \ 
|nmrPipe -fn TP                                           \ 
|nmrPipe -fn ZTP -verb                                    \ 
|nmrPipe -fn SP -size 64 -off 0.44 -end 1 -c 0.5      \ 
|nmrPipe -fn ZF -size 128                                    \ 
|nmrPipe -fn FT -alt                                   \ 
|nmrPipe -fn PS -p0 0 -p1 0 -di            \ 
|nmrPipe -fn ZTP -verb                                    \ 
 -ov -out $OUT 
 
proj3D -y $OUT y.ft 
proj3D -z $OUT z.ft 
 
NMRPipe script for lineal predication of the same 3D 15N-NOESY HSQC spectrum: 
 
FIN=ph.ft        
OUT=lp.ft         
 
nmrPipe -in $FIN -fn TP      \ 
|nmrPipe -fn HT       \ 
|nmrPipe -fn FT -inv      \ 
|nmrPipe -fn LP -ord  8 -fb -after -x1 1 -xn 49 -pred 49 \ 
|nmrPipe -fn SP -size 98 -off 0.44 -end 1.0 -c 0.5  \ 
|nmrPipe -fn ZF -size 196     \ 
|nmrPipe -fn FT -di      \ 
|nmrPipe -fn TP -verb       \ 
|nmrPipe -fn ZTP      \ 
|nmrPipe -fn HT       \ 
|nmrPipe -fn FT -inv             \ 
|nmrPipe -fn LP -ord  8 -fb -after -x1 1 -xn 64 -pred 64 \ 
|nmrPipe -fn SP -size 128 -off 0.44 -end 1.0 -c 0.5  \ 
|nmrPipe -fn ZF -size 256     \ 
|nmrPipe -fn FT -di      \ 
|nmrPipe -fn ZTP -verb       \ 
 -out $OUT 
 
 
proj3D -y $OUT y_lp.ft 
proj3D -z $OUT z_lp.ft 
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APPENDIX C. GIT1 PBD ATOM ASSIGNMENTS 
 
        PPM           ASSIGNMENT
   1   7.897 0.000 H     135 
   2 126.468 0.000 N     135 
   3   7.883 0.000 H      83 
   4 125.278 0.000 N      83 
   7   8.291 0.000 H     103 
   8 125.145 0.000 N     103 
  11   8.672 0.000 H      20 
  12 124.211 0.000 N      20 
  13   8.007 0.000 H      50 
  14 124.059 0.000 N      50 
  15   8.317 0.000 H     104 
  16 123.920 0.000 N     104 
  17   8.346 0.000 H      24 
  18 123.856 0.000 N      24 
  23   8.581 0.000 H      30 
  24 123.388 0.000 N      30 
  31   8.033 0.000 H     121 
  32 122.993 0.000 N     121 
  33   8.587 0.000 H     105 
  34 122.967 0.000 N     105 
  35   8.306 0.000 H       5 
  36 122.988 0.000 N       5 
  39   8.405 0.000 H      28 
  40 122.794 0.000 N      28 
  41   8.267 0.000 H      76 
  42 122.591 0.000 N      76 
  43   7.936 0.000 H      45 
  44 122.669 0.000 N      45 
  47   8.418 0.000 H      10 
  48 122.292 0.000 N      10 
  53   8.728 0.000 H      81 
  54 122.083 0.000 N      81 
  55   8.011 0.000 H      13 
  56 122.081 0.000 N      13 
  57   7.429 0.000 H      33 
  58 122.009 0.000 N      33 
  61   8.147 0.000 H       8 
  62 121.678 0.000 N       8 
  63   7.924 0.000 H     102 
  64 121.689 0.000 N     102 
  67   8.372 0.000 H      85 
  68 121.571 0.000 N      85 
  69   7.236 0.000 H      94 
  70 121.359 0.000 N      94 
  75   8.489 0.000 H     111 
  76 121.215 0.000 N     111 
  77   9.016 0.000 H      56 
  78 121.204 0.000 N      56 
  81   8.052 0.000 H      54 
  82 121.063 0.000 N      54 
  87   8.015 0.000 H     118 
  88 120.681 0.000 N     118 
  89   8.437 0.000 H      41 
  90 120.682 0.000 N      41 
  91   8.516 0.000 H      53 
  92 120.580 0.000 N      53 
  93   8.175 0.000 H       6 
  94 120.567 0.000 N       6 
  95   8.630 0.000 H      23 
  96 120.513 0.000 N      23 
  97   7.726 0.000 H      78 
  98 120.454 0.000 N      78 
  99   8.561 0.000 H      89 
 100 120.428 0.000 N      89 
 101   8.470 0.000 H      52 
 102 120.430 0.000 N      52 
 105   8.111 0.000 H     124 
 106 120.377 0.000 N     124 
 109   8.013 0.000 H      35 
 110 120.035 0.000 N      35 
 111   7.616 0.000 H      51 
 112 120.073 0.000 N      51 
 113   8.927 0.000 H      60 
 114 120.063 0.000 N      60 
 115   8.727 0.000 H      37 
 116 119.920 0.000 N      37 
 117   8.609 0.000 H      16 
 118 119.823 0.000 N      16 
 119   7.661 0.000 H      26 
 120 119.721 0.000 N      26 
 121   8.131 0.000 H      84 
 122 119.692 0.000 N      84 
 125   8.541 0.000 H     122 
 126 119.565 0.000 N     122 
 127   6.977 0.000 H      42 
 128 119.540 0.000 N      42 
 129   8.338 0.000 H      65 
 130 119.466 0.000 N      65 
 131   8.137 0.000 H      86 
 132 119.413 0.000 N      86 
 133   8.474 0.000 H      31 
 134 119.378 0.000 N      31 
 139   8.787 0.000 H      17 
 140 119.201 0.000 N      17 
 141   7.739 0.000 H      73 
 142 119.184 0.000 N      73 
 143   8.356 0.000 H     127 
 144 119.183 0.000 N     127 
 145   7.684 0.000 H      75 
 146 119.215 0.000 N      75 
 147   7.886 0.000 H     107 
 148 118.991 0.000 N     107 
 153   8.046 0.000 H     112 
 154 118.971 0.000 N     112 
 155   7.544 0.000 H     109 
 156 118.956 0.000 N     109 
 159   8.300 0.000 H     120 
 160 118.879 0.000 N     120 
 161   8.561 0.000 H      34 
 162 118.829 0.000 N      34 
 163   7.426 0.000 H      92 
 164 118.651 0.000 N      92 
 165   7.643 0.000 H      91 
 166 118.674 0.000 N      91 
 169   8.046 0.000 H     132 
 170 118.473 0.000 N     132 
 175   7.902 0.000 H     110 
 176 118.092 0.000 N     110 
 179   8.463 0.000 H      69 
 180 117.889 0.000 N      69 
 181   8.307 0.000 H      66 
 182 117.625 0.000 N      66 
 185   7.485 0.000 H      29 
 186 117.483 0.000 N      29 
 187   7.674 0.000 H      87 
 188 117.356 0.000 N      87 
 189   8.377 0.000 H      57 
 190 117.109 0.000 N      57 
 191   8.769 0.000 H      49 
 192 117.127 0.000 N      49 
 193   7.589 0.000 H      40 
 194 116.950 0.000 N      40 
 195   7.241 0.000 H      25 
 196 116.846 0.000 N      25 
 197   7.961 0.000 H     123 
 198 116.721 0.000 N     123 
 199   8.055 0.000 H      22 
 200 116.329 0.000 N      22 
 201   6.722 0.000 H      72 
 202 116.163 0.000 N      72 
 203   7.224 0.000 H      97 
 204 115.883 0.000 N      97 
 205   7.683 0.000 H      63 
 206 115.860 0.000 N      63 
 209   8.104 0.000 H      80 
 210 115.198 0.000 N      80 
 211   8.398 0.000 H      82 
 212 115.020 0.000 N      82 
 215   7.408 0.000 H      39 
 216 115.011 0.000 N      39 
 217   8.215 0.000 H     108 
 218 114.766 0.000 N     108 
 219   8.000 0.000 H      48 
 220 114.588 0.000 N      48 
 221   9.056 0.000 H      74 
 222 114.360 0.000 N      74 
 223   7.942 0.000 H     130 
 224 114.070 0.000 N     130 
 225   7.857 0.000 H      88 
 226 114.030 0.000 N      88 
 227   8.278 0.000 H      90 
 228 113.793 0.000 N      90 
 229   8.678 0.000 H      15 
 230 113.474 0.000 N      15 
 231   7.827 0.000 H      44 
 232 113.311 0.000 N      44 
 235   7.913 0.000 H      61 
 236 112.714 0.000 N      61 
 237   7.827 0.000 H     129 
 238 112.785 0.000 N     129 
 239   8.906 0.000 H      12 
 240 111.652 0.000 N      12 
 241   8.038 0.000 H       7 
 242 108.338 0.000 N       7 
 243   7.397 0.000 H      93 
 244 107.623 0.000 N      93 
 245   9.256 0.000 H      46 
 246 118.748 0.000 N      46 
 247   7.583 0.000 H     113 
 248 117.871 0.000 N     113 
 251   8.378 0.000 H     128 
 252 120.424 0.000 N     128 
 253   8.839 0.000 H      27 
 254 114.868 0.000 N      27 
 255   8.668 0.000 H      99 
 256 111.031 0.000 N      99 
 257   9.363 0.000 H      70 
 258 128.644 0.000 N      70 
 269   8.543 0.000 H      43 
 270 118.477 0.000 N      43 
 272  57.437 0.000 CA    135 
 273  55.507 0.000 CA     83 
 276  52.440 0.000 CA    103 
 277  59.540 0.000 CA     50 
 279   7.715 0.000 H     100 
 280 125.137 0.000 N     100 
 282   7.717 0.000 H      68 
 283 124.945 0.000 N      68 
 285  50.341 0.000 CA    100 
 286  54.266 0.000 CA     68 
 288  65.977 0.000 CA     20 
 290  61.473 0.000 CA    104 
 291  59.607 0.000 CA     24 
 295  59.913 0.000 CA    105 
 296  65.296 0.000 CA     30 
 297   8.108 0.000 H     134 
 298 123.302 0.000 N     134 
 301   8.362 0.000 H      79 
 302 123.042 0.000 N      79 
 304  58.930 0.000 CA     79 
 306  59.919 0.000 CA     28 
 308  55.232 0.000 CA      5 
 310  58.161 0.000 CA     76 
 312  50.924 0.000 CA     10 
 314  55.128 0.000 CA    121 
 315  59.574 0.000 CA     45 
 317   7.756 0.000 H     106 
 318 122.150 0.000 N     106 
 319  57.679 0.000 CA    106 
 322  55.404 0.000 CA     81 
130 
 
 
 323  51.544 0.000 CA     13 
 326  57.954 0.000 CA     33 
 327   8.202 0.000 H     115 
 328 121.882 0.000 N     115 
 330  55.576 0.000 CA    115 
 332  52.888 0.000 CA      8 
 333   8.151 0.000 H      58 
 334 121.817 0.000 N      58 
 335  59.746 0.000 CA     58 
 338  61.676 0.000 CA    102 
 339   7.768 0.000 H      36 
 340 121.547 0.000 N      36 
 342  55.369 0.000 CA     36 
 346   7.769 0.000 H     131 
 347 121.795 0.000 N     131 
 349  57.782 0.000 CA    131 
 352   7.812 0.000 H      55 
 353 121.350 0.000 N      55 
 358   7.831 0.000 H      21 
 359 121.049 0.000 N      21 
 361  58.506 0.000 CA     21 
 362  55.025 0.000 CA     55 
 363   7.885 0.000 H     119 
 364 120.684 0.000 N     119 
 366  55.404 0.000 CA    119 
 367   7.895 0.000 H     133 
 368 120.783 0.000 N     133 
 370  56.059 0.000 CA    133 
 372  59.402 0.000 CA     94 
 374  59.471 0.000 CA     85 
 376  67.363 0.000 CA    111 
 378  67.398 0.000 CA     56 
 380  58.368 0.000 CA     54 
 382  65.881 0.000 CA    118 
 384  64.571 0.000 CA    128 
 386  58.644 0.000 CA     89 
 388  61.091 0.000 CA     53 
 390  66.433 0.000 CA     52 
 392  53.922 0.000 CA     41 
 394  54.473 0.000 CA      6 
 396  68.121 0.000 CA     23 
 398  57.920 0.000 CA     78 
 400  59.195 0.000 CA    124 
 402  59.371 0.000 CA     35 
 404  59.960 0.000 CA     51 
 406  55.304 0.000 CA     60 
 407  55.375 0.000 CA     37 
 410  66.443 0.000 CA     16 
 412  67.768 0.000 CA     26 
 414  61.643 0.000 CA     84 
 416  58.849 0.000 CA     86 
 426  58.133 0.000 CA    107 
 428  55.447 0.000 CA    122 
 430  59.422 0.000 CA     31 
 432  57.990 0.000 CA     42 
 435  58.635 0.000 CA     65 
 436  67.159 0.000 CA    127 
 438  59.602 0.000 CA    120 
 440  63.541 0.000 CA     75 
 442  60.676 0.000 CA     73 
 444  58.348 0.000 CA     91 
 447   7.479 0.000 H      32 
 448 118.878 0.000 N      32 
 451   7.486 0.000 H      62 
 452 119.030 0.000 N      62 
 456  59.315 0.000 CA    109 
 458  58.061 0.000 CA     92 
 459  65.690 0.000 CA    112 
 461   8.039 0.000 H      38 
 462 118.962 0.000 N      38 
 463  58.312 0.000 CA     38 
 465  57.990 0.000 CA     34 
 468  56.772 0.000 CA    132 
 470  58.506 0.000 CA    110 
 472  54.129 0.000 CA     69 
 474  52.785 0.000 CA     66 
 475   8.289 0.000 H     116 
 476 117.246 0.000 N     116 
 478  60.539 0.000 CA    116 
 480  66.915 0.000 CA     57 
 482  56.576 0.000 CA     29 
 484  59.850 0.000 CA     87 
 486  62.779 0.000 CA     49 
 488  58.713 0.000 CA     40 
 490  58.506 0.000 CA     25 
 492  59.367 0.000 CA    123 
 493   8.046 0.000 H     114 
 494 116.145 0.000 N     114 
 495  63.606 0.000 CA    114 
 498  57.541 0.000 CA     22 
 499  65.950 0.000 CA     72 
 503  53.336 0.000 CA     97 
 505  56.128 0.000 CA     63 
 507  56.645 0.000 CA     80 
 509  62.607 0.000 CA     82 
 511  55.542 0.000 CA     39 
 513  68.397 0.000 CA    108 
 515  64.330 0.000 CA     48 
 517  61.642 0.000 CA     74 
 519  64.916 0.000 CA    130 
 521  61.608 0.000 CA     88 
 523  64.571 0.000 CA     90 
 525  57.748 0.000 CA     15 
 527  59.540 0.000 CA     44 
 529  66.777 0.000 CA    129 
 531  46.167 0.000 CA     12 
 533  44.892 0.000 CA      7 
 535  63.434 0.000 CA     93 
 537  69.190 0.000 CA     46 
 539  59.126 0.000 CA    113 
 548  60.784 0.000 CA     61 
 550  67.076 0.000 CA     27 
 554  61.255 0.000 CA     70 
 565  55.948 0.000 CA     43 
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 568  30.457 0.000 CB    135 
 570  39.993 0.000 CB    103 
 571  18.203 0.000 CB     83 
 573  37.703 0.000 CB     20 
 574  29.255 0.000 CB     50 
 576  29.065 0.000 CB     24 
 577  38.910 0.000 CB    104 
 579  37.004 0.000 CB     30 
 581  18.203 0.000 CB    121 
 583  27.985 0.000 CB    105 
 585  42.149 0.000 CB      5 
 587  32.177 0.000 CB     28 
 589  36.115 0.000 CB     45 
 590  43.293 0.000 CB     10 
 593  18.394 0.000 CB     81 
 594  44.245 0.000 CB     13 
 596  41.768 0.000 CB     33 
 597  40.498 0.000 CB      8 
 599  29.763 0.000 CB     58 
 601  17.759 0.000 CB    115 
 603  34.083 0.000 CB    102 
 605  30.017 0.000 CB     85 
 607  32.304 0.000 CB     94 
 609  31.478 0.000 CB    111 
 611  30.907 0.000 CB     56 
 613  41.514 0.000 CB     54 
 615  38.148 0.000 CB    118 
 617  30.081 0.000 CB     41 
 619  30.145 0.000 CB     53 
 622  29.128 0.000 CB     89 
 624  38.211 0.000 CB     52 
 626  38.656 0.000 CB    128 
 628  41.196 0.000 CB      6 
 630  41.514 0.000 CB     78 
 632  27.858 0.000 CB    124 
 634  29.509 0.000 CB     35 
 636  32.050 0.000 CB     51 
 638  18.013 0.000 CB     60 
 640  17.695 0.000 CB     37 
 642  68.382 0.000 CB     16 
 644  31.859 0.000 CB     26 
 646  37.703 0.000 CB     84 
 647   7.884 0.000 H      59 
 648 119.783 0.000 N      59 
 649   7.825 0.000 H     125 
 650 119.193 0.000 N     125 
 651   7.881 0.000 H      77 
 652 119.581 0.000 N      77 
 653   7.841 0.000 H      19 
 654 119.337 0.000 N      19 
 660  58.312 0.000 CA    125 
 662  41.145 0.000 CB    125 
 663  66.552 0.000 CA     19 
 665  31.673 0.000 CB     19 
 667  59.745 0.000 CA     77 
 668  29.689 0.000 CB     77 
 669  32.505 0.000 CB     59 
 671  17.466 0.000 CB    122 
 673  29.817 0.000 CB     42 
 675  32.569 0.000 CB     65 
 677  68.600 0.000 CB    127 
 679  32.505 0.000 CB    120 
 681  41.401 0.000 CB     86 
 683  27.705 0.000 CB     31 
 685  28.921 0.000 CB     17 
 687  30.777 0.000 CB     73 
 690  42.297 0.000 CB    107 
 693  30.137 0.000 CB    132 
 695  37.625 0.000 CB    112 
 696  28.473 0.000 CB     38 
 697  28.217 0.000 CB    109 
 699  40.825 0.000 CB     34 
 701  32.249 0.000 CB     92 
 703  29.817 0.000 CB     91 
 705  28.537 0.000 CB    110 
 707  43.129 0.000 CB     69 
 709  30.201 0.000 CB     66 
 711  39.289 0.000 CB     29 
 713  29.433 0.000 CB     87 
 715  68.472 0.000 CB     57 
 719  36.089 0.000 CB     40 
 721  28.473 0.000 CB     25 
 723  31.801 0.000 CB    123 
 725  30.841 0.000 CB     22 
 727  27.897 0.000 CB    114 
 730  30.521 0.000 CB     97 
 732  40.313 0.000 CB     63 
 734  38.969 0.000 CB     80 
 737  30.073 0.000 CB     39 
 740  28.665 0.000 CB     48 
 742  62.520 0.000 CB     74 
 745  62.648 0.000 CB     88 
 747  26.938 0.000 CB     90 
 749  64.056 0.000 CB     15 
 753  64.056 0.000 CB     44 
 755  63.160 0.000 CB     61 
 757  68.856 0.000 CB    129 
 762  69.462 0.000 CB     93 
 764  28.874 0.000 CB     46 
 765  28.112 0.000 CB    113 
 768  68.216 0.000 CB     27 
 778  39.417 0.000 CB     43 
 780  19.386 0.000 CB     68 
 781  18.554 0.000 CB    100 
 783  56.378 0.000 CA    134 
 785  32.889 0.000 CB    134 
 787  42.489 0.000 CB     79 
 789  41.849 0.000 CB    106 
 794  41.785 0.000 CB     21 
 795  18.042 0.000 CB     55 
 796  17.338 0.000 CB     36 
 797  30.521 0.000 CB    131 
 800  32.569 0.000 CB    133 
 801  18.042 0.000 CB    119 
132 
 
 
 806  55.805 0.000 CA     62 
 808  29.369 0.000 CB     32 
 810  42.553 0.000 CB     62 
 812  36.985 0.000 CB    116 
 813   8.138 0.000 H     117 
 814 122.451 0.000 N     117 
 816  57.990 0.000 CA    117 
 818  39.929 0.000 CB    117 
 824  69.208 0.000 CB    130 
 825  22.283 0.000 CB    108 
 826  59.746 0.000 CA     59 
 827  59.693 0.000 CA     32 
 828  60.379 0.000 CA     17 
 833   3.975 0.000 HA     49 
 834   3.667 0.000 HA     27 
 835   4.090 0.000 HA     74 
 836   4.281 0.000 HA     15 
 837   4.435 0.000 HA     94 
 838   4.229 0.000 HA     33 
 839   3.382 0.000 HA     72 
 840   4.073 0.000 HA     25 
 841   2.473 0.000 HA     42 
 842   4.134 0.000 HA    135 
 844   4.582 0.000 HA    100 
 846   4.175 0.000 HA     50 
 847   4.665 0.000 HA    103 
 848   3.592 0.000 HA     20 
 849   4.061 0.000 HA     24 
 850   4.134 0.000 HA    104 
 851   4.300 0.000 HA    134 
 853   4.040 0.000 HA     28 
 854   4.311 0.000 HA      5 
 855   3.831 0.000 HA     76 
 856   4.029 0.000 HA    121 
 857   4.290 0.000 HA     45 
 858   4.811 0.000 HA     13 
 859   4.519 0.000 HA    117 
 860   3.790 0.000 HA    102 
 861   3.977 0.000 HA     58 
 862   4.842 0.000 HA      8 
 863   3.988 0.000 HA     85 
 864   3.287 0.000 HA    111 
 865   3.824 0.000 HA    115 
 866   3.985 0.000 HA     54 
 867   3.578 0.000 HA    118 
 868   4.038 0.000 HA    124 
 869   4.517 0.000 HA      6 
 870   4.001 0.000 HA     35 
 871   3.790 0.000 HA    128 
 872   4.401 0.000 HA     41 
 873   3.485 0.000 HA     52 
 874   3.972 0.000 HA     53 
 875   4.183 0.000 HA     89 
 876   3.826 0.000 HA     23 
 877   4.103 0.000 HA     37 
 878   3.679 0.000 HA     16 
 879   3.943 0.000 HA    122 
 880   3.877 0.000 HA     31 
 881   3.957 0.000 HA     65 
 882   3.805 0.000 HA    127 
 883   3.892 0.000 HA    120 
 884   4.343 0.000 HA     43 
 885   3.783 0.000 HA     34 
 886   4.255 0.000 HA     84 
 888   3.528 0.000 HA     19 
 889   4.052 0.000 HA    125 
 890   3.950 0.000 HA     59 
 891   3.965 0.000 HA     77 
 892   4.665 0.000 HA     97 
 893   4.207 0.000 HA     39 
 895   4.540 0.000 HA     29 
 896   3.789 0.000 HA     40 
 897   3.862 0.000 HA     87 
 898   3.942 0.000 HA    113 
 899   3.978 0.000 HA     91 
 900   4.055 0.000 HA    110 
 901   4.191 0.000 HA    132 
 902   4.191 0.000 HA    107 
 903   3.236 0.000 HA    112 
 904   3.876 0.000 HA     38 
 905   4.280 0.000 HA     82 
 906   4.138 0.000 HA     90 
 907   3.745 0.000 HA    108 
 908   4.238 0.000 HA     48 
 909   4.280 0.000 HA     80 
 910   4.065 0.000 HA    130 
 912   4.590 0.000 HA     44 
 913   3.923 0.000 HA    129 
 914   4.380 0.000 HA     61 
 915   4.438 0.000 HA     63 
 917   4.196 0.000 HA     22 
 918   3.949 0.000 HA    123 
 919   3.922 0.000 HA     57 
 920   4.488 0.000 HA     69 
 921   4.238 0.000 HA     81 
 922   3.390 0.000 HA     56 
 923   4.144 0.000 HA     83 
 924   3.760 0.000 HA     46 
 925   3.982 0.000 HA     60 
 926   3.834 0.000 HA     17 
 927   4.236 0.000 HA    105 
 928   3.622 0.000 HA     30 
 929   5.008 0.000 HA     10 
 930   4.172 0.000 HA     78 
 931   4.288 0.000 HA    133 
 932   4.119 0.000 HA     55 
 933   4.119 0.000 HA     21 
 934   4.151 0.000 HA    131 
 935   4.098 0.000 HA    106 
 936   4.109 0.000 HA     36 
 937   4.056 0.000 HA     51 
 938   3.389 0.000 HA     26 
 939   4.214 0.000 HA     75 
 940   3.749 0.000 HA     73 
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 941   3.961 0.000 HA    109 
 942   4.013 0.000 HA     62 
 944   4.130 0.000 HA     92 
 946   3.887 0.000 HA      7 
 949   3.738 0.000 HA3    12 
 951   4.574 0.000 HA     66 
 952   4.320 0.000 HA    116 
 953   3.950 0.000 HA     93 
 976   1.760 0.000 HB    128 
 977   1.887 0.000 HB    131 
1374  29.671 0.000 CD    120 
1375   1.507 0.000 HB     83 
1376   2.877 0.000 HB2   103 
1377   2.423 0.000 HB3   103 
1378   1.874 0.000 HB     20 
1379   1.689 0.000 HG12   20 
1380   1.084 0.000 HG13   20 
1382   0.746 0.000 HD1    20 
1383   0.860 0.000 HG2    20 
1384   2.083 0.000 HB3    50 
1385   1.891 0.000 HB3   135 
1386   2.065 0.000 HB2   135 
1387   4.305 0.000 HB    127 
1388   4.248 0.000 HB    129 
1389   4.279 0.000 HB    130 
1390   1.836 0.000 HB3   132 
1391   2.081 0.000 HB2   132 
1392   1.848 0.000 HB3   133 
1393   1.766 0.000 HB2   133 
1394   1.766 0.000 HB3   134 
1395   1.848 0.000 HB2   134 
1397   2.055 0.000 HB3   124 
1398   2.162 0.000 HB2   124 
1399   1.861 0.000 HB    123 
1400   1.376 0.000 HB    122 
1401   1.483 0.000 HB    121 
1402   1.873 0.000 HB    120 
1403   4.310 0.000 HA    119 
1404   1.536 0.000 HB    119 
1405   1.876 0.000 HB    118 
1406   2.674 0.000 HB3   117 
1407   2.976 0.000 HB2   117 
1408   3.117 0.000 HB    116 
1409   1.325 0.000 HB    115 
1412   4.198 0.000 HA    114 
1413   3.077 0.000 HB2   114 
1414   2.712 0.000 HB3   114 
1415   2.152 0.000 HB    113 
1416   1.700 0.000 HB    112 
1417   2.014 0.000 HB    111 
1418   1.987 0.000 HB3   110 
1419   2.235 0.000 HB2   110 
1420   1.316 0.000 HB    108 
1421   1.651 0.000 HB    107 
1422   1.563 0.000 HB    106 
1423   2.247 0.000 HB    105 
1424   2.805 0.000 HB    104 
1425   1.359 0.000 HB    102 
1426   3.761 0.000 HA3    99 
1427   3.999 0.000 HA2    99 
1430   4.365 0.000 HB     93 
1431   1.761 0.000 HB     91 
1432   2.000 0.000 HB     92 
1434   3.120 0.000 HB2    90 
1435   2.473 0.000 HB3    90 
1437   1.872 0.000 HB3    89 
1438   2.005 0.000 HB2    89 
1439   3.976 0.000 HA     88 
1440   3.814 0.000 HB     88 
1441   1.964 0.000 HB     87 
1443   3.124 0.000 HB3    84 
1444   3.939 0.000 HB     82 
1445   1.518 0.000 HB     81 
1446   2.735 0.000 HB2    80 
1447   2.630 0.000 HB3    80 
1453   1.526 0.000 HB3    79 
1454   3.721 0.000 HA     79 
1455   1.995 0.000 HB2    79 
1456   1.799 0.000 HB     78 
1457   1.918 0.000 HB     77 
1460   1.381 0.000 HB3    76 
1461   1.627 0.000 HB2    76 
1462   3.764 0.000 HB3    75 
1463   3.837 0.000 HB2    75 
1464   3.867 0.000 HB     74 
1465   1.876 0.000 HB     73 
1466   2.215 0.000 HB     72 
1467   1.253 0.000 HB3    69 
1468   1.903 0.000 HB2    69 
1469   3.952 0.000 HA     68 
1470   1.281 0.000 HB     68 
1473   1.804 0.000 HB2    62 
1474   0.977 0.000 HB3    62 
1476   4.005 0.000 HB     61 
1477   1.489 0.000 HB     60 
1480   1.904 0.000 HB     59 
1484   1.843 0.000 HB3    58 
1485   2.074 0.000 HB2    58 
1487   2.162 0.000 HB     56 
1488   1.443 0.000 HB     55 
1489   1.757 0.000 HB     54 
1492   3.243 0.000 HB2    53 
1493   3.155 0.000 HB3    53 
1494   1.823 0.000 HB     52 
1497   1.820 0.000 HB3    51 
1498   2.035 0.000 HB2    51 
1499   2.194 0.000 HB2    50 
1502   3.588 0.000 HB2    45 
1503   3.296 0.000 HB3    45 
1506   4.087 0.000 HB2    44 
1507   3.972 0.000 HB3    44 
1508   2.575 0.000 HB     43 
1509   2.356 0.000 HB3    42 
1512   1.523 0.000 HB3    41 
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1513   1.829 0.000 HB2    41 
1516   3.239 0.000 HB2    40 
1517   3.150 0.000 HB3    40 
1520   1.787 0.000 HB3    39 
1521   2.196 0.000 HB2    39 
1522   2.128 0.000 HB3    38 
1523   2.205 0.000 HB2    38 
1526   1.324 0.000 HB     37 
1527   1.637 0.000 HB     36 
1528   1.850 0.000 HB     35 
1531   1.367 0.000 HB3    34 
1532   1.791 0.000 HB2    34 
1535   1.996 0.000 HB2    33 
1536   1.333 0.000 HB3    33 
1539   2.229 0.000 HB     31 
1541   2.095 0.000 HB     30 
1542   2.613 0.000 HB     29 
1543   1.844 0.000 HB     28 
1544   3.674 0.000 HB     27 
1545   2.414 0.000 HB     26 
1546   2.177 0.000 HB3    25 
1549   2.169 0.000 HB2    24 
1550   2.065 0.000 HB3    24 
1553   1.658 0.000 HB3    21 
1554   1.868 0.000 HB2    21 
1556   2.122 0.000 HB     19 
1559   3.983 0.000 HB     16 
1560   3.973 0.000 HB     15 
1562   2.577 0.000 HB      6 
1563   1.563 0.000 HB      5 
1570   4.221 0.000 HB     23 
1571   1.809 0.000 HB3    22 
1572   2.000 0.000 HB2    22 
1573   3.761 0.000 HB     49 
1576   3.039 0.000 HB2    48 
1577   2.727 0.000 HB3    48 
1578  62.831 0.000 CB     49 
1579   1.759 0.000 HB     65 
1585  45.269 0.000 CA     99 
1587   2.261 0.000 HG    135 
1588  34.300 0.000 CG    135 
1589   1.428 0.000 HG    134 
1590  24.676 0.000 CG    134 
1591   1.641 0.000 HD    134 
1592  28.937 0.000 CD    134 
1593   2.964 0.000 HE    134 
1594  42.260 0.000 CE    134 
1595   1.447 0.000 HG    133 
1596  24.667 0.000 CG    133 
1597   1.642 0.000 HD    133 
1599  29.073 0.000 CD    133 
1600   2.915 0.000 HE    133 
1601  42.150 0.000 CE    133 
1602   2.155 0.000 HG3   132 
1603   2.320 0.000 HG2   132 
1604  36.114 0.000 CG    132 
1605   1.652 0.000 HG3   131 
1606   1.693 0.000 HG2   131 
1607  27.185 0.000 CG    131 
1608   3.155 0.000 HD    131 
1609  43.478 0.000 CD    131 
1610   1.227 0.000 HG2   130 
1611  21.382 0.000 CG2   130 
1612   1.288 0.000 HG2   129 
1613  22.431 0.000 CG2   129 
1614   0.864 0.000 HG2   128 
1615  18.025 0.000 CG2   128 
1616   1.109 0.000 HG13  128 
1617   1.672 0.000 HG12  128 
1618  29.099 0.000 CG1   128 
1619   0.700 0.000 HD1   128 
1620  14.109 0.000 CD1   128 
1622   1.185 0.000 HG2   127 
1623  21.522 0.000 CG2   127 
1624   2.379 0.000 HG3   124 
1625   2.486 0.000 HG2   124 
1626  33.977 0.000 CG    124 
1627   1.370 0.000 HG    123 
1628  24.948 0.000 CG    123 
1629   1.610 0.000 HD    123 
1630  29.213 0.000 CD    123 
1631   2.877 0.000 HE    123 
1632  42.080 0.000 CE    123 
1633   1.445 0.000 HG    120 
1634  24.715 0.000 CG    120 
1635   0.667 0.000 HD1   118 
1636  17.676 0.000 CD1   118 
1639   0.862 0.000 HG2   118 
1640   1.088 0.000 HG13  118 
1642   1.681 0.000 HG12  118 
1643  29.213 0.000 CG1   118 
1644  18.095 0.000 CG2   118 
1645   2.407 0.000 HG    113 
1646  33.968 0.000 CG    113 
1648   0.704 0.000 HD1   112 
1649   0.655 0.000 HG2   112 
1650   1.004 0.000 HG13  112 
1651  17.466 0.000 CG2   112 
1652   1.560 0.000 HG12  112 
1653  27.046 0.000 CG1   112 
1654  14.040 0.000 CD1   112 
1655   0.815 0.000 HG2   111 
1656   0.354 0.000 HG1   111 
1657  20.892 0.000 CG1   111 
1658  23.479 0.000 CG2   111 
1659   2.383 0.000 HG    110 
1660  34.038 0.000 CG    110 
1662   2.219 0.000 HB    109 
1663   2.456 0.000 HG    109 
1664  33.968 0.000 CG    109 
1665   0.858 0.000 HD2   106 
1666   0.804 0.000 HD1   106 
1667   1.531 0.000 HG    106 
1668  27.046 0.000 CG    106 
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1669  23.410 0.000 CD1   106 
1670  24.668 0.000 CD2   106 
1671   2.370 0.000 HG3   105 
1672   2.451 0.000 HG2   105 
1673  34.108 0.000 CG    105 
1674   0.162 0.000 HG1   102 
1675   0.631 0.000 HG2   102 
1676  20.752 0.000 CG1   102 
1677  20.822 0.000 CG2   102 
1679   2.064 0.000 HB     94 
1680   0.892 0.000 HG1    94 
1681   0.898 0.000 HG2    94 
1682  20.892 0.000 CG1    94 
1683  20.719 0.000 CG2    94 
1684   1.364 0.000 HG2    93 
1685  22.640 0.000 CG2    93 
1686   1.688 0.000 HG     92 
1687  25.787 0.000 CG     92 
1688   1.582 0.000 HD     92 
1689  29.213 0.000 CD     92 
1690   2.914 0.000 HE     92 
1691  42.150 0.000 CE     92 
1692   1.676 0.000 HG     91 
1693  27.116 0.000 CG     91 
1694   3.152 0.000 HD     91 
1695  43.478 0.000 CD     91 
1696   2.326 0.000 HG     89 
1697  36.276 0.000 CG     89 
1698   2.319 0.000 HG     87 
1699  34.178 0.000 CG     87 
1700   4.005 0.000 HA     86 
1701   2.057 0.000 HB     86 
1702   1.551 0.000 HG     86 
1703  27.046 0.000 CG     86 
1704   0.769 0.000 HD1    86 
1705   0.801 0.000 HD2    86 
1706  25.158 0.000 CD1    86 
1707  25.437 0.000 CD2    86 
1708   2.000 0.000 HB     85 
1709   1.677 0.000 HG     85 
1710  28.025 0.000 CG     85 
1711   3.220 0.000 HD     85 
1712  43.478 0.000 CD     85 
1713   3.190 0.000 HB2    84 
1714  63.337 0.000 CB     82 
1715   0.804 0.000 HG     79 
1716  26.766 0.000 CG     79 
1717   0.901 0.000 HD     79 
1718  25.158 0.000 CD1    79 
1719   1.699 0.000 HG     78 
1720  27.093 0.000 CG     78 
1721   0.867 0.000 HD1    78 
1722   0.893 0.000 HD2    78 
1723  24.528 0.000 CD2    78 
1724  24.109 0.000 CD1    78 
1726   1.563 0.000 HG3    77 
1727   1.753 0.000 HG2    77 
1728  27.046 0.000 CG     77 
1729   3.158 0.000 HD     77 
1730  43.408 0.000 CD     77 
1731  41.829 0.000 CB     76 
1732   1.354 0.000 HG     76 
1733  27.255 0.000 CG     76 
1734   0.548 0.000 HD1    76 
1735   0.595 0.000 HD2    76 
1736  22.780 0.000 CD2    76 
1737  23.200 0.000 CD1    76 
1738  60.400 0.000 CB     75 
1739   3.192 0.000 HD3    73 
1740   3.312 0.000 HD2    73 
1741  43.528 0.000 CD     73 
1742   1.649 0.000 HG3    73 
1743   1.702 0.000 HG2    73 
1744  28.164 0.000 CG     73 
1745  31.731 0.000 CB     72 
1746   0.707 0.000 HG1    72 
1747   1.007 0.000 HG2    72 
1748  21.871 0.000 CG1    72 
1749  24.109 0.000 CG2    72 
1750   1.662 0.000 HG     69 
1752   0.905 0.000 HD1    69 
1753   0.926 0.000 HD2    69 
1754  27.232 0.000 CG     69 
1755  23.252 0.000 CD1    69 
1756  25.130 0.000 CD2    69 
1757   1.503 0.000 HB3    66 
1758   1.729 0.000 HB2    66 
1759   1.323 0.000 HG3    66 
1760   1.390 0.000 HG2    66 
1761  27.331 0.000 CG     66 
1762   3.002 0.000 HD     66 
1763  43.519 0.000 CD     66 
1764   2.965 0.000 HE     65 
1765   1.433 0.000 HG     65 
1766  24.676 0.000 CG     65 
1767   1.640 0.000 HD     65 
1768  28.950 0.000 CD     65 
1769  42.224 0.000 CE     65 
1770   2.964 0.000 HB3    63 
1771   0.736 0.000 HG     62 
1772  26.425 0.000 CG     62 
1773   0.698 0.000 HD1    62 
1774  21.957 0.000 CD1    62 
1776   2.385 0.000 HG3    59 
1777   2.446 0.000 HG2    59 
1778  33.936 0.000 CG     59 
1779   2.490 0.000 HG     58 
1780  36.720 0.000 CG     58 
1781   1.106 0.000 HG2    57 
1782  21.374 0.000 CG2    57 
1783   0.805 0.000 HG1    56 
1784   0.963 0.000 HG2    56 
1785  21.050 0.000 CG1    56 
1786  24.417 0.000 CG2    56 
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1787   1.700 0.000 HG     54 
1788  27.108 0.000 CG     54 
1789   0.866 0.000 HD1    54 
1790   0.894 0.000 HD2    54 
1791  24.047 0.000 CD1    54 
1792  24.522 0.000 CD2    54 
1794   0.823 0.000 HG2    52 
1797  17.885 0.000 CG2    52 
1798   0.701 0.000 HD1    52 
1799  16.697 0.000 CD1    52 
1801   1.841 0.000 HG1    52 
1802  32.368 0.000 CG1    52 
1804   1.442 0.000 HG     51 
1805  24.808 0.000 CG     51 
1806   1.643 0.000 HD     51 
1807  29.025 0.000 CD     51 
1808   2.918 0.000 HE3    51 
1809   2.963 0.000 HE2    51 
1810  42.202 0.000 CE     51 
1811   2.390 0.000 HG     50 
1812  34.036 0.000 CG     50 
1814   2.228 0.000 HB     46 
1815   0.865 0.000 HG1    46 
1816   0.939 0.000 HG2    46 
1817  20.962 0.000 CG1    46 
1818  24.407 0.000 CG2    46 
1819   1.268 0.000 HG3    41 
1820   1.351 0.000 HG2    41 
1821  24.689 0.000 CG     41 
1822   1.603 0.000 HD     41 
1823  29.258 0.000 CD     41 
1824   2.912 0.000 HE3    41 
1825   2.961 0.000 HE2    41 
1826  42.124 0.000 CE     41 
1827   2.365 0.000 HG     39 
1828  36.359 0.000 CG     39 
1829   2.406 0.000 HG3    38 
1830   2.453 0.000 HG2    38 
1831  33.970 0.000 CG     38 
1832   1.522 0.000 HG3    35 
1833   1.677 0.000 HG2    35 
1834  27.220 0.000 CG     35 
1835   3.154 0.000 HD     35 
1836  43.417 0.000 CD     35 
1837   0.601 0.000 HD1    34 
1838   0.704 0.000 HD2    34 
1839  22.790 0.000 CD1    34 
1840   1.631 0.000 HG     34 
1843  26.798 0.000 CG     34 
1845  25.462 0.000 CD2    34 
1846   1.140 0.000 HG     33 
1847   0.555 0.000 HD1    33 
1848  27.149 0.000 CG     33 
1850  23.181 0.000 CD1    33 
1851   0.597 0.000 HD2    33 
1852  22.790 0.000 CD2    33 
1853   4.016 0.000 HA     32 
1854   2.148 0.000 HB2    32 
1855   2.389 0.000 HG2    32 
1856  36.276 0.000 CG     32 
1857   2.076 0.000 HB3    32 
1858   2.209 0.000 HG3    32 
1859   2.375 0.000 HG     31 
1860  34.066 0.000 CG     31 
1861   1.702 0.000 HG12   30 
1862   1.007 0.000 HG13   30 
1863   0.751 0.000 HG2    30 
1864  17.256 0.000 CG2    30 
1865   0.791 0.000 HD1    30 
1866  13.061 0.000 CD1    30 
1867  28.968 0.000 CG1    30 
1868   2.907 0.000 HE3    28 
1869  42.083 0.000 CE     28 
1870   1.607 0.000 HD3    28 
1871  29.300 0.000 CD     28 
1873  24.980 0.000 CG     28 
1874   1.635 0.000 HD2    28 
1875   1.447 0.000 HG2    28 
1876   1.505 0.000 HG3    28 
1877   2.960 0.000 HE2    28 
1878   1.157 0.000 HG2    27 
1879  21.664 0.000 CG2    27 
1880   0.761 0.000 HG1    26 
1881   0.965 0.000 HG2    26 
1882  21.746 0.000 CG1    26 
1883  23.338 0.000 CG2    26 
1884   2.454 0.000 HG2    25 
1885  33.964 0.000 CG     25 
1886   2.407 0.000 HG3    25 
1887   2.219 0.000 HB2    25 
1888   2.379 0.000 HG     24 
1889  36.250 0.000 CG     24 
1890  67.532 0.000 CB     23 
1891   1.110 0.000 HG2    23 
1892  21.382 0.000 CG2    23 
1893   3.149 0.000 HE     22 
1894  43.408 0.000 CE     22 
1895   1.670 0.000 HD     22 
1896  27.185 0.000 CD     22 
1897   1.693 0.000 HG     22 
1898  25.927 0.000 CG     22 
1899   0.869 0.000 HD1    21 
1900  24.039 0.000 CD1    21 
1901   0.893 0.000 HD2    21 
1902  24.528 0.000 CD2    21 
1904  27.084 0.000 CG     21 
1905   1.701 0.000 HG     21 
1908  29.913 0.000 CG1    20 
1909  13.200 0.000 CD1    20 
1910  17.046 0.000 CG2    20 
1911   1.000 0.000 HG1    19 
1912   1.006 0.000 HG2    19 
1913  22.361 0.000 CG1    19 
1914  24.109 0.000 CG2    19 
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1915   1.878 0.000 HB3    17 
1916   2.329 0.000 HG     17 
1917  34.248 0.000 CG     17 
1919   1.949 0.000 HB2    17 
1920   1.190 0.000 HG2    16 
1921  23.002 0.000 CG2    16 
1922   2.458 0.000 HB3     8 
1923   2.633 0.000 HB2     8 
1924   1.413 0.000 HB3    13 
1925   1.638 0.000 HB2    13 
1926   0.983 0.000 HD1    13 
1928   1.179 0.000 HD2    13 
1929   1.826 0.000 HG     13 
1930  32.710 0.000 CG     13 
1931  26.276 0.000 CD1    13 
1932  23.689 0.000 CD2    13 
1934   0.802 0.000 HD1     5 
1935   0.856 0.000 HD2     5 
1936  23.410 0.000 CD1     5 
1937  24.598 0.000 CD2     5 
1938   1.542 0.000 HG      5 
1939  27.046 0.000 CG      5 
1940   2.533 0.000 HB3    10 
1941   2.764 0.000 HB2    10 
1942   1.814 0.000 HB3    97 
1943   1.987 0.000 HB2    97 
1944   2.089 0.000 HG3    97 
1945   2.128 0.000 HG2    97 
1946  35.577 0.000 CG     97 
1947   1.342 0.000 HB    100 
1966   2.027 0.000 HB3     9 
1968  62.814 0.000 CA      9 
1969  31.987 0.000 CB      9 
1970   1.689 0.000 HB2     9 
1971   4.486 0.000 HA      9 
1972   1.895 0.000 HG3     9 
1974  27.325 0.000 CG      9 
1975   3.626 0.000 HD3     9 
1976   3.764 0.000 HD2     9 
1977  50.541 0.000 CD      9 
1978   1.995 0.000 HG2     9 
1979 135.248 0.000 N       9 
1995   4.431 0.000 HA     14 
1996  61.366 0.000 CA     14 
1997   2.036 0.000 HB3    14 
1998   1.751 0.000 HB2    14 
1999  32.500 0.000 CB     14 
2000   2.883 0.000 HD3    14 
2001   3.140 0.000 HD2    14 
2002  50.191 0.000 CD     14 
2003   0.444 0.000 HG3    14 
2004   1.013 0.000 HG2    14 
2005  26.137 0.000 CG     14 
2006 132.305 0.000 N      14 
2007   4.404 0.000 HA     47 
2009  66.226 0.000 CA     47 
2010   2.326 0.000 HB2    47 
2011   1.993 0.000 HB3    47 
2012  30.472 0.000 CB     47 
2013   3.562 0.000 HD3    47 
2014   3.640 0.000 HD2    47 
2015  49.142 0.000 CD     47 
2016   2.093 0.000 HG3    47 
2017   2.269 0.000 HG2    47 
2018  27.955 0.000 CG     47 
2019 137.322 0.000 N      47 
2020   4.413 0.000 HA     64 
2021   2.373 0.000 HB     64 
2022  62.467 0.000 CA     64 
2023  32.710 0.000 CB     64 
2024   1.989 0.000 HG2    64 
2025  28.164 0.000 CG     64 
2026   3.571 0.000 HD3    64 
2027   3.615 0.000 HD2    64 
2028  50.471 0.000 CD     64 
2029   1.951 0.000 HG3    64 
2030 134.870 0.000 N      64 
2031   4.541 0.000 HA     67 
2032   2.474 0.000 HB2    67 
2033   1.700 0.000 HB3    67 
2034  62.888 0.000 CA     67 
2036  32.080 0.000 CB     67 
2037 136.983 0.000 N      67 
2038   4.295 0.000 HA     71 
2039   1.627 0.000 HB3    71 
2040   2.355 0.000 HB2    71 
2041  65.950 0.000 CA     71 
2042  31.448 0.000 CB     71 
2044  28.164 0.000 CG     71 
2045   3.671 0.000 HD3    71 
2046   3.788 0.000 HD2    71 
2047  50.471 0.000 CD     71 
2048   1.947 0.000 HG3    71 
2049   1.999 0.000 HG2    71 
2050 133.890 0.000 N      71 
2051   4.286 0.000 HA     96 
2052   1.936 0.000 HB3    96 
2053   2.237 0.000 HB2    96 
2054  63.986 0.000 CA     96 
2055  31.737 0.000 CB     96 
2056   3.627 0.000 HD3    96 
2057   3.759 0.000 HD2    96 
2058  50.471 0.000 CD     96 
2059   1.951 0.000 HG3    96 
2060   1.995 0.000 HG2    96 
2063  27.395 0.000 CG     96 
2064 133.852 0.000 N      96 
2066 140.076 0.000 N      95 
2067   4.395 0.000 HA    101 
2068   1.818 0.000 HB3   101 
2069   2.164 0.000 HB2   101 
2070  62.917 0.000 CA    101 
2071  31.923 0.000 CB    101 
2072   3.576 0.000 HD3   101 
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2073   3.763 0.000 HD2   101 
2074  50.331 0.000 CD    101 
2075   1.947 0.000 HG3   101 
2076   1.996 0.000 HG2   101 
2077  27.325 0.000 CG    101 
2078 134.908 0.000 N     101 
2079   4.258 0.000 HA     98 
2080   1.854 0.000 HB3    98 
2081   2.246 0.000 HB2    98 
2082  64.020 0.000 CA     98 
2083  31.673 0.000 CB     98 
2084   3.633 0.000 HD3    98 
2085   3.762 0.000 HD2    98 
2086  50.471 0.000 CD     98 
2087   1.949 0.000 HG3    98 
2088   1.998 0.000 HG2    98 
2089  27.325 0.000 CG     98 
2090 135.889 0.000 N      98 
2091   4.604 0.000 HA     11 
2092   2.100 0.000 HB     11 
2093  63.331 0.000 CA     11 
2094  32.313 0.000 CB     11 
2095   3.834 0.000 HD3    11 
2096   3.951 0.000 HD2    11 
2097 138.303 0.000 N      11 
2103  50.680 0.000 CD     11 
2104   1.914 0.000 HG     11 
2105  26.067 0.000 CG     11 
2200   7.484 0.000 H      18 
2201 119.075 0.000 N      18 
2202   4.471 0.000 HA     18 
2204  57.452 0.000 CA     18 
2206  40.268 0.000 CB     18 
2207   2.476 0.000 HB3    18 
2208   2.696 0.000 HB2    18 
2224   6.614 0.000 HD2    29 
2239   7.242 0.000 HD1    40 
2249   7.037 0.000 HD1    45 
2280   7.298 0.000 HE     63 
2330   6.853 0.000 HD1   104 
2343   7.081 0.000 HD    116 
2361   8.134 0.000 H     126 
2362 121.593 0.000 N     126 
2365  67.315 0.000 CA    126 
2366  31.682 0.000 CB    126 
2367   3.520 0.000 HA    126 
2368   2.278 0.000 HB    126 
2369   0.879 0.000 HG1   126 
2370   1.037 0.000 HG2   126 
2371  24.038 0.000 CG2   126 
2372  21.229 0.000 CG1   126 
2387   3.849 0.000 HA2    12 
2394   0.828 0.000 HD1   107 
2395  25.481 0.000 CD1   107 
2396   1.687 0.000 HG    107 
2397  27.301 0.000 CG    107 
2403   7.136 0.000 HD     63 
2404   2.834 0.000 HB2    63 
2405   6.703 0.000 HE    116 
2406   6.353 0.000 HE1    42 
2407   2.460 0.000 HB2    42 
2408   7.156 0.000 HD     84 
2409   6.778 0.000 HE     84 
2410   6.740 0.000 HD2    53 
2411   4.232 0.000 HB     57 
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